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1. Introduction 
 
All organisms, including bacteria and highly complex species like mammalians and 
humans, own mechanisms to detect and process stimuli from their environment, which 
finally trigger a physiological reaction. This happens with support of complex networks, 
the so called signalling cascades, which were adapted to the living- and environmental 
conditions of the respective species during evolution and which ensured its survival and 
reproducibility.  
The first step in these signalling cascades is the detection of the outer stimulus by a 
receptor that is often located in the cell membrane. The membrane is therefore often 
called “the interface” to the environment. A super-family of such transmembrane 
receptors, which is widespread in higher organisms with more than 2000 members, is 
the rhodopsin-like seven-transmembrane-helix-receptors or G-protein coupled 
receptors (GCPRs)1. The second name is related to the fact that these receptors interact 
in their active state with a guanine nucleotide-binding proteins that conveys the signal 
from the receptor to a variety of effectors that belong to the signalling cascade inside 
the cell. Other members of this family include odorant and taste sensors1, hormone- as 
well as neurotransmitter receptors2 and light-receptors3. Light-receptors, like 
rhodopsins, can be found as photosensitive pigments in all three kingdoms of life: 
eukaryotes, archea and eubacteria. Due to the fact that they react to experimentally easy 
and exact manageable light instead of chemical substances, they often are used as model 
systems for the whole class of rhodopsin-like seven-helix-receptors.  
In contrast to rhodopsins from higher organisms, which bind the G-protein transducin 
and initiate an electro-physiological reaction that finally leads to nerve impulses, sensory 
rhodopsins from archea are simpler and therefore more accessible for investigations. 
These proteins exhibit the same structural features as those found in other rhodopsins: 
They consist of seven transmembrane helices that form a binding pocket for the 
covalently attached retinal-chromophore, which is bound to a conserved lysine residue 
via a protonated Schiff base (sb). The irradiation with visible light leads to the activation 
of these pigments, which subsequently undergo a cyclic reaction, the ‘photo-cycle’. The 
primitive vision process of bacteria, phototaxis, is relatively easy to investigate in 
Halobacterium salinarum or Natronobacterium pharaonis. Under constant light conditions the 
flagellar bundle, which is responsible for locomotion, changes its rotary direction 
approximately every ten seconds. This leads to an undirected random motion of the 
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bacterium4. Irradiation with blue light increases the frequency of change of the rotary 
direction, whereas orange light decreases this frequency. As a result the bacterium 
directs its motion away from blue to orange light, which is used by the light-driven ion-
pumps bacteriorhodopsin (BR) and halorhodopsin (HR) (figure 1.1)5,6. These bacterial 
rhodopsins, which show similar structural features, utilise sunlight to generate energy for 
the translocation of protons (BR) respectively chloride anions (HR) across the cell 
membrane. The proton-motive force so produced is used for ATP-synthesis. 
 
 
 
Figure 1.1. Schematic representation7 of the four archeabacterial rhodopsins.  
The illustration (taken from Klare, 2002) of the sensory 
rhodopsins SRI and SRII with their cognate transducers HtrI 
and HtrII in 2:2 stoichiometry is based on publications from 
Chen and Spudich8 as well as Gordeliy et al.9. The extra-cellular 
side is at the top. 
 
In H.salinarum the sensory rhodopsins SRI and SRII were identified as being responsible 
for phototactic behaviour10. SRI is predominantly expressed by the organism under 
anaerobic conditions, mediates the photophilic response of the bacterium towards 
orange light as well as a photophobic answer in a two-photon process, towards blue 
light. Under aerobic conditions the bacterium utilises the photophobic SRII receptor to 
avoid blue light11,12.  
Archeabacterial as well as eucaryotic rhodopsins have the above-mentioned 
chromophore-retinal as prosthetic group. It is bound via a Schiffs base to helix VII (also 
called helix G) and on light stimulus changes its conformation. In case of eukaryotic 
rhodopsin this conformational change occurs from the 11-cis ground state to an all-trans 
excited state. However, the archeabacterial rhodopsins are different: the all-trans ground 
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state undergoes an isomerization after photon absorption to a 13-cis state. In addition 
the chromophore does not dissociate from the protein after the absorption of a 
photon, but thermally relaxes in a cyclic reaction to an all-trans ground state. This 
photocycle was studied in detail for the photophobic SRII receptor13 (figure 1.2), the 
sensory rhodopsin I14 as well as for the cognate ion pumps BR15 and HR16.  
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Figure 1.2. Model of the photocycle13 (taken from Chizhov, 1998) of the photophobic 
receptor SRII from N.pharaonis based on a sequence of irreversible 
reactions. Absorbance maxima of the spectral intermediates K, L, M, N 
and O are indexed13,17. 
 
After photo-excitation the protein undergoes several intermediate states that can be 
spectroscopically distinguished and analysed by their different absorption maxima. In 
the case of NpSRII the photocycle can be described as follows: The absorption of a 
single photon leads to a 13-cis isomerisation of the chromophore (NpSRII→K). After 
approximately one microsecond the protein reacts with conformational changes (K→L). 
These changes alter the affinity of several residues towards protons leading to the 
donation of the Schiff base proton to Asp75 in the extra-cellular proton channel of the 
protein. At this point a proton is released into the medium at the extracellular site 
(L→M). After that, the cytoplasmic proton-channel opens and the Schiff base becomes 
re-protonated (M→N→O). Finally, the retinal re-isomerises and the protein relaxes to 
the ground state (O→NpSRII). 
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The knowledge about the response of the receptor to orange light is related to the 
question - ‘which photo intermediate serves as signalling state of the receptor?’. Initial 
investigations reported that the signalling state is initiated by the deprotonation of the 
Schiff base and is maintained until the relaxation of the protein to the ground-sate18-20. 
Therefore the M-state and the following intermediates would be the signalling state. 
Later EPR experiments with higher time resolution21 allowed to correlate the formation 
of the signalling state to the UV-spectroscopically silent transition between the early and 
the late M intermediate. 
The mechanism of signal transduction from the receptor to the inner cell is an object of 
interest in recent investigations, which still remains unclear. The sensory rhodopsins 
form a stable complex with a transducer molecule in the cell membrane. Yao and 
Spudich (1992)22 identified an open reading frame encoding for a putative transducer 
protein. This HtrI protein23 consists of two transmembrane helices and a huge 
cytoplasmic domain. It was shown later that the genes encoding for HsSRII and NpSRII 
as well as their respective transducer proteins are located together in one operon23,24. All 
identified transducers are highly homologous to the eubacterial chemoreceptors, like the 
aspartate- (Tar) or the serine-receptor (Tsr) from E.coli, which leads to the assumption 
that both classes of proteins, the methyl accepting chemotaxis proteins (MCPs) and the 
Htrs, are structurally related as well. Especially for the cytoplasmic domain a remarkable 
homology between both classes is found. 
The signal transduction observed in prokaryotic chemotaxis is analogous to 
archeabacterial phototaxis. Rudolph and Oesterheld25,26 were able to show that a 
signalling cascade similar to the eubacterial system exists in H.salinarum. A deletion of 
the archeabacterial Che-operon that was named according to the prokaryotic system 
proofed that the identified phosphorylation cascade is involved in the phototaxis signal 
transduction: This deletion led to the loss of the chemo- as well as the phototactic 
properties of the bacterium. A schematic representation of the signal transduction 
components is given in figure 1.3.  
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Figure 1.3. Illustration9 (taken from Gordeliy, 2002) of the two-component signalling 
cascade including a model of the receptor-transducer complex, the 
homo-dimeric histidine kinase CheA, the scaffolding protein CheW and 
the receptor, the aspartate kinase Che Y and the 
methyltransferase/methylesterase CheR respectively CheB. 
 
The scaffolding protein CheW mediates the interaction between the histidine kinase 
CheA and the cytoplasmic domain of the chemoreceptor/transducer. In case of a 
“negative” signal, namely binding of a repellent molecule or activation of the 
photophopic receptor, CheA is activated and therefore autophosphorylated. The 
phosphate is then transferred to the response regulator CheY, an aspartate kinase. Only 
phosphorylated CheY is able to bind to the FliM proteins of the flagellar motor. 
According to the so-called stochastic model27 this binding increases the energy level of 
the clockwise turning state of the motor and simultaneously decreases the energy level 
of the counter-clockwise state. The more of the 30 binding sites are occupied by 
phosphorylated CheY the more the equilibrium is shifted to the clockwise rotation state 
of the flagellar motor leading to a tumbling motion of the E.coli bacterium. A “positive” 
signal inhibits the auto-phosphorylation of CheA, the phosphorylated CheY level 
decreases due to an auto-dephosphorylation activity of CheY and due to the activity of 
the phosphatase CheZ. This leads to a decreasing occupancy of the FliM proteins and a 
favoured counter-clockwise rotation of the flagellar motor. As a result a continuous 
swimming motion of the bacterium is observed. 
CheA can phosphorylate as well the methylesterase CheB that subsequently 
demethylates the chemoreceptor protein. This demethylation decreases the auto-
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phosphorylation activity of CheA and is therefore part of a feedback mechanism. This 
allows the bacterium to maintain the capability to direct its motion to more favourable 
conditions independent of the local concentration of a repellent or attractive substance 
or the local intensity of a repellent or attractive intensity of light.  
The analogy between the two signal transduction pathways of photo- and chemotaxis, 
allows transferring the knowledge about the better-understood conformational changes 
of the chemoreceptors to the less understood conformational changes in the phototactic 
transducers. The question of the conformational changes that are involved in 
transmembrane signal transduction is intensively discussed. Chervitz and Falke 
preferred based on X-ray crystallography, 19F NMR investigations and many disulfide 
cross-linking experiments with the aspartate receptor from E.coli the so-called 
“swinging-piston”-model. In this model the binding of aspartic acid induces a 
displacement of helix α4 (TM2) relative to the other helices and orthogonal to the plane 
described by the membrane. They observed a displacement of approximately 1.6 Å into 
the direction of the cytoplasm in combination with a tilt of the helix of about 5°28. This 
hypothesis, is supported by EPR experiments, which suggest such a translational motion 
as well; however without evidences for an additional tilt29,30. Nevertheless these 
investigations do not exclude an additional swinging motion.  
It remains unclear, if these conformational changes are transferred to the cytoplasm. 
The authors of the X-ray crystallography studies28 as well as the authors of the EPR 
studies29 assume a transduction of this “signal” along the whole cytoplasmic domain due 
to the rigidity of α–helices. A prerequisite for influencing the histidine kinase activity is 
therefore a motif that links the aspartate- and the CheA binding domain. Sequence 
analysis31 and further cross-linking experiments32 produced hints for the presence of two 
amphiphatic helices, nevertheless they did not yield any information about the spatial 
arrangement of these helices.  
Weis et al.33 used electron microscopy to examine ordered assemblies of the serine 
receptor in membrane extracts isolated from cells engineered to overproduce the 
receptor. The authors report that the measured receptor length is ca. 20 % shorter than 
that described for the model of Kim et al.34 and suggest a more compact arrangement of 
the polypeptide in the linker region (figure 1.4), which provides a plausible explanation 
for the discrepancy.  
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Figure 1.4 Electron micrograph33 (taken from Weis, 2003) of an isolated serine receptor. 
bilayer specimen p, periplasmic ligand binding domain; b, membrane bilayer; 
c, cytoplasmic domain; o, zone of overlap; l, linker domain; scale bar, 25 nm. 
The measured receptor length is ca. 20 % shorter than that described for the 
model of Kim et al.34 suggesting a more compact arrangement of the 
polypeptide in the linker region (l). 
 
However, the transfer of results obtained for chemoreceptors towards Htrs is limited by 
the fact that sequence alignments of MCPs and Htrs revealed an up to 105 amino acid 
long sequence insertion into the transducers starting from the end of the second 
amphiphatic helix19,31.  
This insertion is reported for archeabacterial phototransducers HtrI and HtrII as well as 
for the Htrs IV-VI26 from H.salinarum and for the MCPs from Caulobacter crescentus35. 
This leads to the question about how these additional amino acids influence the process 
of signal transduction and how signal domains with different structures undergo 
comparable conformational changes that regulate the activity of the bound CheA.  
In summary the homology of Htr transducers to chemoreceptors and the requirement 
of Che proteins in the signalling cascade support a similar pathway in both haloarcheal 
phototaxis and bacterial chemotaxis. Nevertheless, the exact structural bases of the 
signal transfer from the phototaxis receptor to the transmembrane domain of its 
cognate transducer and hence the CheA binding domain is still unclear.  
An important step in understanding the structural basis of signal transduction in 
archeabacterial phototaxis was the determination of the crystal structure of sensory 
rhodopsin II alone36,37 and co-crystallized with a truncated transducer variant comprising 
the two transmembrane helices TM1 and TM2 and a short 30 amino acids part of the 
cytoplasmic linker domain9.  
The structure shows the receptor helices F and G tightly interacting with the transducer 
helices TM1 and TM2 within the membrane (figure 1.5, panel A). 
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Figure 1.5. Panel A. Side view9 (taken from Gordeliy, 2002) of the complex of SRII 
and HtrII from N.pharaonis. CS, cytoplasmic side; ES, extra-
cellular side. 
Panel B. Illustration7 (taken from Klare, 2002) of the signalling com- 
plex from N.pharaonis including a modelled full-length 
transducer based on the X-ray crystal structure of the 
archeabacterial transmembrane part (Gordeliy et al.9) and of 
the cytoplasmic part of the aspartate receptor from E.coli 
(Kim et al.34). The unknown structure of the linker domain is 
hidden by the question mark. 
 
 
This recent study and the observation that the SRII activation causes an outward 
movement of helix F19,20 results in a displacement of transducer helix TM29. This 
motion of TM2 is likely to be the common determinant of CheA kinase activity 
modulation.  
This view is further supported by experiments with chimeric fusion proteins10. These 
chimeras contained the SRII fused to the transmembrane domain of the transducer 
HtrII, in which post-TM2 domains were replaced with cytoplasmic signalling and 
adaptation domains of E.coli chemotaxis receptors. These constructs were able to 
mediate a phototaxis responses in E.coli cells, which was shown with in vivo swimming 
experiments and with in vitro phosphorylation assays38.  
In summary all these studies9,10,19,20,38 provide a detailed insight into the structural and 
functional organisation of the transmembrane signal-generating domain of the receptor-
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transducer unit and the cytoplasmic signalling and adaptation domain. Nevertheless, 
until now almost no structural information is available about the linker domain between 
these two units. By transmitting the conformational changes of the transmembrane 
domain to the cytoplasmic signalling kinase and methyl-acceptor domains, the linker has 
an important role in signal uptake and propagation.  
Interestingly, a structural linker element between a sensor and a transmitter module is 
widely found in histidine kinases, adenylyl cyclases, methyl-accepting proteins and 
phosphatases, therefore these linkers were named HAMP domains39. Although the 
primary sequence homology among predicted HAMP linkers is low, they all share 
similar helix-turn-helix folds based on secondary structure prediction40. Mutational40 and 
cysteine scanning32 analysis revealed biased signalling modes, suggesting that the linker 
plays an active role in signal transduction rather than being just a simple structural 
connecting element. The wide distribution of the HAMP linkers, not only in different 
sensors but also in all three kingdoms of life39, eukaryotes, archea and eubacteria, 
suggests that they share a common mechanism for signal transduction. 
Altogether the exact mechanism of the archeabacterial phototaxis still remains 
mysterious particularly in the area concerning signal propagation from the receptor unit 
to the signalling domain. New insights in this field are not only important for 
understanding phototaxis but can also contribute to the understanding of signal 
transduction in general. 
 
The aim of this project was to build the foundation for further structural investigations 
of the photophobic receptor-transducer-complex from N.pharaonis. Crystallography9 
yielded insights into the structural and functional organisation of the transmembrane 
domains of the complex components. Nevertheless, it did not provide any information 
about the structure of the C-terminal cytoplasmic fragment. In order to determine its 
structure, magic angle spinning solid state NMR (MAS ssNMR) spectroscopy would be 
applied. A semi-synthetic access to a domain-specific isotope labelled HtrII protein 
would be established to improve the spectral resolution of applied MAS ssNMR.  
In a first step special attention was paid to the generation of an isotope labelled peptide 
comprising the cytoplasmic part of the transducer with an N-terminal cysteine, which 
was subsequently fused to the recombinant transmembrane domain of the transducer 
protein using the Expressed Protein Ligation method. Furthermore the obtained 
proteins were characterised using a receptor binding assay and first NMR experiments. 
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In addition the influence of the formation of the receptor-transducer complex on the 
process of signal transduction in this functional unit would be investigated applying 
steady state and time-resolved rapid-scan FTIR spectroscopy. 
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2. Material and Methods 
2.1 Chemicals 
 
All chemicals were purchased from following companies with highest purity available: 
 
Supplier Compound 
Amersham Pharmacia (Freiburg, 
Germany) 
GSH-Sephadex Fast Flow, low molecular weight 
protein ladder, pGEX-2T1 and -4T1 vectors  
Applichem (Darmstadt, Germany) ammonium sulfate, methanol, IPTG 
Baker (Griesheim, Germany) ammonium chloride, chloroform, diethyl ether, 
ethanol, hydrochloric acid, magnesium sulfate 
heptahydrate, potassium dihydrogenphosphate, 
2-propanol, sodium chloride, sodium hydroxide, 
urea, 
Boehringer Ingelheim (Mannheim, 
Germany) 
Expand high fidelity DNA polymerase 
Calbiochem (Darmstadt, Germany) DDM, GdmHCl 
Fluka (Neu-Ulm, Germany) DIEA, disodium molybdate dihydrate, p-cresol, 
L-histidine, manganese(II) chloride tetrahydrate, 
nickel(II) chloride hexahydrate, TCEP 
euriso-top (Saarbrücken, Germany) u-[13C] D-glucose, [15N] ammonium chloride, 
[D] chloroform, [D3] methanol OH, [D] formic 
acid OH 
Gibco (Eggenstein, Germany) yeast extract, peptone 140, T4 DNA ligase, 
1 kbp DNA ladder 
Gerbu (Gaiberg, Germany) ampicillin, kanamycin sulfate, EDTA 
Merck (Darmstadt, Germany) ammonium persulfate, calcium chloride dihydrate, 
copper(II) chloride dihydrate, disodium hydro-
genphosphate, ferric(II) sulfate heptahydrate, HF, 
imidazole 
New England Biolabs (Schwalbach, 
Germany) 
DNA restriction enzymes, pTXB1 vector 
Novabiochem (Schwalbach, 
Germany) 
BOC protected amino acid building blocks and 
resins for solid phase peptide synthesis, HBTU 
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Promchem (Wesel, Germany) acetonitrile 
Qiagen (Hilden, Germany) plasmid purification kit, DyeEx Spin Kit, gel 
extraction kit, Ni-NTA Superflow 
Roth (Karlsruhe, Germany), bis-tris, D2O, TFA  
Serva (Heiselberg, Germany) agarose, boric acid, bromphenol blue, Coomassie 
blue R250, Triton X-100, xylencyanol,  
Sigma (Steinheim, Germany). ε-amino-n-caproic acid, cobalt(II) chloride 
hexahydrate, α-cyano-4-hydroxy cinnamic acid, 
ethidium bromide, D-glucose, 1-mono-oleoyl-rac-
glycerol 
 
Table 2.1. Chemicals. 
 
 
2.2 General instrumentation 
 
Incubation of cells was performed under aerobic conditions in an incubator from New 
Brunswick (Nürtingen, Germany). For electroporation a GenePulser from Bio-Rad 
(Munich, Germany) with electroporation cuvettes from Invitrogen (Leek, Netherlands) 
was used. Centrifugation usually was performed using eppendorf bench top centrifuges 
5 415 C, D (Cologne, Germany) or Allegra X-15R centrifuge with SX4750A rotor 
(Beckman Coulter, Palo Alto, CA, USA). Preparative ultracentrifugation was carried out 
in a L-80 XP Ultracentrifuge with 45Ti/70Ti rotors (Beckman Coulter, Palo Alto, CA, 
USA). For cell harvesting an Avanti J-20 XP centrifuge with JLA 8.1 000 rotor 
(Beckman Coulter, Palo Alto, CA, USA) was used. Cell lysis was done in a 
Microfluidizer M-110S from Microfluidics Corporation (Newton, MA, USA). 
Polymerase chain reactions were performed using OmniGene Temperature Cycler with 
lid heating and in-tube temperature control from Hybaid (Heidelberg, Germany). SDS 
polyacrylamide gel electrophoresis was carried out on Mini-Protean 3 systems from Bio-
Rad (Munich, Germany). High performance liquid chromatography was performed 
using System Gold facilities from Beckman Coulter (Palo Alto, CA, USA) with either 
analytical Prontosil 120-5 C18 column (Bischoff, Leonberg, Germany) or semi-
preparative Ultrasphere 120-5 C18 from Beckman Coulter (Palo Alto, CA, USA). 
Measurements of pH were done with a PHM 62 Standard pH-Meter from Radiometer 
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(Copenhagen, Denmark). Deionized water (ddH2O) was made with an apparatus from 
Milipore (Eschborn, Germany). Dialysis tubes MWCO 3.5 kDa and 12-14 kDa were 
from Spectrum (Gardena, CA, USA). Mass spectra were measured with a LCQ mass 
spectrometer from Finnigan (Bremen, Germany) or a Voyager-DE Pro MALDI-TOF 
mass spectrometer from Perseptive Biosystems (Weiterstadt, Germany). 
 
 
2.3 Bacteria, plasmids and oligodesoxynucleotides 
 
E.coli X1-Blue:  F’::Tn 10 proA+B+ lacIq ∆(lacZ)M15/recA1 endA1 
gyrA96(Nalr) thi hsdR17 (rk- mk+) supE44 relA1 lac 41 
E.coli BL21(DE3):  F- ompT[lin] hsdSB(rB-mB-) λ(DE3) 42 
pET19btev+pARG  provided by A.J. Scheidig43,44 
pET27bmod psopII his19 Wegener et al., 2000 
pET27bmod phtrII11419 Wegener et al., 2000 
pET27bmod phtrII114 G84C provided by J.P. Klare  
pET27bmod phtrII15719 Wegener et al., 2000 
pGEX-2T-1/4T-1 Amersham Pharmacia (Freiburg, Germany) 
pRPS1    provided by R.P. Seidel23 
pTXB1   New England Biolabs (Schwalbach, Germany)45 
pTXB1his modified vector from New England Biolabs with a 
histidine-tag between Mxe intein and CBD (provided by 
R.P. Seidel) 
The following oligodesoxynucleotides were purchased from MWG Biolabs (Ebersberg, 
Germany): 
htr_ndeI_rev 5’-CAA TAA CAC CAT ATG TCG CTG AAC GTA TCA CG-3’ 
sapI_htr_for 5’-AGC GAG GCG GCT CTT CCG CAG CCC AGC GTG GCA G-3’ 
TEV_htr_for 5’-CGC GGA TCC GAA AAC CTT TAT TTT CAG TGT GAC ACC 
GCC GCC TGC CTT TC-3’ 
Xa_htr_rev 5’-CGG AAT TCT CAT CAC TCG CGA CGG GTC TCA AGC TCG 
ACA TC-3’ 
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2.4 Solid phase peptide synthesis 
 
The peptides HtrII(84-109)NBD G84C, HtrII(84-113) and HtrII(84-113) G84C were 
made by solid phase peptide synthesis46 using the in situ neutralization and HBTU 
activation protocol for BOC protected amino acids47. The peptides were synthesized on 
a preloaded BOC-amino acid-OCH2-phenylacetamidomethyl (PAM) solid support. 
Reactive side chains of tri-functional amino acids were protected as follows: Arg(Tos), 
Asp(OcHx), Cys(pMeBzl), Glu(OcHx), His(DNP), Lys(2-Cl-Z), Ser(Bzl) and Thr(Bzl). 
The side chains of all other amino acids were unprotected. The syntheses were usually 
performed in 0.2 mmole scale in glass vessels with filter funnel (pore-size 2) and vacuum 
connection. The preloaded resin was swollen for 20 minutes in DMF. The N-terminal 
BOC protecting group of the first amino acid was removed by rinsing the resin two 
times with neat TFA followed by incubation with TFA (2 x 1 min) and two subsequent 
washing steps with DCM (1 x 1 min) followed by DMF (1 x 1 min). The amino acids (2 
mmoles, 10 equivalents) were activated with 3.8 ml of 0.5 M HBTU solution in DMF in 
presence of 1 ml DIEA immediately before coupling. For activation only 1.9 mmole 
HBTU were used to prevent blocking of the unprotected α-amino group of the N-
terminal amino acid by a tetramethylguanidine hydrochloride moiety with excess 
HBTU47. All couplings were monitored by Kaiser tests48 and repeated if necessary. For 
the non-natural amino acid L-BOC-Dab(Fmoc)-OH the coupling time was prolonged 
from 12 min to 1 hour. In order to achieve fluorescent labelling of the Dab residue, the 
orthogonal Fmoc-protecting group of the γ-amino moiety was removed after 
completion of the synthesis by rinsing the resin twice with 2 ml 20 % piperidine in 
DMF followed by a 3 min and 30 min treatment with 20 % piperidine in DMF. After a 
1 min washing step with DMF (1 x 1 min) deprotection was monitored by the Kaiser 
test. The unprotected γ-amino-moiety was reacted with 1 mmole NBD chloride in the 
presence of 0.5 mmole DIEA for 30 min. Subsequently the resin was washed with DMF 
and a ninhydrine test was performed to verify successful fluorescence labelling.  
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2.4.1 Deprotection and HF cleavage 
 
Before removing the peptides from the solid support, all DNP protecting groups of 
histidine residues were cleaved off. Therefore the resin was incubated 2 x 1 min with a 
solution of 21 ml DMF, 6 ml β-mercaptoethanol and 3 ml DIEA followed by two 
washing steps with DMF and DCM. The N-terminal BOC group was then removed 
according to the above-mentioned protocol and the resin was washed with DCM and 
dried in vacuum. In order to cleave the synthesized peptide from the solid support, the 
resin was treated with neat HF at 0 °C in presence of 5 % p-cresol as a scavenger49. 
After removing HF in vacuum the crude peptide was precipitated with ice-cold diethyl 
ether, transferred on a glass filter funnel and washed with ice-cold diethyl ether. The 
precipitate was dissolved in 50 % acetonitrile in water containing 0.1 % TFA, separated 
from the polymer support by filtration and lyophilized. 
 
 
2.4.2 Peptide purification 
 
All peptide purifications were performed using reversed phase high performance liquid 
chromatography (RP-HPLC). Therefore the lyophilized crude peptide was dissolved in 
6 M guanidine hydrochloride, 100 mM sodium phosphate, pH 8.0 and loaded on a semi-
preparative C18 column (Beckman Coulter, Palo Alto, CA, USA). Elutions were 
performed using linear solvent gradients starting with 25 % solvent B (acetonitrile, 
0.08 % TFA) in solvent A (water, 0.1 % TFA) to 38 % B in 13 min, monitoring 
absorbance at 214 nm (and 480 nm for the NBD-labelled peptide). Fractions containing 
the desired peptide were pooled, lyophilized and stored at –20 °C in the dark. 
 
 
2.5 Biological methods 
2.5.1 Cell culture 
 
E.coli XL1 blue bacteria were cultured in LB medium (10 g peptone, 5 g yeast extract, 
10 g sodium chloride per litre ddH2O, pH 7.2). Ampicillin or kanamycin was added as 
selection markers in 100 µg/l respectively 50 µg/l concentrations. Cell densities were 
determined by measuring the turbidity of the medium at 578 nm. 
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2.5.2 Agarose gel electrophoresis 
 
DNA was separated by horizontal gel electrophoresis using gels with 0.7 % to 2 % 
agarose in TBE buffer (89 mM TrisHCl, 89 mM boric acid, 0.9 mM EDTA, 0.6 mg/l 
ethidium bromide, pH 8.9). Before separation, the samples were mixed with 3x sample 
buffer (TBE buffer, 10 % ficoll, 0.025 % bromphenol blue, 0.025 % xylencyanol). 
 
 
2.5.3 Purification and isolation of DNA fragments 
 
The desired DNA fragment was cut out of the agarose gel and extracted using the 
QIAquick gel extraction kit from Qiagen (Hilden, Germany). 
 
 
2.5.4 Isolation of plasmid DNA 
 
Preparation of plasmid DNA was performed using a modified plasmid midi-prep-kit 
(Qiagen, Hilden, Germany). After cell lysis and protein precipitation the cleared 
cytoplasmic supernatant was incubated with 10 µg/ml Rnase A for one hour at 37 °C 
and subsequently purified using the provided anion exchange column. The purified 
plasmid DNA was additionally precipitated with ice-cold ethanol and washed with 70 % 
ethanol in water. 
 
 
 
2.5.5 Polymerase chain reaction (PCR) 
 
The amplification of DNA fragments was carried out using the polymerase chain 
reaction50 using 10 ng DNA, 10 pmole 5’- and 3’-oligodesoxynucleotides, 5 nmoles 
dNTPs and 1.7 U expand high fidelity polymerase in 50 µl scale. Thermocycling was 
performed in a thermocycler with lid heating and in tube temperature control. The 
polymerase was added after a first denaturing step at 95 °C for 3 min and followed by a 
cooling step on ice. Optimal hybridization temperature was calculated according to the 
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base composition of the oligodesoxynucleotides51. The thermocycling for the different 
amplifications was chosen as follows: 
htr(1-83)    20x (95 °C for 15 sec, 72 °C for 70 sec) 
tevhtr(84-114) G84C  5x   (95 °C for 15 sec, 45 °C for 30 sec, 72 °C for 30 sec) 
    15x (95 °C for 15 sec, 65 °C for 30 sec, 72 °C for 30 sec) 
The first denaturing step was extended to 1 min at 95 °C. 
 
 
2.5.6 DNA sequencing 
 
DNA sequencing was performed using the ABI Prism BigDye Terminator Cycle 
Sequencing Ready Reaction Kit and a DNA-Sequencer Model 373 (Applied Biosystems, 
Weiterstadt, Germany). Sample purification after thermocycling was purified using the 
DyeEx Spin Kit (Qiagen, Hilden, Germany) after the addition of Dextran blue. 
 
 
2.5.7 DNA restriction 
 
DNA (0.2 to 1 µg) was incubated in presence of the corresponding restriction enzymes 
in 10 µl scale for one hour at 37 °C. The amount of used enzyme was calculated 
according to the standard given by the manufacturer. In order to prevent unspecific 
DNA cleavage, glycerol concentrations above 5 % were avoided. 
 
 
2.5.8 DNA ligation 
 
DNA ligation was carried out using 100 ng digested vector and 3 molar equivalents of 
digested DNA fragment in the presence of 1 U T4 DNA ligase buffered with T4 DNA 
ligase buffer (50 mM TrisHCl, 10 mM MgCl2, 1 mM ATP, 1 mM DTT, 5 % PEG 8 000, 
pH 7.6) in 20 µl scale. After 3 h of incubation at 37 °C the reaction mix was diluted with 
3 volumes of sterile ddH2O. 
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2.5.9 Transformation 
 
For transformation of plasmid DNA into E.coli cells electroporation was used52. 75 µl 
suspension of electro-competent cells52 containing 10 % glycerol were mixed with 20 µl 
of diluted DNA ligation mix on ice in an electroporation cuvette. After an electrostatic 
discharge (2 mm electrode gap, 800 Ω ohmic resistors, 1.5 kV voltages and 25 µF 
capacities) the mixtures were suspended in 0.5 ml antibiotic free LB medium and 
incubated for 1 h at 37 °C and 150 rpm. Selection was carried out on either 100 mg/l 
ampicillin or 50 mg/l kanamycin containing agar plates. 
 
 
2.6 Biochemical methods 
2.6.1 Protein expression and purification  
2.6.1.1 Htr-MxeCBD fusion protein 
 
As pre-culture 2 ml LB medium, 2 µl 100 g/l ampicillin were inoculated with a single 
colony BL21(DE3) pTXB1hishtr and shaken at 37 °C and 150 rpm for approximately 
8 h. For expressions in 12 l-scale 250 ml overnight culture (250 LB, 0.25 ml 100 g/l 
ampicillin) were mixed with 0.25 ml of pre-culture (1/1000) and incubated overnight at 
37 °C and 150 rpm. 6 x 2 l cultures (12 l LB, 12 ml 100 g/l ampicillin) in 5 l flasks with 
indications were inoculated with over night culture to a cell density of OD578=0.05 and 
incubated at 37 °C and 150 rpm. The addition of 0.5 mM IPTG at OD578=0.8-1.0 
induced expression and incubation was continued at 37 °C and 150 rpm. Cells were 
harvested after 3 h, washed in approximately 100-150 ml cell washing buffer (150 mM 
NaCl, 25 mM NaPi, 2 mM EDTA, pH 8.0) and stored at –80 °C. 
 
 
2.6.1.1.1 Purification of HtrMxeCBD from membranes 
 
Cells were suspended in cell washing buffer (150 mM NaCl, 25 mM NaPi, 2 mM 
EDTA, pH 8.0), 5 ml per gram cells, and lysed using a microfluidizer with 900 kPa pre-
pressure. Membrane components were separated immediately by centrifugation (45Ti or 
70Ti rotor, 45 000 rpm, 4 °C, 1 h). Supernatant was discarded and the obtained pellet 
homogenized (5 ml per gram cells) in solubilisation buffer Amem (300 mM NaCl, 50 mM 
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NaPi, 5 mM imidazole, 2 % DDM, pH 8.0) and moderately stirred overnight at 4 °C. 
Insoluble components were removed by centrifugation (45Ti or 70Ti rotor, 45 000 rpm, 
4 °C, 1 h).  
The clear solubilisate was loaded on a 10 ml 1 x 15 cm Ni-NTA FPLC column 
equilibrated in Bmem (300 mM NaCl, 50 mM NaPi, 0.05 % DDM, pH 8.0). After a first 
washing step with Bmem the column was washed with 10 % Dmem (300 mM NaCl, 50 mM 
NaPi, 200 mM imidazole, 0.05 % DDM, pH 8.0) in Bmem (corresponds to 20 mM 
imidazole). Elution was achieved by washing with 50 ml 100 % Dmem with a flow-rate of 
2 ml/min. HtrMxeCBD fusion protein containing fractions were pooled and 
concentrated up to 3 g/l using a 30 kDa MWCO and dialysed against 100 volumes Bmem 
without stirring (due to protein precipitation) using a 12-14 kDa MWCO tube at 4 °C. 
The yield was spectroscopically determined at a wavelength of 280 nm. Therefore a 
sample was diluted 1:10 with 6 M guanidine hydrochloride, 100 mM NaPi, pH 7.5 
(A280=0.993 corresponded to a concentration of 1 g/l, calculation: Expasy ProtParam 
algorithm53) 
 
 
2.6.1.1.2 Purification of Htr-MxeCBD from inclusion bodies 
 
Cells were suspended in cell washing buffer (150 mM NaCl, 25 mM NaPi, 2 mM 
EDTA, pH 8.0), 5 ml per gram cells, and lysed using a microfluidizer with 900 kPa pre-
pressure. Cytoplasma was removed immediately by centrifugation (45Ti or 70Ti rotor, 
20 000 rpm, 4 °C, 1 h) and the obtained pellet was washed four times in approximately 
50-60 ml cell washing buffer containing 0.25 % Triton X-100 followed by two washing 
steps with cell washing buffer to remove excessive detergent. Inclusion bodies were 
obtained as off-white pellets and were stored in 0.5 g portions at –80 °C. 
Inclusion bodies (0.5 g) were dissolved in 10 ml denaturing buffer (6 M guanidine 
hydrochloride, 50 mM NaPi, 10 mM TCEP, 0.1 % DDM, pH 8.0) and stirred at RT 
over night. Insoluble components were removed by centrifugation (70Ti, 35000 rpm, 
4 °C, 30 min). Refolding of the denatured protein was initiated by dialysis (3.5 kDa 
MWCO) against 500 ml folding buffer 8M (8 M urea, 300 mM NaCl, 50 mM NaPi, 
20 mM L-histidine, 1 mM TCEP, 0.02 % DDM, pH 8.0) at RT for 2-3 h with moderate 
stirring.  
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The urea concentration was lowered stepwise by buffer exchange to 6 M, 4 M, 3 M and 
to 2 M. These dialysis steps were performed at 4 °C for 2-3 h without stirring. The 
dialysis against 4 M was prolonged over night. After each dialysis step solutions were 
centrifuged (70Ti, 35000 rpm, 4 °C, 30 min) to remove precipitated material.  
The soluble protein was concentrated up to 30-40 g/l using a 10 kDa MWCO 
centriprep concentrator (Millipore, Bedford, MA, USA) at 3000 rcf. The Yield was 
spectroscopically determined at a wavelength of 280 nm. Therefore a sample was diluted 
1:10 with 6 M guanidine hydrochloride, 100 mM NaPi, pH 7.5 (A280=0.993 corresponds 
to a concentration of 1 g/l, calculation: Expasy ProtParam algorithm53) 
 
 
2.6.1.2 Tobacco etch virus protease (TEV protease) 
 
As pre-culture 2 ml LB medium, 2 µl 100 g/l ampicillin, 2 µl 50 g/l kanamycin were 
inoculated with a single colony BL21(DE3) pET19b tev + pARG and incubated over 
day (ca. 8 h) at 37 °C and 150 rpm. For expressions in 12 l scale, 250 ml of an over night 
culture (250 ml LB, 0.25 ml 100 g/l ampicillin, 0.25 ml 50 g/l kanamycin) were mixed 
with 0.25 ml of pre-culture (1/1000) and incubated over night at 37 °C and 150 rpm.  
6 x 2 l cultures (12 l LB, 12 ml 100 g/l ampicillin, 12 ml 50 g/l kanamycin) in 5 l flasks 
with indentations were inoculated with over night culture to a cell density of 
OD578=0.05 and incubated at 37 °C and 150 rpm. The Addition of 0.1 mM IPTG at 
OD578=0.8-1.0 induced protein expression and incubation was continued at 37 °C and 
150 rpm. Cells were harvested after 4 h, washed in approximately 100-150 ml cell 
washing buffer (150 mM NaCl, 25 mM NaPi, 2 mM EDTA, pH 8.0) and stored at 
-80 °C. 
Cell lysis was carried out in lysis buffer (500 mM NaCl, 25 mM NaPi, 10 % glycerine, 
1 mM MgCl2, 1 mM benzamidine pH 7.5) with 5 ml per gram cells using a 
microfluidizer with 900 kPa pre-pressure. Membrane components were separated 
immediately by centrifugation (45Ti or 70Ti rotor, 45 000 rpm, 4 °C, 1 h). The obtained 
clear supernatant was loaded with a 1 ml/min flow rate on a 10 ml Ni-NTA 1 x 10 cm 
FPLC column equilibrated in A1 buffer (500 mM NaCl, 25 mM NaPi, 10 % glycerine, 
1 mM MgCl2, pH 7.5). After a washing step with 10 % A2 buffer in buffer A1 (A1, 
200 mM imidazole), elution was achieved by washing the column with 50 ml A2 buffer 
(flow-rate of 2 ml/min).  
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Fractions containing the desired TEV protease were pooled and concentrated up to 3-
5 g/l using a 10 kDa MWCO and afterwards dialysed against 100 volumes TEV storage 
buffer (500 mM NaCl, 25 mM NaPi, 10 % glycerine, 5 mM DTT, pH 7.5) with gentle 
stirring using a 12-14 kDa MWCO tube at 4 °C. The yield was spectroscopically 
determined at a wavelength of 280 nm. Therefore a sample was diluted 1:10 with 6 M 
guanidine hydrochloride, 100 mM NaPi, pH 7.5 (A280=1.162 corresponds to a 
concentration of 1 g/l, calculation: Expasy ProtParam algorithm53). 
 
 
2.6.1.3 NpHtr(1-114), NpHtr(1-114) G84C, NpHtrII(1-157) and NpSRII 
 
As pre-culture 2 ml LB medium, 2 µl 50 g/l kanamycin were inoculated with a single 
colony BL21 (DE32) pET27bmod phtr114, phtr114 G84C, phtr157 or psopII 
respectively and shaken over day (ca. 8 h) at 37 °C and 150 rpm. For expressions in 12 l 
scale, a 250 ml of an over-night culture (250 ml LB, 250 µl 50 g/l kanamycin) were 
mixed with 0.25 ml of pre-culture (1/1000) and incubated over night at 37 °C and 150 
rpm. 6 x 2 l cultures (12 l LB, 12 ml 100 g/l kanamycin) in six 5 l flasks with 
indentations were inoculated with over night culture to a cell density of OD578=0.05 and 
incubated at 37 °C and 150 rpm. The addition of 1 mM IPTG at OD578=0.8-1.0 induced 
expression and incubation was continued at 37 °C and 150 rpm. Cells were harvested 
after 2.5 h, washed in approximately 100-150 ml cell washing buffer (150 mM NaCl, 
25 mM NaPi, 2 mM EDTA, pH 8.0) and stored at -80 °C.  
Purification protocol was performed as introduced by Hohenfeld54 and Wegener19. Cells 
were suspended in cell washing buffer (150 mM NaCl, 25 mM NaPi, 2 mM EDTA, 
pH 8.0) with 5 ml per gram cells, and lysed using a microfluidizer (900 kPa pre-
pressure). The membrane components were separated immediately by centrifugation 
(45Ti or 70Ti rotor, 45 000 rpm, 4 °C, 1 h). The supernatant was discarded and the 
obtained pellet homogenized (5 ml per gram cells) in solubilization buffer Amem 
(300 mM NaCl, 50 mM NaPi, 2 % DDM, pH 8.0) and moderately stirred over-night at 
4 °C.  
Insoluble components were removed by centrifugation (45Ti or 70Ti rotor, 45000 rpm, 
4 °C, 1 h). After addition of 5 mM imidazole the obtained clear solubilisate was loaded 
on a 15 ml Ni-NTA FPLC column (1 x 15 cm) equilibrated in Bmem (300 mM NaCl, 
50 mM NaPi, 0.05 % DDM, pH 8.0) with a flow-rate of 1 ml/min. After a first washing 
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step with Bmem (flow-rate of 2 ml/min), the column was washed with 10 % Dmem 
(300 mM NaCl, 50 mM NaPi, 200 mM imidazole, 0.05 % DDM, pH 8.0) in Bmem 
(corresponds to 20 mM imidazole). Elution was carried out using 50 ml 100 % Dmem 
(flow rate of 2 ml/min).  
Fractions containing the desired protein were pooled and diluted with buffer Emem 
(10 mM TrisHCl, 0.05 % DDM) 1:4 (1:10 for NpSRII) and loaded with 1 ml/min on a 
20 ml DEAE FPLC column (1.5x10 cm) equilibrated with buffer Emem. The column was 
washed with 16 % (6 % for NpSRII) buffer Gmem (500 mM NaCl, 10 mM TrisHCl, 
0.1 %DDM, pH 8.0) in Emem. Elution was achieved by a washing step with 50 ml Gmem 
(flow-rate of 2 ml/min). The fractions containing the desired protein were pooled and 
concentrated up to 3-5 g/l using a 10 kDa MWCO. The yield was spectroscopically 
determined at 228.5 nm and 234.5 nm according to Ehresmann et al.55 (at 498 nm, 
ε498=40 000 cm·l·mol-1 for NpSRII). 
 
 
2.6.2 Isotope labelling of peptides and proteins  
 
For isotope labelling of proteins LB medium was substituted by synthetic minimal 
medium M9 (7.5 g disodium hydrophosphate dihydrate, 3.0 g potassium 
dihydrogenphosphate, 0.5 g sodium chloride, 0.25 g magnesium sulfate heptahydrate, 
14 mg calcium chloride dihydrate, pH 7.1). Medium was supplemented after autoclaving 
with 10  ml per litre trace elements (9 ml 10xSL4, 10 ml SL6, ad 100 ml ddH2O, filtered 
sterile). One litre SL6 stock solution contained 100 mg zinc (II) sulfate, 30 mg 
manganese (II) chloride, 300 mg boric acid, 200 mg cobalt (II) chloride hexahydrate, 10 
mg copper (II) chloride dihydrate, 20 mg nickel (II) chloride hexahydrate and 30 mg 
disodium molybdate dihydrate. For preparation of 100 ml 10xSL4 stock solution 
500 mg EDTA were dissolved in 80 ml ddH2O and 200 mg ferric (II) sulfate 
heptahydrate were added. The volume was adjusted to 90 ml. 10xSL4 was always freshly 
prepared due to the oxidation of Fe (II) to Fe (III).  
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2.6.2.1 NpHtrII(84-114) G84C peptide 
 
As pre-culture 2 ml M9 medium, 20 µl 100 g/l ammonium chloride, 10 µl 40 % D-
glucose, 2 µl 100 g/l ampicillin were inoculated with a single colony BL21 (DE32) 
pGEX-2T1-tevhrt and incubated over day at 37 °C and 150 rpm.  
For expressions in 2 l scale, 100 ml overnight culture (100 ml M9, 1 ml 100 g/l 
ammonium chloride, 0.5 ml 40 % D-glucose, 100 µl 100 g/l ampicillin) was mixed with 
0.1 ml of pre-culture (1/1 000) and incubated overnight at 37 °C and 150 rpm. A 2 litre 
culture (2 l M9, 4 g solid [13C] D-glucose, 2 g solid [15N] ammonium chloride, 100 g/l 
ampicillin) in a 5 l flask with indications was inoculated to a cell density of OD578=0.05 
and incubated at 37 °C and 150 rpm. The addition of 0.5 mM IPTG at OD578=0.8-1.0 
induced expression and incubation was continued at 37 °C and 150 rpm. Cells were 
harvested after 3 h, washed in approximately 50 ml cell washing buffer (150 mM NaCl, 
25 mM NaPi, 2 mM EDTA, pH 8.0) and stored at –80 °C if necessary.  
Cell lysis was carried out in cell washing buffer (150 mM NaCl, 25 mM NaPi, 2 mM 
EDTA, pH 8.0) with 5 ml per gram cells using a microfluidizer with 900 kPa pre-
pressure. Membrane components were separated immediately by centrifugation (45Ti or 
70Ti rotor, 45 000 rpm, 4 °C, 1 h). The obtained clear supernatant was loaded on a 
15 ml GSH-Sephadex Fast Flow FPLC column (1.5 x 10 cm) equilibrated with cell 
washing buffer with a flow-rate of 1 ml/min. After a washing step with cell washing 
buffer, elution was achieved by washing with 50 ml cell washing buffer containing 
10 mM reduced glutathion 8flow-rate of 2 ml/min).  
Fractions containing the desired GST-tevHtr fusion protein were pooled and 
concentrated up to 10-15 g/l using a 10 kDa MWCO and afterwards dialysed against 
100 volumes TEV cleavage buffer (150 mM NaCl, 10 mM TrisHCl, 1 mM TCEP, 
0.5 mM EDTA) with gentle stirring using a 12-14 kDa MWCO tube at 4 °C.   
The yield was spectroscopically determined at a wavelength of 280 nm. Therefore a 
sample was diluted 1:10 with 6 M guanidine hydrochloride, 100 mM NaPi, pH 7.5 
(A280=1.392 corresponds to a concentration of 1 g/l, calculation: Expasy ProtParam 
algorithm53). 
TEV cleavage of the fusion protein to release the isotope labelled peptide 
NpHtrII(84-114) G84C was performed at RT using 1 mg TEV protease per 50 mg 
GST-tevHtr. The cleavage mixture was gently agitated. The proteolytic digest was 
monitored using analytical C18 reversed phase HPLC with a linear solvent gradient 
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starting with 5 % B (acetonitrile, 0.08 % TFA) to 65 % B in A (ddH2O, 0.1 % TFA) in 
30 min monitoring absorbance at 214 and 280 nm.  
After almost quantitative cleavage, the desired peptide was separated  from GST by 
filtration using a 10 kDa MWCO concentrator at 3000 rcf. The concentrated solution 
containing the GST-tag was washed four times with 15 ml TEV cleavage buffer. The 
flow-through was lyophilized and dissolved in approximately 5 ml buffer containing 6 M 
guanidine hydrochloride, 100 mM NaPi, pH 7.5.  
The resulting clear solution was loaded in 2.5 ml portions on a semi-preparative C18 
column (Beckman Coulter, Palo Alto, CA, USA) equilibrated with 5 % solvent B 
(acetonitrile, 0.08 % TFA) in A (water, 0.1 % TFA). Elution of the desired peptide was 
carried out using a linear solvent gradient from 5 % to 65 % B in A in 30 min 
monitoring the absorbance at a wavelength of 214 nm. Fractions containing the desired 
peptide were pooled, lyophilized and stored at –20 °C in darkness. 
 
 
2.6.2.2 NpHtrII (1-114), NpHtrII (1-157) and NpSRII 
 
As pre-culture 2 ml M9 medium, 20 µl 100 g/l ammonium chloride, 10 µl 40 % D-
glucose, 2 µl 50 g/l kanamycin were inoculated with a single colony BL21 (DE32) 
pET27bmod phtr114, phtr157 or psopII respectively and shaken over day at 37 °C and 
150 rpm (ca. 8 h).  
For expressions in a 2 l scale 100 ml over night culture (100 ml M9, 1 ml 100 g/l 
ammonium chloride, 0.5 ml 40 % D-glucose, 100 µl 50 g/l kanamycin) were mixed with 
0.1 ml of pre-culture (1/1000) and incubated over night at 37 °C and 150 rpm.  
A 2 litre culture (2 l M9, 4 g solid [13C] D-glucose, 2 g solid [15N] ammonium chloride, 
50 g/l kanamycin) in a 5 l flasks with indications was inoculated to a cell density of 
OD578=0.05 and incubated at 37 °C and 150 rpm. The addition of 1 mM IPTG at 
OD578=0.8-1.0 induced expression and incubation was continued at 37 °C and 150 rpm. 
Cells were harvested after 2 h (1.5 h in case of Htr114), washed in approximately 50 ml 
cell washing buffer (150 mM NaCl, 25 mM NaPi, 2 mM EDTA, pH 8.0) and stored at 
-80 °C. Purification protocol was performed as above-mentioned (see section 2.6.1.3).  
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2.6.3 Isolation of polar lipids from H.salinarum 
 
Samples of PM lipids were kindly supplied by A. Göppner. The applied method was 
introduced by Kates et al.56 and optimised by using purified purple membranes instead 
of complete bacterial cells. The purple membrane (BR content 300 to 350 mg) was 
suspended in 200 ml 4 M NaCl. After addition of 500 ml methanol and 250 ml 
chloroform, the mixture was stirred under nitrogen atmosphere in darkness. The 
obtained suspension was centrifuged for 15 min at 3800 rcf in metal tubes. The yellow 
supernatant was pooled under nitrogen atmosphere and in the dark. The residual pellets 
were extracted once with 500 ml methanol and 250 ml chloroform. 
The pooled supernatants were filtered using a paper filter (Whatman No.1) that was 
swollen for 2 h in methanol/chloroform 1:1. Afterwards 500 ml ddH2O and 500 ml 
chloroform were added to the filtrate and extraction was performed using shaking. 
Phase separation was achieved over night in darkness under argon atmosphere.  
The chloroform phase was separated and subsequently evaporated under reduced 
pressure at 30 °C in the dark using a rotary evaporator (Büchi, Essen, Germany). The 
obtained residue was suspended in 12 ml chloroform and centrifuged at 24 000 rcf, 0 °C 
for half an hour. The chloroform containing supernatant was evaporated again and the 
resulting residue was suspended in 45 ml acetone at 0 °C using ultrasonic pulses.  
After the addition of 1 ml 10 % MgCl2 in methanol, the suspension was centrifuged at 
1 000 rcf (0 °C). The supernatant was discarded and the obtained pellet was extracted 
several times with 10 ml acetone until off-white extracts were obtained.  
The residue was dried in vacuum, weighted and dissolved in methanol/chloroform 1:1 
to obtain a 40 g/l solution. This solution was injected in darkness through a fine needle 
into 20 volumes of 50 mM NaPi, pH 8.0 under argon atmosphere. The obtained 
suspension was homogenized using ultrasonic pulses and subsequently lyophilized. The 
obtained powder was suspended in the original volume of the phosphate buffer and a 
stabile suspension (2 g/l) was obtained, which was stored at –80 °C.  
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2.6.4 Reconstitution in PM lipids 
 
For the reconstitution in PM lipids protein solutions containing less than 0.5 % DDM 
were used. The solubilised protein or protein complex was mixed 1:1 (w/w) with lipids 
and incubated for 10 min at 4 °C with gentle agitation. Next, the NaCl concentration 
was adjusted to 1 M by the addition of solid sodium chloride, followed by a further 
incubation step of 10 min at 4 °C with gentle agitation. Subsequently absorber beads 
(Bio-Rad, Munich, Germany) were added (1 g/100 mg DDM) and this mixture was 
shaken overnight at 4 °C in darkness. A successful reconstitution was indicated by the 
transition of the initially clear mixture to a turbid suspension. After a short 5 sec 
ultrasonic pulse to achieve a desorption of reconstituted protein from the adsorber 
beads, the beads were separated by filtration and the turbid suspension obtained was 
centrifuged for 15 min (15 000 rcf, 4 °C). This pellet was washed twice and finally 
suspended either 20 mM NaPi pH 8.0 (MAS ssNMR samples) or in water (FTIR 
samples) to a final concentration  of approximately 200-250 mM. 
 
 
2.7 Analytical methods 
2.7.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
For separation of proteins according to their apparent molecular weight a SDS-PAGE 
variant introduced by Schägger and von Jagow57 was used. Vertical gels in 0.75 mm 
thickness were used in gel chambers from Bio-Rad. Samples were mixed with 1 volume 
2x SDS sample buffer (6 % SDS, 35 % glycerol, 120 mM TrisHCl, 0.41 M mono-
thiogylcerol, 0.05 % bromphenol blue, pH 8.0).  
Samples with protein concentrations less than 0.04 g/l or containing GdmHCl were 
precipitated by the addition of either 1 volume of ice-cold 10 % aqueous TCA or 
2 volumes of ice-cold acetone. The samples were subsequently  incubated for 30 min on 
ice and centrifuged for 15 min at 15 000 rpm in a bench top centrifuge. The supernatant 
was discarded and the pellet washed with 1 volume ice-cold 70 % ethanol and dissolved 
in 10 µl 1x SDS sample buffer.  
A mixture of phosphorylase b (97.0 kDa), albumin (66.0 kDa), ovalbumin (45 kDa), 
carboanhydrase (30.0 kDa), trypsin inhibitor (20.1 kDa) and α-lactalbumin (14.4 kDa) 
from Amersham Pharmacia Biotech (Freiburg, Germany) was applied as molecular 
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weight standard. Electrophoresis itself was performed using a constant electric current 
corresponding to starting voltage of 80 mV.  
Gels were stained using Coomassie brilliant blue by boiling the gel 1 min in Coomassie 
staining buffer (0.1 % Coomassie Brilliant blue R250, 40 % ethanol, 10 % acetic acid) 
and incubated for  15 min with shaking. Destaining was performed by shaking the gel 
with a piece of absorbent paper tissue in Coomassie destaining buffer (10 % acetic acid, 
5 % ethanol) over night. Alternatively staining was also carried out using the Silver 
Staining Plus Kit (Bio-Rad, Munich, Germany). For gel preparation the following 
solutions were used: 
acrylamide bisacrylamide mixture 48 % acrylamide, 1.5 % bisacrylamide 
gel buffer    3.0 M TrisHCl, 0.3 % SDS, pH 8.45 
cathode buffer    0.1 M TrisHCl, 0.1 % SDS, 0.1 % tricine, pH 8.25 
anode buffer    0.2 M Tris pH 8.9 
stacking  gel (4 %)  180 µl acrylamide bisacrylamide mixture, 0.6 ml gel 
buffer, 1.45 ml ddH2O, 12.5 µl 10 % APS, 2 µl TEMED 
separation  gel (16.5 %) 1.25 ml acrylamide bisacrylamide mixture, 1.25 ml gel 
buffer, 1.25 ml ddH2O, 19 µl 10 % APS, 10 µl TEMED 
 
 
2.7.2. Blue-native polyacrylamide gel electrophoresis (BN-PAGE) 
 
For monitoring the capability of truncated transducer variants to form a complex with 
SRII, blue-native-PAGE introduced by Schägger and von Jagow57 was used. Vertical 
10-20 % gradient gels in 1.5 mm thickness were used in gel chambers from Pharmacia 
(Upsalla, Sweden). The gradient was mixed at 4 °C using a gradient mixer with the 
concentrated acrylamide solution in the second reservoir. After 2 h the gel was 
polymerised at rt overnight.  
Samples contained 25 µg SRII, the corresponding amount of transducer and less than 
0.5 % DDM detergent. They were concentrated up to 25 µl using a 10 kDa MWCO, 
mixed with 12.5 µl 3x sample buffer and incubated overnight at 4 °C. The samples were 
injected below the cathode buffer that was filled into the sample pockets. Unused 
sample pockets were filled with 25 µl Gmem+12.5 µl 3x sample buffer in order to ensure 
a homogenous running front during electrophoresis.  
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Electrophoresis itself was performed using 150 V, 25 mA and 20 W until the running 
front reached the gradient gel and from there 500 V, 15 mA and 20 W. Gels were 
stained by the Coomassie Serva blue G dye contained in the cathode buffer. Destaining 
was carried out by replacing the cathode buffer by the corresponding buffer without 
Coomassie after the running front had passed half of the gradient gel. For gel 
preparation the following solutions were used: 
 
acrylamide solution  48 % acrylamide, 1.5 % bisacrylamide 
gel buffer   150 mM bis-trisHCl, 1.5 M ε-aminocaproric acid, pH 7.0 
3x sample buffer  4.5 ml glycerol, 0.31 g bis-trisHCl, ad 10 ml ddH2O, 
pH 7.0) 
cathode buffer   50 mM trichine, 15 mM bis-tris, 0.02 % Coomassie Serva 
blue G, pH 7.0, filtered 
anode buffer   50 mM bis-trisHCl, pH 7.0 
stacking gel (4 %) 0.8 ml acrylamide solution, 3.33 ml gel buffer, 120 µl 
10 % APS, 12 µl TEMED ad 10 ml ddH2O 
gradient solution (10 %)  3 ml acrylamide solution, 5 ml gel buffer, 3 g glycerol, 
20 µl 10 % APS, 7 µl TEMED, ad 15 ml ddH2O 
gradient solution (20 %)  6 ml acrylamide solution, 5 ml gel buffer, 3 g glycerol, 
70 µl 10 % APS, 7 µl TEMED, ad 15 ml ddH2O 
 
 
2.7.3 Mass spectrometry  of membrane proteins 
2.7.3.1 Matrix-assisted laser desorption ionisation (MALDI) 
 
This method was adapted from Cadene et al.58. A saturated solution of α-cyano-4-
hydroxy cinnamic acid in acetonitrile water 2:1 (sample matrix) was prepared. 20 µl of 
this solution were diluted with 60 µl isopropanol.  
20 µl of this dilution were applied on a gold-coated sample plate and homogenously 
spread with the flank of a pipette tip over the complete surface and air-dried. This 
procedure was repeated 2-3 times and the homogenous, crystalline thin layer so 
obtained was wiped away with a soft paper tissue resulting a yellow shimmering ultra 
thin layer covering the entire plate. 1 µl detergent containing protein sample (≥1 g/l) 
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was diluted with 9 µl sample matrix. 1 µl of this dilution was applied onto the plate 
surface.  
After a few seconds a yellow homogenous, crystalline layer was obtained. In case of 
needle formation or inhomogeneous layers the procedure was repeated. Before the 
sample was able to dry completely, the supernatant containing the majority of detergent 
and buffer salts, was removed by soaking with a soft paper tissue.  
The sample was washed with a drop 1 % aqueous TFA and air-dried. The 
measurements were performed using the following instrument settings: linear operation 
mode, positive polarity, 25 000 V accelerating voltage, 93 % grid voltage, 0.3 % guide 
wire, 750 nsec extraction delay time, 20 Hz laser repetition rate and 1 500 Da low mass 
gate. 
 
 
2.7.3.2 Electro spray  ionisation (ESI) 
 
A modified protocol, originally introduced by Hufnagel et al.59 was used. 0.1 ml of 
micellar protein solution (≥1 g/l) was diluted with 15 ml desalting buffer (10 mM 
TrisHCl, 0.02 % DDM, pH 8.0) and concentrated up again to 0.5 ml using a 10 kDa 
MWCO membrane.  
0.5 ml protein sample were mixed with 9.5 ml precipitator (10 ml acetone, 1 ml 25 % 
aqueous ammonium hydroxide, 100 µl 6 M aqueous TCA) and vortexed for 2 min. 
After incubation on ice for 30 min, the sample was centrifuged at 5 000 rpm (4 °C, 
3 min) in a bench top centrifuge. The supernatant was discarded and the pellet 
subsequently washed twice with 90 % aqueous acetone, once with acetone and finally 
with n-hexane.  
Finally the pellet was air-dried, dissolved in 5 µl of neat formic acid, diluted with 45 µl 
TFE and 200 µl ESI sample buffer (10 ml chloroform, 10 ml methanol, 3.5 ml ddH2O). 
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2.8 Expressed protein ligation 
2.8.1 EPL using Htr-MxeCBD intein precursor isolated from membranes  
 
The purified Htr-MxeCBD intein fusion protein (see section 2.6.1.1.1) in 3 g/l 
concentration was mixed in 1.3:1 stoichiometry with the lyophilized C-terminal peptide 
segment containing an N-terminal cysteine using ultrasonic pulses and MESNA was 
added in 200 mM concentration.  
The reaction mix was incubated with gentle agitation on a turning wheel. After 72 h  of 
incubation the reaction mix was diluted 1:10 with dilution buffer (10 mM TrisHCl, 
0.05 %DDM, pH 8.0) and loaded with a flow-rate of 1 ml/min on a 20 ml DEAE 
FPLC column (1.5 x 10 cm) equilibrated with dilution buffer. After a washing step with 
16 % elution buffer (500 mM NaCl, 10 mM TrisHCl, 0.1 %DDM, pH 8.0) in dilution 
buffer. Elution was achieved by washing with 50 ml elution buffer with a flow-rate of 
2 ml/min.  
Fractions containing the desired product were pooled and concentrated up to 3-5 g/l 
using a 10 kDa MWCO. The yield was determined spectroscopically at 228.5 nm and 
234.5 nm according to Ehresmann et al.55.  
 
 
2.8.2 EPL using Htr-MxeCBD intein precursor isolated from inclusion bodies 
 
The refolded Htr-MxeCBD intein fusion protein (see section 2.6.1.1.2) in 30 g/l 
concentrations was mixed in 2:1 stoichiometry with the lyophilized C-terminal peptide 
segment containing an N-terminal cysteine using ultrasonic pulses and MESNA was 
added in 200 mM concentration. 67 mg 1-Mono-oleoyl-rac-glycerol portions were 
melted in a water bath at 40 °C and centrifuged for 5 sec at maximal speed in a bench 
top centrifuge. The molten lipids and the reaction mix were rapidly mixed by injecting 
100 µl mix in one jet into each lipid drop. The obtained mixture became highly viscous 
and turbid at once and was centrifuged at 23 °C at 10 000 rpm in a bench top centrifuge 
for 1 min. Subsequently six 10 min centrifugation steps were carried out starting with 
5 000 rpm, accelerating rotary speed after each step by 1 000 rpm ending with 
10 000 rpm and turning the cups 90° clockwise after each step. The formation of the 
lipidic cubic phase was indicated by the transition from a turbid mixture to a 
homogenous, transparent gel. The lipidic cubic phase reaction mixtures were incubated 
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at 23 °C. After 3 days the samples were filled up to 1 ml with 10 % DDM, 10 mM 
TrisHCl, 5 mM DTT, pH 8.0, subsequently diluted 1:10 with dilution buffer (2 %DDM, 
10 mM TrisHCl, 5 mM DTT, pH 8.0) and moderately stirred over night at 4 °C. The 
solubilisate was loaded with a flow-rate of 1 ml/min on a 20 ml DEAE FPLC column 
(1.5x10 cm) equilibrated with equilibration buffer (10 mM TrisHCl, 0.05 %DDM, 
pH 8.0). After a washing step with 16 % elution buffer (500 mM NaCl, 10 mM TrisHCl, 
0.1 %DDM, pH 8.0), elution was achieved by washing with 50 ml elution buffer with a 
flow-rate of 2 ml/min. Fractions containing the desired product were pooled and 
concentrated up to 3-5 g/l using a 10 kDa MWCO. Yield was determined 
spectroscopically at 228.5 nm and 234.5 nm according to Ehresmann et al.55. 
 
 
2.9 Sample preparation for NMR spectroscopy 
 
Lyophilized powders of isotope (un)labelled peptides  were dissolved in 8 % D2O in 
H2O, 20 mM NaPi, and pH 6.5 in approximately 1 mM concentration using ultrasonic 
pulses and transferred into Shigemi NMR tubes (Allison Par, PA, USA) with 4.22 mm in 
diameter.. All measurements were performed at 25 °C using a  Bruker 500 MHz (11.7 T) 
or a Varian 600 MHz (14.1 T) NMR spectrometer. The water signal was suppressed by 
selective pre-saturation during the preparation period and/or mixing time.  
For MAS ssNMR experiments 5 mg membrane protein or membrane protein complex 
were reconstituted in PM lipids and washed with 20 mM NaPi pH 8.0 (see section 
2.6.3). The membrane pellet obtained was manually transferred in several portions into a 
sample rotor of 4.0 respectively 2.5 mm in diameter using Transferpettors (Brandt, 
Oberursel, Germany). Centrifugation steps at 15 000 rpm in a bench top centrifuge for 
1 min were performed between each transfer step to achieve a homogenous rotor 
packing. All measurements were performed using either a Bruker 400 MHz (9.3 T) or a 
Bruker 600 MHz (11.7 T) NMR spectrometer with MAS probe head by K Seidel of the 
working group of M. Baldus at the Max-Planck-Institute for biophysical chemistry 
(Göttingen, Germany)  .  
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2.10 Sample preparation for FTIR spectroscopy 
 
For FTIR experiments 1 mg membrane protein or membrane protein complex were 
reconstituted in PM lipids and washed with 20 mM NaPi pH 8.0 and suspended in pure 
ddH2O (see section 2.6.3). The preparation of so-called sandwich-samples was 
performed by drying 1-1.5 nmol of reconstituted protein onto the lower sample 
window. The dried membranes were hydrated with 20 µl buffer (200 mM bis-tris-
propane, 150 mM NaCl, pH 8.0). The second plane window squeezed the excess buffer 
into the circular groove, which formed a buffer reservoir ensuring a sufficient sample 
hydration. The thickness of the cuvette was between 2.5 and 4.5 µm. The static FTIR 
measurements were performed at 17 °C using a Bruker IFS 28 FTIR spectrometer with 
a Sens-IR Diamond Micro-ATR unit. All time-resolved rapid-scan measurements were 
carried out at 17 °C on a home-built FTIR spectrometer (Siebert,F., Freiburg, Germany) 
by I. Radu of the working group of F. Siebert at the Albert-Ludwigs-University 
(Freiburg, Germany). 
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3. Results 
3.1 Expression and biochemical evaluation of NpHtrII(1-114) G84C 
 
Gordeliy et al.9 recently reported a crystallographic structure of the SRII/HtrII 
signalling complex. While detailed insights into the transmembrane interactions of the 
complex were obtained, unfortunately no electron density of the cytoplasmic HAMP 
linker domain of the transducer protein was observed.  
In order to address the unknown structure of the cytoplasmic linker domain in NpHtrII, 
magic angle spinning solid-state NMR spectroscopy was applied. Although MAS 
techniques have greatly extended the sensitivity and the spectral resolution of solid-state 
NMR spectroscopy, it would not be possible to resolve the NMR signals of the entire 
SRII/HtrII-complex or even of the complete Htr114 construct with MAS ssNMR 
techniques due to limited spectral resolution. Therefore domain specific isotope 
labelling of only the cytoplasmic Htr114 C-terminus of unknown structure using the 
expressed protein ligation technique would reduce the problem of signal overlapping.  
As ligation site in the EPL reaction Gly83-Gly84 was selected. This ligation junction was 
desirable in a semi-synthetic approach since all the residues of the putative cytoplasmic 
receptor binding site with unknown structure are located C-terminal to this site60. In 
addition Gly-83 at position –1 promised high in-vitro intein cleavage efficiencies45 in 
combination with high ligation efficiencies61.  
In order to investigate, if a G84C mutation caused by a successful EPL reaction is 
functionally tolerated in a C-terminally truncated NpHtr114 construct, an in vitro binding 
assay using a recombinant NpHtr114 G84C mutant and the SRII receptor was 
performed. Therefore the gene encoding for the NpHtr114 G84C mutant with a seven-
histidine purification tag at its C-terminus was cloned into the pET27bmod vector 
under the control of the T7 promoter. The corresponding clone was kindly supplied by 
J.P. Klare. This  protein was expressed and purified using Ni-NTA affinity 
chromatography followed by DEAE ion exchange chromatography (figure 3.1, 
panel A).  
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Figure 3.1. Purification and biochemical evaluation of NpHtrII(1-114) G84C. 
Panel A: The SDS-PAGE analyzing purification procedure. The  
two protein bands for Ni-NTA respectively DEAE 
eluate indicated protein monomer (12.6 kDa) and dimer 
(25.2 kDa). 
Panel B: MALDI-MS spectrum of the purified protein with. 
The signal with (M+H)+=12623 Da referred to the 
target protein. Signals with 11055 amu and 10446 amu 
could not be assigned 
Panel C: Blue-native PAGE monitoring the formation of a 1:1 
SRII/Htr(1-114) G84C complex  referring SRII alone. 
 
The SDS-PAGE analyzing the purification of the G84C mutant showed two protein 
bands for the Ni-NTA and the DEAE-elution, respectively. The molecular weight 
indicated by the mobility of these bands is in a good agreement with the masses for a 
monomer (12.6 kDa) and a dimer (25.2 kDa) of the mutant. Dimer formation due to 
oxidative disulfide cross-linking of the Cys84 residues was excluded, since the SDS 
sample buffer used contained mono-thioglycerol as reducing agent. However, 
incubation of the purified protein with 1 mM TCEP before addition of SDS sample 
buffer significantly reduced the observed amount of dimerisation (results not shown). 
This leads to the conclusion that disulfide cross-linked Htr(1-114) G84C remains 
partially in the dimeric state after the addition of SDS sample buffer due to hydrophobic 
or ionic interactions even without intact disulfide bonds. 
In order to identify Htr(1-114) G84C, MALDI-MS experiments were performed. The 
mass spectrum of the purified protein (figure 3.1, panel B) showed signals with 
12623 amu, 11055 amu and 10446 amu. While the signals with 11055 amu and 
10446 amu could not be assigned, the observed signal with (M+H)+=12623 Da referred 
to the NpHtr(1-114) G84C mutant. The observed experimental mass was smaller 
(∆M=-86 Da) than the calculated molecular weight of M=12709.6 Da. This 
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phenomenon was previously as well observed for heterologously expressed N.pharaonis 
transducers62 and could not be explained by an N-terminal methionine deletion 
(∆M=-131.2 Da). For an additional discussion concerning the observed molecular 
weights of different transducer variants see as well section 3.3.1.2.  
Hippler-Mreyen et al. successfully characterised the SRII/HtrII complex formation of 
differently truncated transducer constructs using blue-native gel electrophoresis60,62-64. 
This established in vitro assay was used to evaluate the capability of the truncated G84C 
mutant to bind to its cognate receptor. The gel so obtained  displayed an intensive band 
with a lower mobility compared to the SRII reference for a sample containing the 
mutant and the receptor in 1:1 stoichiometry (figure 3.1, panel C). Above this band that 
was assigned to a 1:1 SRII/Htr(1-114) G84C complex, a second band with lower 
intensity was observed. Based on the results of the above-mentioned study60,62, this  
band was assigned to a 2:2 complex.  
The in vitro binding study clearly indicated that the G84C mutant in a truncated 114 
amino acids comprising form is able to interact with its native binding partner SRII. 
Therefore a G84C mutation caused by a successful generation of the transducer using 
EPL, should not prevent the access to a functional transducer variant. 
 
 
3.2 Peptide generation 
3.2.1 NpHtrII(84-113) 
 
H-GDTAASLSTLAAKASRMGDGDLDVELETRR-OH 
M=3107.4 Da 
 
Investigations of the interaction between the SRII receptor and its cognate transducer 
suggested that the linker domain of the Htr comprising amino acids 84-114 is essential 
for the correct binding of the whole transducer to the receptor60. In isothermal 
calorimetric titrations (ITC) the interaction between the cytoplasmic linker domain itself 
and the SRII receptor should be characterised.  
The corresponding peptide comprising amino acid residues 84-113 was chemically 
synthesized using SPPS47 on a BOC-arginine pre-loaded PAM-resin in 0.1-mmole scale. 
Ninhydrine tests48 displayed a low coupling efficiency of Arg99. Therefore this coupling 
was repeated and reaction time was extended from 12 min to 30 min. After removing 
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the N-terminal BOC group the synthesized peptide was cleaved from solid support and 
purified with C18 RP-HPLC using a linear gradient from 25 % buffer B (acetonitrile, 
0.08 % TFA) in buffer A (water, 0.1 % TFA) to 38 % buffer B in buffer A in 13 min. 
Fractions containing the desired peptide were pooled, lyophilized and stored at –20 °C 
in the dark. 
 
 
Figure 3.2. MALDI-MS (panel A) and analytical HPLC chromatogram (panel B) of 
purified NpHtr(84-113). 
Signals with 3107 amu and 3089 amu corresponding to the target 
peptide and a water elimination product (∆M=-18.0 Da) that could not 
be separated indicated by the single signal in the analytical RP-HPLC 
chromatogram with a retention time of 25.6 min. 
 
The purified peptide was analyzed by mass spectrometry and analytical RP-HPLC. The 
mass spectrum of NpHtr(84-113) showed signals of two different peptide species that 
could not be separated with any chosen HPLC gradient. The main product with 
M=3107.0 Da corresponded to the target peptide with the calculated mass of 
3107.4 Da. The molecular weight of the side product with M=3089.0 Da revealed a 
water  elimination (∆M=-18.0 Da). One possible explanation could be succinimide 
formation65,66 from aspartic acid residues. The target peptide contains four of these 
residues and this could have led to an accumulation of the respective cyclized side 
product. However, without a suitable separation method the relative amount of side 
product in comparison with the target peptide could not be determined. The overall 
yield of the isolated fractions was 26.7 mg (8.7 %) based on the 0.1 mmole scale of the 
synthesis. 
For the ITC experiments, the SRII receptor was dialyzed against ITC buffer containing 
150 mM NaCl, 50 mM TrisHCl, 0.05 %DDM, pH 8.0 at 4 °C. The lyophilized peptide 
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was dissolved in ITC dialysis buffer. The protein concentrations of SRII and peptide 
were 0.055 mM and 0.47 mM, respectively. Hippler-Mreyen et al. performed the 
titrations of the weakly binding transducers Htr(1-101) and Htr(1-82) at room 
temperature. Therefore all experiments of this study were done at 22 °C on a VP-ITC 
Micro Calorimeter (Microcal Inc.). For control experiments, the peptide was titrated in 
ITC buffer.  
In first titrations with 10 mM TrisHCl buffered saline strong transprotonation heats 
were measured due to an exhausted buffering capacity of the peptide solution: the acidic 
peptide (pI below 5) shifted the pH of the solution. Therefore all further titrations were 
performed with 50 mM TrisHCl. For the interaction of the cytoplasmic domain of the 
transducer with the SRII receptor the following binding curve was obtained (figure 3.4). 
 
 
 
Figure 3.3. Isothermal calorimetric titration curve of SRII titrated with HtrII(84-113). 
The peptide was dissolved in ITC buffer containing 150 mM NaCl, 
50 mM TrisHCl, 0.05 %DDM, pH 8.0 (470 µM) and added at 25 °C to 
the SRII (55 µM) in 25 increments of 10 µl in 12.6 sec with a time 
spacing of 300 sec. 
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The titration curve (figure 3.3) shows signals with negative amplitudes corresponding to 
an exothermal process. At the end of the titration a signal plateau is reached and the 
measured heat corresponds to the dilution heat of the peptide into the buffer (ca. 
-1 kJ/mole). After the time integration of raw data, this observed signal offset was 
mathematically corrected by subtraction. Subsequently the binding parameters, like 
binding enthalpy and dissociation constant, were determined using the one single 
binding site model and a SRII+nHtr(84-113)→SRII*nHtr(84-113) binding scheme, 
where n represents the observed number of peptide molecules required for the 
formation of a complex with SRII (fitting curve is represented as grey line, figure 3.3). 
Data were evaluated by employing the Origin-ITC software package. Table 3.1 
summarises the obtained parameters. 
 
 
 
 
 
 
 
 
 
Table 3.1. Thermodynamic parameters of various SRII/Htr complexes. 
Comparison of dissociation constant (KD), molar ratio (n) 
and binding heat (∆H). Values for Htr(83-149) are taken 
from Sudo et al.67 and those for Htr(1-101) and Htr(1-82) 
from Hippler-Mreyen et al.60. 
 
The Htr(84-113) peptide itself was able to interact with the receptor as was recently 
reported for a similar, however longer peptide67. Most of the above-mentioned titrations 
were done at different temperatures and therefore a direct comparison is difficult 
because of the strong temperature-dependence of binding heats; however, the 
dissociation constants (KD) can be compared due to their weaker temperature-
dependency.  
The observed dissociation constant of 240 nM for Htr(84-113) is comparable to that 
obtained for the corresponding Htr(1-114) transducer construct (230 nM). The 
observed binding is one order of magnitude stronger than those of the longer peptide 
(10 µM) and the Htr(1-101) construct (10 µM). Apparently, the peptide Gly84-Arg113 
 Temperature 
(K) 
KD 
(µM) 
n 
 
∆H 
(kJ⋅mole-1) 
Htr(84-113) 295 0.24 1.4 -4.6 
Htr(83-149) 308 10 - - 
Htr(1-114)  318 0.23 1.0 -17.6 
Htr(1-101) 295 10 1.0 -5.8 
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comprises the essential part of the receptor binding domain, which was already 
postulated by Hippler-Mreyen et al.60 based their measurements with different C-
terminally truncated transducers.  
The observed molar ratio (n=1.4) deviates from the value n=1.0 found for the 
Htr(1-114) variant suggesting a lowered effective peptide concentration compared to  
the determined value of 470 µM. Due to the absence of an accurate method to specify 
the concentration of a short peptide without aromatic residues, the concentration was 
determined gravimetrically. Unfortunately, this method neglects residual salt in the 
lyophilized peptide sample, which may explain the observed deviation.  
The C-terminal extension of the peptide up to Gln14967 resulted in a significant 
weakening of the SRII/Htr interaction by a factor of ca. 40 (table 3.1). However, the 
observed binding curve67 showed, instead of the expected sigmoid shape, a hyperbolic 
one, which is unusual for a binding event. Therefore a comparison of the results 
obtained for both peptides seems inadvisable.  
The capacity of the peptide Htr(84-113) to interact specifically with the SRII receptor 
raises questions about the secondary structure of the peptide comprising the receptor-
binding domain. Therefore CD-spectroscopy experiments were performed under 
conditions used for the ITC measurements. 
 
Figure 3.4. CD-spectra of wt Htr(84-113) with and without DDM at 20 °C. 
The negative signals at 200 nm and 220 nm indicate random 
coil secondary structure with α-helical tendencies. The positive 
signal below 195 nm was due to light scattering. 
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The observed CD-spectra (figure 3.4) at 20 °C were recorded in ITC buffer with and 
without DDM and were dominated by strong negative signals at around 200 nm that 
were caused by a predominant random coil structure. The addition of detergent led to a 
minor shift of the signal to lower wavelength. Additionally increased light scattering 
below a wavelength  of 195 nm was observed that caused the deviation of the signals in 
that range. Nevertheless both spectra showed a slight negative signal at around 220 nm 
(n→π*) indicating partially α-helical folding. A signal at around 205 nm of a π→π* 
transition of an α-helix could not be observed due to signal overlapping with a strong 
negative signal of the random coil folding. The positive signal below a wavelength of 
195 nm was due to light scattering and did not indicate a β-sheet folding.  
In summary the peptide Htr(84-114) comprising the main part of the receptor-binding 
domain is predominantly unfolded with α-helical tendencies observed with and without 
DDM as a detergent. Taking the specific binding capability of the peptide into account, 
it may be the case that the unfolded peptide folds upon receptor binding68,69. This 
hypothesis is supported by Sudo et al.67, who observed in 1H,15N 2D HSQC NMR 
experiments with Htr(83-149) chemical shift changes that were interpreted as structural 
changes by the authors.    
 
 
3.2.2 NpHtrII(84-109)NBD G84C 
 
H-CDTAAXLSTLAAKASRMGDGDLDVELHHHHHHL-OH 
M=3722.9  X=NBD-Dab 
 
The first step in the semi-synthesis of the transmembrane transducer protein was the 
generation of the C-terminal NpHtrII segment. In order to improve qualitative and 
quantitative evaluation of the expressed protein ligation reaction, a fluorescently labelled 
peptide comprising the Htr residues 84-109 and an artificial C-terminal poly-histidine 
purification tag was synthesized. The overall length of the peptide was limited to 33 
residues. In consideration of the reaction steps needed for the NBD-labelling 
(figure 3.5), this limitation should ensure a sufficient product yield47.  
Gly84 was substituted by a cysteine residue and a Ser89 was replaced by an NBD-
labelled diaminobuturic acid residue. The peptide was chemically synthesized46 on a 
BOC-leucine-PAM solid support in a 0.1 mmole scale using in situ neutralization and 
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HBTU activation protocol for BOC protected amino acids47. Coupling of the non-
natural amino acid L-BOC-Dab(Fmoc)-OH was extended from 12 min to 1 h and 
monitored by Kaiser tests48. After sequence completion the orthogonal Fmoc protecting 
group of Dab was removed with 20 % piperidine in DMF. The resulting free γ-amino 
moiety (1) was reacted with 10 eq of NBD chloride (2) in presence of 5 eq of DIEA as 
base for 30 min (figure 3.5). 
 
 
 
Figure 3.5. NBD labelling of NpHtrII(1-109)NBD G84C. 
All histidine residues were DNP-protected. 
The free γ-amino moiety of Dab (1) was 
reacted with 10 eq of NBD chloride (2) in 
presence of 5 eq of DIEA as base. 
 
 
After NBD labelling of the peptide, the DNP protecting groups of the six consecutive 
histidines were cleaved off. Subsequently the N-terminal BOC group of the synthesized 
peptide was removed with TFA to avoid the risk of a possible tert-butylation70 during the 
HF49cleavage from the solid support.  
Purification was performed using semi-preparative C-18 RP-HPLC with a linear 
acetonitrile gradient in water (25 % to 38 % in 13 min). Fractions containing the desired 
peptide were pooled, lyophilized and stored at –20 °C in darkness. 
The purified peptide was analyzed by mass spectrometry and analytical RP-HPLC. 
While the chromatogram of the HPLC analysis (figure 3.6, panel B) showed only one 
single product peak (28.0 min) besides the observed buffer peak (5.5 min), the mass 
spectrum of the purified peptide revealed signals of two different species, which could 
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not be separated with any HPLC gradient (figure 3.6). The main product with 
protonated states (M+2H)2+=1861.8, (M+3H)3+=1242.3, (M+4H)4+=931.7 and 
(M+5H)5+=745.7 amu corresponded to a deconvoluted mass of M=3723.0 Da that is in 
good agreement with the calculated mass of the desired peptide NpHtrII(84-109)NBD 
G84C (M=3722.9). The second peptide species with (M+2H)2+=1793.6, 
(M+3H)3+=1236.0 and (M+4H)4+=897.3 amu displayed an experimental mass of 
3585.2 Da suggesting an histidine deletion (∆M=-137.1 Da).  
 
 
Figure 3.6. ESI-MS (panel A) and analytical HPLC chromatogram (panel B) of purified 
NpHtrII(84-109)NBD G84C. 
MS signals at 1861.8 amu, 1242.3 amu, 931.7 amu and 745.7 amu 
corresponded to the desired peptide (Mcalc=3722.9). Signals 1793.6 amu, 
1236.0 amu and 897.3 amu suggested an histidine deletion product 
(∆M=-137.1 Da), which could not be separated indicated by the single 
signal in the analytical RP-HPLC chromatogram (panel B). 
 
The histidine purification tag of the histidine deletion side product would contain only 
five consecutive histidines. Such a deletion should only have no effect on the function  
of the tag; therefore no further purification steps were performed. Without a suitable 
separation the relative amount of side product in comparison with the target peptide 
could not be determined. The overall yield of the isolated fractions was 35.7 mg (9.6 %) 
based on 0.1 mmole synthesis scale.  
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3.2.3 NpHtrII(84-113) G84C 
 
H-CDTAASLSTLAAKASRMGDGDLDVELETRR-OH 
M=3153.4 Da 
 
A fluorescent-labelled peptide comprising an N-terminal cysteine (see previous section) 
is a useful tool to ease monitoring of EPL reactions by densitometric investigations of 
SDS-PAGE gels. However, the used modifications, like histidine purification tag or the 
NBD moiety, may influence the biochemical properties of the respective product. 
Therefore an unmodified C-terminal segment with an N-terminal cysteine residue was 
chemically synthesized to facilitate the semi-synthetic access to an unmodified 
transducer. 
The solid phase synthesis succeeded by using the in situ neutralization and HBTU 
activation protocol for BOC protected amino acids47 on BOC-arginine pre-loaded 
PAM-resin in 0.1 mmole scale. Ninhydrine tests48 displayed a low coupling efficiency of 
Arg99 as similar to that observed for the wild type sequence. Therefore this coupling 
was performed twice and prolonged to 30 min. After removal of  the N-terminal BOC 
group to avoid tert-butylation70, the synthesized peptide was cleaved from solid support 
with neat HF in the presence of 5 % p-cresol49 and 1 % cysteine as scavengers. After 
removing HF in vacuum the crude peptide was suspended in diethyl ether resulting in a 
highly viscous precipitate. During extensive washing with diethyl ether the sediment 
became more granular. After dissolving in 50 % acetonitrile in water containing 0.1 % 
TFA, the peptide was separated from resin beads by filtration and lyophilized.  
In order to verify successful peptide synthesis, the crude peptide was analyzed using 
ESI-MS. The mass spectrum of the crude peptide showed two intensive signals at 
3168.3 amu and 3153.3 amu in addition to two signals of less intensity at 3015.1 amu 
and 2997.0 amu with low spectral resolution (figure 3.7).  
The signal at 3153.3 amu was assigned to the target peptide with a calculated molecular 
weight of M=3153.3 Da. The signal with M=3168.3 Da (∆M=+15 amu) suggested a 
possible oxidation of Met100 to the corresponding sufoxide71. In addition, in spite of 
coupling Arg99 twice, an arginine deletion product with a calculated mass of 2997.2 Da 
(∆M=-156.2 Da) was detected with and without oxidized Met100 (Mcalc=3013.2). 
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Figure 3.7. ESI mass spectrum of the crude peptide NpHtrII (84-113) G84C. 
The signal at 3153.3 amu was assigned to the target peptide 
(M=3153.3 Da). The signal with M=3168.3 Da (∆M=+15 amu) 
suggested Met100 oxidation. In addition, the signals at 
3015.1 amu and 2997.2 amu suggested an arginine deletion 
product with and without oxidized Met100. 
 
 
In order to reduce the sulfoxide side products, the crude peptide was dissolved in 6 M 
guanidine hydrochloride, 50 mM Tris, 30 % TFE, pH 8.5 and incubated for 3 days in 
presence of 3 % DTT at rt71. MS experiments revealed that the reduction of the 
sulfoxide could not be achieved quantitatively (results not shown), however residual 
Met(O) containing species could be separated from the desired product with C18 RP-
HPLC. Purification was performed using the above-mentioned gradient conditions (see 
previous section). Fractions containing the desired peptide were pooled, lyophilized and 
stored at –20 °C in the dark.  
The purified peptide was analyzed by mass spectrometry and analytical RP-HPLC. The 
chromatogram of the HPLC analysis (figure 3.8, panel B) showed besides the observed 
buffer peak one single product peak. 
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Figure 3.8. MALDI-MS (panel A) and analytical HPLC chromatogram (panel B) 
of purified NpHtrII(84-113) G84C. 
MS signal at 3154.6 amu corresponded to the (M+H)+=3153.4 Da 
signal of the desired product. Purity was confirmed by HPLC 
analysis showing one single product peak.  
 
 
The purity of the target peptide was confirmed by the mass spectrum (figure 3.8, panel 
A) revealing only one signal at 3154.6 amu corresponding to the (M+H)+=3153.4 Da 
signal of the desired product. The overall yield of the isolated fractions was 24.4 mg 
(7.7 %) based on 0.1 mmole synthesis scale.  
 
 
3.2.4 Isotope labelled NpHtrII(84-114) G84C peptides 
 
The establishment of C-terminal domain specific isotope labelling of the membrane 
protein NpHtrII in a C-terminally truncated form requires a low cost access to 
uniformly isotope labelled peptides containing an N-terminal cysteine residue.  
Although labelled amino acid building blocks for solid phase peptide synthesis (SPPS) 
are commercially available, the financial outlay for the synthesis of a peptide comprising 
an entire protein domain would be immense.  
Fortunately highly optimised, relatively inexpensive protocols for recombinant labelling 
of proteins using synthetic minimal media containing [13C] D-glucose and/or [15N] 
ammonium chloride as sole carbon respectively nitrogen sources are well established72,73. 
The combination of recombinant isotope labelling with the proteolytic removal of an 
N-terminal glutathion-S-transferase leader sequence looked promising  as  a suitable 
preparative method to generate an EPL peptide building block.  
Results 
 46
Therefore the gene encoding for Htr(84-114) G84C was genetically fused to a GST-tag 
with an tobacco etch virus (TEV) protease recognition site  (ExxYxQ▼, where x can be 
every amino acid)74 and a cysteine at the P1’ position75 (first C-terminal residue after 
glutamine) using PCR with the pRPS1 plasmid as template. The resulting fragment was 
purified using a PCR purification kit (Qiagen) and subsequently cloned into the BamHI 
and EcoRI sites of a dephosphorylated BamHI/EcoRI linearized pGEX-2T vector that 
allows high-level expression of the desired GSTtevHtr fusion protein under control of 
the T7-promoter.  
In order to investigate the expression of the desired GSTtevHtr fusion protein under 
minimal medium conditions, three 50 ml cultures in minimal medium containing 2 g/l 
D-glucose and 1 g/l ammonium chloride were inoculated to cell densities of 
OD578=0.05 and incubated at 37 °C. Induction was performed using 1 mM IPTG at 
OD578=0.4, 0.6 and 0.9, respectively. Samples were taken after 2 h, 4 h and 8 h and 
protein expression analysed using SDS-PAGE. 
 
 
 
 
Figure 3.9. SDS-PAGE of GSTtevHtr expression optimization 
Maximal GSTtevHtr (30.4 kDa) expression was 
observed after 3-4 hours under 1 mM IPTG at 
OD578=0.9 conditions, indicated by black box. 
 
The SDS-PAGE gel (figure 3.9) revealed good over-expression of the desired fusion 
protein upon IPTG induction as seen by the protein band appearing below the 30-kDa-
reference band. Maximal GSTtevHtr (30.4 kDa) expression was observed after 3-4 
hours for all different cell densities chosen as induction points. Longer incubation times 
up to 8 h led to a decrease of the amount of protein indicated by faint bands, suggesting 
1 mM IPTG at OD578=0.9 and incubation for 4 h, (indicated here by black box) as 
optimal expression conditions. 
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Isotopic labelling was hence performed on a 2 l scale using these optimized expression 
conditions with synthetic minimal media containing 2 g/l [13C] D-glucose and/or 1 g/l 
[15N] ammonium chloride. After protein expression, cells were lysed and the cytoplasmic 
fractions purified exploiting the specific binding of the glutathione-S-transferase tag to 
immobilized glutathion (GSH). After washing the column with cell washing buffer, the 
target protein was eluted with reduced glutathion in cell washing buffer and 
then dialyzed against 100 volumes of TEV cleavage buffer. Purification procedure was 
analytically monitored by SDS-PAGE (figure 3.10).  
 
 
 
 
Figure 3.10. Analytical SDS-PAGE monitoring GSTtevHtr purification. 
Band below 30 kDa reference band indicated high over-
expression of GSTtevHtr in isotope enriched minimal 
medium. The isotope labelled GSTtevHtr was obtained 
analytically pure. 
 
The subsequent SDS-PAGE gel (figure 3.10) revealed high over-expression of the 
desired fusion protein upon IPTG induction in isotope enriched minimal medium as 
seen by the protein band below the 30-kDa-reference band. The eluate so obtained 
from the GSH column contained analytically pure isotope labelled GST-tevHtr fusion 
protein indicated by a single protein band. It was necessary to remove the used GSH 
from the eluted fraction by dialysis to prevent disulfide cross-linking with the N-
terminal cysteine containing peptide during proteolytic digest (data not shown). The 
yield of the fusion protein  was spectroscopically determined at a wavelength of 280 nm, 
where A280=1.392 (calculation: Expasy ProtParam algorithm) corresponded to a 
concentration of 1 g/l. Generally 20-30 mg purified protein per litre culture were 
obtained. 
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In addition to the successful establishment of a suitable isotope labelling protocol for  
the GSTtevHtr fusion protein the proteolytic removal of the N-terminal glutathion-S-
transferase leader sequence had to be optimised to liberate the isotope labelled EPL 
peptide building block. The conditions for the proteolytic TEV cleavage of the fusion 
protein were optimized by varying the substrate/protease ratios and incubation times. 
The progress of the cleavage was monitored by analytical SDS-PAGE (figure 3.8). Panel 
A summarizes the results of obtained for TEV/GSTtevHtr ratios  from 1/100, 1/250, 
1/500 up to 1/1000,  incubated at rt for 24 h.  
 
 
Figure 3.11. SDS-PAGE gels monitoring the optimization of proteolytic TEV 
digest of GSTtevHtr fusion protein. 
Panel A: Variation of TEV protease/GSTtevHtr ratio in 20 µl  
scale. After 24 h the appearance of GSTtev protein 
bands below GSTtevHtr bands indicated proteolytic 
cleavage.  
Panel B: Time course with a ratio increased to 1/50 at rt in 20 µl  
scale revealed 2/3 processing after 2 h followed by only 
minor changes. 
Panel C: Up-scaling to 1 ml reaction with 1/50 ratio 2 h at rt.  
The absence of any starting material indicated 
quantitative TEV cleavage. 
 
 
The SDS-PAGE gel monitoring the effect of the TEV protease/GSTtevHtr ratio on 
the proteolytic cleavage efficiency is given in figure 3.11, panel A.  In all cases the 
resulting GSTtev cleavage product with a molar mass of 27.1 kDa was detected, 
however a quantitative cut was not achieved in any of the digests.  
Therefore the TEV/GSTtevHtr ratio was increased to 1/50 and the time course of the 
reaction was investigated by SDS-PAGE. The observed relative intensities of the 
GSTtevHtr and GSTtev protein bands of around 1 to 2 (figure 3.11, panel B) revealed 
that within 2 h, approximately two thirds of the target protein was processed. In the 
following hours only minor changes occurred.  
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In order to consider adsorption of the TEV protease to the reaction cups in 20 µl scale 
reactions as a cause for incomplete digestion, an up-scaled 1 ml reaction was tested with 
a 1/50 ratio of TEV to GSTtevHtr for 2 h at rt. The reaction mixture was gently mixed 
on a spinning wheel and monitored by SDS-PAGE. Under these conditions a 
quantitative cleavage of the fusion protein was achieved; no more starting material was 
detectable even with a three times higher protein amount analyzed (figure 3.11, panel C).  
The cleaved Htr-peptide was not visible in the SDS-Page gels. Since the molecular 
weight of the cleaved peptide is only a tenth of the weight of the GSTtevHtr fusion 
protein, the amount of free peptide contained in a sample of 2 µg GSTtevHtr that was 
generally used for SDS-PAGE analysis, was below the detection limit.  
After almost quantitative proteolytic cleavage, all isotope labelled peptides were 
separated from the GST-tag using semi-preparative C18 RP-HPLC techniques with a 
linear gradient of acetonitrile in water from 5-65 % in 30 min and subsequently analyzed 
by mass spectrometry. 
Figure 3.12 summarizes the chromatograms obtained and mass spectra for unlabelled, 
[15N] and [13C, 15N] NpHtrII (84-114) G84C. All peptides were prepared with high purity 
as documented by single product peaks in RP-HPLC analysis. In addition, the observed 
molar masses of unlabelled, [15N] labelled and [13C, 15N] double labelled peptide were in 
good agreement with the respective calculated molar masses of M=3282 Da, 
M=3282+0.99·41=3323 Da and M=3282+0.99(132+41)=3453 Da with 0.99 
representing the 13C, 15N enrichment of respective isotope sources. The efficiency of 
isotope labelling could be determined to be 99 % and corresponds very well to the 
isotope enrichment of the respective 13C and  15N sources.  
The yields of the labelled peptides were usually 2.4-4.8 mg purified peptide per 2 l 
medium or 60-80 % based on the amounts of purified GSTtevHtr fusion proteins (yield: 
20-30 mg/l). 
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Figure 3.12. Analytical HPLC chromatograms and MALDI-MS of isotope labelled 
NpHtrII(84-114) G84C peptides. All variants were obtained 
analytically pure after TEV cleavage and C18 RP-HPLC with a linear 
acetonitrile gradient from 5-65 % in 30 min (retention time of 
26.5 min in all cases).  
Panel A: unlabelled peptide (Mcalc=3282 Da) 
Panel B: [15N] labelled peptide (Mcalc=3323 Da) 
Panel C: [13C, 15N] labelled peptide (Mcalc=3453 Da) 
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3.3 Expressed protein ligation 
3.3.1 EPL utilising HtrMxeCBD isolated from E.coli membranes  
3.3.1.1 HtrMxeCBD purification and evaluation 
 
The expressed protein ligation utilises inteins to generate activated α-thioester species 
that are subsequently joined together with a peptide containing an N-terminal cysteine. 
The generation of such peptides in isotope labelled form, a prerequisite for segmental 
isotope labelling of the halobacterial transducer, was described in section 3.2. In the 
following section the utilisation of these peptides in the EPL of the transmembrane 
protein HtrII in a C-terminal truncated version shall be described. 
For high-level expression of the transducer segment containing two transmembrane 
helices, a modified pTXB1 vector (New England Biolabs) was used, which encodes the 
GyrA intein from Mycobacterium xenopi N-terminally fused to a seven-histidine 
purification tag followed by a chitin binding domain (CBD). The modified construct 
was kindly supplied by R.P. Seidel. The htr(1-83) gene encoding for the two 
transmembrane helices of the HtrII was amplified using PCR and the pRPS1 plasmid as 
a template. The resulting DNA-fragment was purified with a PCR purification kit, 
subsequently digested and ligated into the Nde I and Sap I sites of modified pTXB1his 
vector. The ATG of the Nde I site is used as the start codon of the DNA-transcription. 
Sap I cloning allowed direct fusion of the transducer to the N-terminal cysteine residue 
of the intein45. Upon successful transformation of the plasmid into E.coli cells, protein 
expression of HtrMxeCBD was carried out at 37 °C for 3 h using 1 mM IPTG.  
Analytical SDS-PAGE was used to monitor the time course of the expression. 
The SDS-PAGE gel (figure 3.13) displays that the fusion protein is highly over-
expressed after IPTG induction as seen by the protein band above the 30 kDa reference 
band that appeared after 1 h of induction. After 2 h incubation no significant increase of 
the HtrMxeCBD fusion protein expression level could be achieved.  
Subsequent analysis of protein partitioning revealed a strong HtrMxeCBD protein band 
derived from the inclusion body fraction (figure 3.13) suggesting the localisation of the 
majority of the desired protein in insoluble aggregates. A minor amount is successfully 
incorporated into the membrane and therefore accessible in soluble form after 
solubilization with DDM. 
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Figure 3.13. SDS-PAGE monitoring HtrMxeCBD expression and partitioning. 
Protein band above the 30 kDa reference documented over-
expression of HtrMxeCBD ceiling after 2 h. The majority of 
HtrMxeCBD is located in inclusion bodies, only a minor amount 
is membrane incorporated. 
 
 
While lowering the expression temperature from 37 °C to 25 °C or 15 °C increased the 
amount of membrane-localized protein, the absolute protein yields purified from the 
respective membrane fractions was approximately 50 % lower compared to expressions 
performed at 37 °C (data not shown). 
Protein purification was performed using the specific affinity of the internal histidine tag 
to Ni-NTA matrix. After binding of the protein and a washing step with 20 mM 
imidazole the target protein was eluted with 200 mM imidazole and dialysed against 100 
volumes of imidazole free buffer Bmem. The Purification was monitored by analytical 
SDS-PAGE (figure 3.14, Panel A). The yield was spectroscopically determined at a 
wavelength of 280 nm. A fusion protein concentration of 1 g/l corresponded to 
A280=0.993 (calculation: Expasy ProtParam algorithm53). Typical yields were 3 mg per 
litre medium. 
The SDS-PAGE gel documenting the Ni-NTA purification of HtrMxeCDB solubilised 
from E.coli membranes revealed two protein bands for the purified eluate.  
A Comparison of gels analysing HtrMxeCDB originating from membranes (figure 3.14, 
panel A) or from inclusion bodies (figure 3.13) revealed an in-homogeneity of the 
soluble fraction: An upper band with an apparent molecular weight of 37.4 kDa, as 
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expected for the desired fusion protein and a second band with higher mobility 
appearing at approximately 32 kDa were distinguished.  
 
 
Figure 3.14. SDS-PAGE monitoring HtrMxeCBD purification and time course of its 
intein cleavage. 
Panel A: Ni-NTA based purification of HtrMxeCDB solubilised from 
E.coli membranes. Two protein bands found for eluate 
revealed a full-length and a degraded intein fusion protein. 
Panel B: Intein cleavage test.  Disappearing of the protein bands of  
both the desired long and the truncated intein fusion protein 
species suggested quantitative intein cleavage of both intein 
species. After 12 h only one band with an apparent molecular 
weight of 29 kDa for the cleaved MxeCBD intein was 
observed. 
 
 
The relative amount of both species varied from one protein preparation to another and 
was determined to vary from 33-66 % (upper band compared to lower band). The 
overall yield of the isolated fractions was spectroscopically determined at a wavelength 
of 280 nm. A fusion protein concentration of 1 g/l corresponded to A280=0.993 
(calculation: Expasy ProtParam algorithm53). Typical yields were 3 mg per litre medium. 
A subsequent intein cleavage test (without peptide to ligate), which was initiated by the 
addition of 200 mM MESNA, indicated an almost quantitative disappearing of both 
corresponding intein bands (figure3.15, panel B). After 12 h only one band with an 
apparent molecular weight of 29 kDa, assigned to the cleaved MxeCBD intein, could be 
observed (figure 3.14, panel B) revealing an almost quantitative intein cleavage efficiency 
of both intein species. 
In addition, the appearing of the single protein band corresponding to the cleaved 
intein, suggests a degradation of the N-terminal Htr-extein of the HtrMxeCBD fusion 
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protein as a reason for the observed double band. This implicated the presence of two 
α-thioester species: a full-length species with a calculated molecular mass of ca. 8 kDa∗ 
deriving from the desired full-length fusion protein and an N-terminally degraded 
species of approximately 3 kDa originating from the degraded fusion species. 
In order to support this hypothesis with experimental evidence, MALDI-MS 
experiments were performed. The mass spectrum of the purified HtrMxeCBD showed 
two signals that were broadened due the presence of detergent in the sample (figure 
3.15, panel A).  
In agreement with the results of the SDS-PAGE analysis (figure 3.14, panel A), 
molecular masses of M=37329 Da for the full-length protein (calculated 37357 Da) and 
M=32499 Da for the N-terminally degraded species were detected.  
This smaller mass signal suggests residue Ala47 as a possible degradation site in the 
HtrMxeCBD protein. The corresponding N-terminally degraded HtrMxeCBD(47-353) 
species has a calculated mass of M=32460 Da. Since Ala47 is part of a poly-alanine 
region forming a extra-cellular loop between TM1 and TM29,  it is likely that proteases 
can cleave in this region. However, the low spectral resolution prevents an explicit 
elucidation of this context.  
  
 
Figure 3.15. MALDI-MS experiments monitoring HtrMxeCBD cleavage reaction. 
Panel A: MS of HtrMxeCBD solubilised from membranes. The two 
signals at 37329 amu and 32499 amu were assigned to the 
desired HtrMxeCBD (M=37357) and to an N-terminally 
degraded HtrMxeCBD(47-353) form (M=32460 Da). 
Panel B: After completion of the intein cleavage reaction the signal 
at 29145 amu corresponded to the cleaved MxeCBD intein 
(M=29075). 
 
                                                 
∗ calculated by the subtraction of the molecular mass of the cleaved intein (29 kDa) from the molecular 
mass of the respective intein fusion protein species (37 kDa respectively 32 kDa). 
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After completion of the intein cleavage reaction only one broad signal of M=29145 Da 
was observed (figure 3.15, panel B). In the range of the spectral resolution this signal 
corresponded to the expected mass of the spliced intein (M=29075). signals of 
uncleaved intein species were not present confirming the quantitative intein cleavage 
efficiency that was already observed in the SDS-PAGE analysis (figure 3.13, panel B) 
Unfortunately no experimental evidence for the presence of two α-thioester species, the 
full-length Htr(1-83)-COSR and the postulated degraded Htr(47-83)-COSR, could  be 
obtained with these experiments: Besides the strong mass signal of the cleaved intein no 
signals for the respective thioesters could be resolved.  
 
 
3.3.1.2 Expressed protein ligation 
 
Expressed protein ligation experiments with the transducer were initially performed 
using the NBD-labelled fluorescent peptide NpHtrII(84-109)NBD G84C (see section 
3.2.2) to investigate the time course of the reaction by densitometric fluorescence 
methods.  
The Intein fusion protein HtrMxeCBD and the above-mentioned peptide, containing an 
N-terminal cysteine, were mixed in 1:1 ratio. Subsequently 200 mM MESNA were 
added to initiate the intein cleavage reaction. The ligation was carried out at rt with 
gentle agitation on a turntable. The progress of the reaction was monitored by SDS-
PAGE with the NBD-labelled peptide that was incubated under identical conditions in 
the absence of an intein, as a control.  
The SDS-PAGE gel was first analysed densitometrically (AIDA software, raytest, 
Staubenhardt, Germany) at 510 nm using 478 nm as excitation wavelength (figure 3.16, 
panel A) and subsequently stained with Coomassie (figure 3.16, panel B). 
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Figure 3.16. SDS-PAGE of expressed protein ligation of fluorescent Htr analogue. 
Panel A: Densitogram (excitation: 473 nm, emission: 510 nm). 
Protein bands 1 and 2 that appeared during EPL were 
assigned to the desired EPL product and an N-terminally 
degraded product. As reference NBD-labelled peptide was 
used that was incubated under identical conditions. 
Panel B: Coomassie staining. Disappearing of the protein bands of  
the full-length and the truncated intein fusion protein is 
slowed down referring to intein cleavage tests. Presence of 
HtrMxeCBD protein band after 36 h indicated incomplete 
intein cleavage during  EPL. 
Panel C: Time course of the EPL reaction based on densitometric 
protein band evaluation of unligated peptide (black), 
degraded (grey) and desired ligation product (light grey). 
Data traces were individually fit according to a first order 
reaction model revealing time constants of 7.1 h-1 (peptide), 
7.9 h-1 (degraded product) and 8.2 h-1 (desired product). 
 
 
Both analysis indicated that during the EPL reaction two new protein bands above the 
peptide reference band appeared (figure 3.16, panel A and B, band 1 and 2). Taking into 
account the results of the analysis of the previously described intein cleavage 
experiments using SDS-PAGE (figure 3.14, panel B) and MS (figure 3.15, panel A and 
B), which suggested the presence of two thioester species, these new bands were 
assigned to the desired target transducer and to an N-terminally degraded transducer 
variant. 
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In addition, the densitometric analysis of the obtained SDS-PAGE gel revealed two 
further faint bands with mobilities comparable to those observed for the cleaved and 
uncleaved intein species (figure 3.16, Panel A, indicated by arrow). Unspecific 
adsorption of the fluorescent peptide to the intein fusion proteins and to the spliced 
intein could be a possible explanation for this observation76.  
Coomassie staining of the SDS-PAGE gel showed a protein band of uncleaved 
HtrMxeCBD (starting material) after 36 h of reaction time (figure 3.16, panel B). This 
result suggests a decelerated intein cleavage kinetics referring to the cleavage tests 
without peptide (see section 3.3.1.1). 
The graphic representation of the densitometric analysis of the peptide, the degraded 
and the desired product plotted against reaction time is given in figure 3.16, panel C. 
The data were normalised to the observed densitometric intensity of the peptide at the 
beginning of the reaction. After 36 h reaction time the amount of unligated peptide was 
reduced to 54 % corresponding to a ligation efficiency of 46 %.  The relative amount of 
degraded product (37 %) is approximately four times higher than the amount of the 
desired product (9 %). Data traces were individually fitted according to a first order 
reaction model revealing time constants of 7.1 h-1 (peptide), 7.9 h-1 (degraded product) 
and 8.2 h-1 (desired product).  
The ligation efficiency could be slightly improved in further experiments by prolonging 
the reaction time to 72 h and shifting the stoichiometry of the reaction to a 30 % 
HtrMxeCBD excess. However, a quantitative ligation of the peptide could not be 
achieved in any case (results not shown). 
First purification experiments of this reaction mixture consisting of the three major 
compounds, the residual peptide, the long and the short ligation product were 
performed by analytical size exclusion chromatography (SEC) using a Superdex 200 
column and 300 mM NaCl, 50 mM NaPi, 0.05 % DDM, pH 8.0 as running buffer with 
a flow-rate of 0.5 ml/min.  
. 
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Figure 3.17. Purification of EPL reaction mix using size exclusion chromatography 
Panel A: SEC chromatogram monitoring 214 nm and 480 nm (ab- 
sorption maximum of NBD). Superdex 200 column with 
300 mM NaCl, 50 mM NaPi, 0.05 % DDM, pH 8.0 as 
running buffer and a flow-rate of 0.5 ml/min. Peaks after 
30 min and 39 min were assigned to the co-eluting long and 
short ligation products and to unligated peptide The signal 
after 42 min was not assigned.  
Panel B:  Densitogram (excitation: 473 nm, emission: 510 nm) of SDS- 
PAGE gel analysing SEC fractions The two protein bands 
(band 1 and 2) of fractions 27 min to 34 min were assigned 
to co-eluting full-length and degraded EPL product.  Lower 
band (fractions 32 min to 42 min) originates from unligated 
peptide. 
 
 
The chromatogram (figure 3.17, panel A) displayed a first peak after 19 min 
corresponding to the void volume of the column. After approximately 30 min a broad 
peak appeared at 480 nm. At this wavelength the absorbance maximum of the NBD-
label is monitored. With analytical SDS-PAGE analysis (figure 3.17, panel B) this signal 
could be assigned to the co-eluting long and short ligation products, which were not 
separable under these conditions. Two further peaks appeared after 39 min and 42 min 
whereas only the first one was identified as the fluorescent peptide. The second one was 
not assigned. Residual MESNA that was used during EPL caused the last strong signal 
after 57 min. The presence of detergent in the buffers reduced the resolution of the size 
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exclusion chromatography column and therefore an insufficient separation of the three 
major components of the reaction mixture was achieved. 
Analytical anion exchange chromatography using a 5x50 mm MonoQ column 
equilibrated under low salt conditions (10 mM Tris, 10 mM NaCl, 0.05 % DDM, 
pH 8.0) was also tested. The crude ligation mixture was dialysed twice against low salt 
buffer to facilitate binding of the analytes to the column matrix and subsequently loaded 
on the anion exchange column. Elution was performed using a linear gradient from 
10 mM to 350 mM NaCl in 7 min and analysed using SDS-PAGE. The gel (figure 3.18.) 
revealed two protein bands (band 1 and 2) in fractions 4.5 min to 7.0 min that were 
assigned to the desired respectively the degraded ligation product, which  were not 
separable under these conditions and co-eluted at high salt concentrations. However, 
unligated peptide eluted under low salt conditions indicated by a single band in fractions 
0.5 min to 4.0 min and was therefore successfully separated from the two ligation 
products. 
 
 
 
Figure 3.18. Purification of EPL reaction mix using anion exchange chromatography. 
5x50 mm MonoQ column equilibrated in 10 mM Tris, 10 mM NaCl, 
0.05 % DDM, pH 8.0. Elution by linear gradient from 10 mM to 
350 mM NaCl in 7 min (indicated by triangle) and monitored by SDS-
PAGE. 
Densitogram (excitation: 473 nm, emission: 510 nm) of the obtained 
gel: The two protein bands (band 1 and 2) of fractions 4.5 min to 7.0 
min were assigned to co-eluting full-length and degraded EPL product. 
Single band in fractions 0.5 min to 4.0 min indicates residual peptide 
successfully separated from the both ligation products. 
 
 
Based on the results of these analytical purification experiments, anion exchange 
chromatography was chosen for preparative scale purification of EPL products. Due to 
the lack of a preparative MonoQ anion exchange chromatography column, this material 
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was replaced in accordance to the already established purification protocols for 
recombinant Htr variants7,20 by DEAE anion exchange material.  
In first preparative purification attempts the crude EPL reaction mix was dialyzed 
against low salt buffer to adjust ion strength and to remove excess MESNA. Later on, 
dialysis was replaced by simple 1:10 dilution with salt free buffer. This procedure was 
less time and material consuming and did not negatively affect the purification 
procedure. The diluted sample was loaded onto the DEAE column, which was then 
washed with a buffer containing 80 mM NaCl. Elution was performed by washing of 
the column with elution buffer containing 500 mM NaCl Purification was monitored 
with analytical SDS-PAGE.   
 
 
Figure 3.19. Analytical SDS-PAGE of expressed protein ligation purification 
Panel A: DEAE anion exchange chromatography after 72 h 
reaction time. After purification no bands of cleaved 
intein (MxeCBD) and unligated peptide could be 
observed. The elution fraction revealed bands with 
mobilities ≥21.1 kDa (arrow) and ≤14.4 kDa (band 1) 
in addition to a third band with higher mobility 
(← band 2). 
Panel B: Ni-NTA affinity chromatography. The two bands 
≥21.1 kDa and ≤14.4 kDa in addition to the band 
with higher mobility (← band 2) correspond to dimer 
and monomer of the full-length ligation product and 
to the degraded one specifically interacting with Ni-
NTA matrix. 
 
Figure 3.19, panel A shows a silver stained SDS-PAGE gel monitoring the  purification 
of the EPL reaction after reaction time of 72 h. After removal of MESNA by dialysis, 
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the EPL product appeared as an intensive band with a molecular weight ≥21.1 kDa 
(figure 3.19, panel A, indicated by arrow) below the protein band of the cleaved 
MxeCBD intein. The observed mobility of that band suggested the formation of a 
homo-dimer that was also observed for the recombinant G84C mutant (see section 3.1). 
Reasons for that may be oxidative disulfide bridging of the Cys84 residue in the absence 
of MESNA after dialysis or ionic interactions under the conditions with low salt 
concentrations. 
Protein bands for uncleaved HtrMxeCBD (starting material) were not present indicating  
a successful improvement of the intein cleavage efficiency according to the prolonged 
reaction time from 36 h (see figure 3.16, panel B) to 72 h.  
SDS-PAGE analysis of the DEAE elution fraction after purification revealed the 
appearance of a protein band below the 14 kDa reference band (figure 3.19, 
panel A, band 1) that was in a good agreement with the expected mass of the desired 
ligation product. In addition, weakening of the band with a molecular weight ≥21.1 kDa  
was observed (figure 3.19, panel A, indicated by arrow). 
The presence of a protein band (← band 2) below the band of the monomeric target 
protein suggested incomplete separation of the two EPL products in the preparative 
purification scale. However, an enrichment of the desired full-length product was 
observed. The absence of protein bands of the cleaved MxeCBD intein and the 
unligated peptide suggest a quantitative separation of these compounds from both EPL 
products.  
 
In order to investigate the possible dimer formation of the full-length EPL product 
under the low salt conditions of the DEAE purification protocol (figure 3.19, panel A, 
indicated by arrow), a Ni-NTA metal affinity chromatography was carried out.  
Since the EPL ligation products are the only compounds of the DEAE elution fraction 
comprising an artificial histidine purification tag (the tag of the used NBD-labelled 
peptide), a dimer of the full-length product should specifically interact with the Ni-NTA 
matrix. However, a contamination with comparable molecular weight should be washed 
away.  
Therefore a sample of the DEAE elution fraction was loaded onto an analytical Ni-
NTA spin column equilibrated with 300 mM NaCl, 50 mM NaPi, 0.05 % DDM, 
pH 8.0,  washed with the respective buffer containing 20 mM imidazole and eluted with 
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300 mM NaCl, 200 mM imidazole, 50 mM NaPi, 0.05 % DDM, pH 8.0. The 
experiment was monitored by SDS-PAGE.  
A Coomassie stained gel (figure 3.19, panel B) documented two protein bands for the 
DEAE eluate as starting material and for the Ni-NTA eluate (indicated by arrow and 
band 1) in addition of a third band with higher mobility ( band 2). Due to the observed 
specific interaction with the Ni-NTA matrix and the results for the recombinant Htr(1-
114) G84C mutant (see section 3.1), these bands were assigned to the dimer and the 
monomer of the full-length ligation product as well as to the degraded transducer.  
Compared to a recombinant (1-114)NpHtrII reference, the full length EPL product 
exhibited a slightly higher mobility in SDS-PAGE, which corresponded to the mass 
difference between the two proteins due to the absence of the amino acid residues 110-
114 in the semi-synthetic transducer variant. 
In further experiments the results of this model EPL reaction should be transferred to 
ligations with isotopic labelled peptides. Special attention should be paid to the question, 
if the desired full-length ligation product with the native C-terminus can be separated, in 
contrast to the ligation product with the NBD-labelled terminus, from the N-terminally 
degraded variant.   
The ligation experiments were therefore repeated with a [15N] labelled peptide under the 
established conditions. Yields were spectroscopically determined according to 
Ehresmann et al.55 and were usually around 50 % compared to the used amount of 
peptide. The resulting product was purified as described using preparative DEAE anion 
exchange chromatography.  
In first MALDI-MS experiments performed to characterise the ligation product, no 
valid data with sufficient spectral resolution could be obtained. Therefore the 
biochemical evaluation of the semi-synthetic product was performed using alternative 
biochemical methods.  
In order to test ligation product for the free cysteine side chain as a result of a successful 
EPL, this residue was labelled with I-AEDANS, a thiol reactive fluorescence dye77. A 
purified EPL sample was incubated at 37 °C with 10 mM I-AEDANS. After 2 h the 
reaction was quenched by the addition of 40 mM DTT and further incubation for 1 h at 
37 °C. Subsequently the sample was analysed using SDS-PAGE densitometric  
fluorescence experiments.  
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Figure 3.20. Biochemical characterisation of the purified [15N] labelled EPL product. 
Panel A: SDS-PAGE gel of purified and I-AEDANS labelled product. 
Protein bands below 14.4 kDa and above 21.1 kDa were 
assigned to the monomeric and dimeric full-length product. 
The faint band below indicated traces of N-terminally 
degraded by-product. 
Panel B: Densitogram of the corresponding gel (excitation: 360 nm; 
emission at 450 nm). The intensive and the fate signal with 
less mobility corresponded to the full-length monomer and 
dimer. 
Panel C: Size exclusion chromatogram. The dominant signal after 
35 min was assigned to the monomeric full-length ligation 
product due to SDS-PAGE (inset). 
Panel D: MALDI-MS. The obtained spectrum of the EPL product  
showed signals at 11380 amu and 6590 amu. 
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The Coomassie stained SDS-PAGE gel (figure 3.20, panel A) of a sample of the labelled 
protein displayed a protein band below the 14.4 kDa reference and a second band of 
less intensity above the 21.1 kDa reference. The bands were assigned according to the 
results of the NBD-labelled model reaction to the monomer and the dimer of the 
desired full-length transducer.  
A mobility comparison of the labelled and the unlabelled samples (figure 3.20, panel A, 
lane 1 and 2) displayed a remarkable shift of the fluorescence labelled protein to higher 
molecular masses. A faint band below the protein band of the full-length monomer 
indicated traces of N-terminally degraded by-product of the EPL reaction.  
The densitogram of the SDS-PAGE gel upon excitation at 360 nm revealed an intensive 
fluorescent signal and a faint signal with less mobility (figure 3.20, panel B, lane 1).  A 
Comparison with the results obtained by Coomassie staining revealed the correlation of 
the fluorescence signals with the protein bands of the full-length monomer and dimer. 
In order to exclude unspecific adsorption of the lipophilic label to the membrane 
proteins,  the cysteines in a second sample were first capped with iodo acetamide and 
then incubated with the fluorescent I-AEDANS label. This reference sample showed 
only a minor fluorescence signals (figure 3.21, panel B, lane 2).  
In summary the I-AEDANS labelling experiments confirmed the presence of the free 
cysteine side chain of the ligation product as a result of a successful EPL. 
In further experiments samples of the purified ligation product were analysed for 
residual unligated peptide that would disturb subsequent NMR experiments. Size 
exclusion chromatography (SEC) using a Superdex 200 column was found to be a 
sufficient method to detect residual peptide in purification experiments of the ligation 
mixture with the NBD-labelled model peptide. These experiments were therefore 
repeated with a sample of the isotope labelled EPL product. The chromatogram of the 
ligation product revealed a dominant signal after 35 min (figure 20, panel C), which 
could be assigned to the ligation product by SDS-PAGE (figure 20, panel C, inset). No 
signals for residual peptide were found.  
The above-mentioned low spectral resolution in MALDI-MS experiments finally could 
be improved by modifying the protocol introduced by Hufnagel et al. in a way, that the 
matrix was dissolved in 66 % acetonitrile in 1 % aqueous TFA. This led to a more 
homogenous crystallization of the samples on the ultra-thin matrix-layer.  
The mass spectrum (figure 3.20, panel D) of the ligation product showed molecular 
masses of 11380 Da and 6590 Da.  
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The expected mass of the full-length [15N] labelled product was calculated to be 
11605 Da. The mass difference of ∆M=225 Da cannot be explained with a single N-
terminal methionine deletion78. In order to address this problem, a set of reference 
MALDI measurements were carried out using samples of (1-157)NpHtrII, 
(1-114)NpHtrII and (1-114)NpHtrII G84C. Sample preparation and instrument settings 
were comparable for all measurements. The results are summarized in table 3.1. 
 
Protein Theoretical mass [Da] Experimental mass [Da] ∆M [Da] 
[15N] 84-114 Htr(1-
114) G84C 
11564+41=11605 11380this work -225 
Htr(1-157) 17421 17222this work,62 -199 
Htr(1-114) 12663 12543this work,62 -120 
Htr(1-114) G84C 12709 12622this work -87 
 
Table 3.2. Theoretical and experimental masses of different transducer variants. 
 
In general all experimental masses were significantly smaller than the theoretically 
expected masses. This phenomenon was previously observed for heterologously 
expressed N.pharaonis transducers as well62.  
In the cases of the recombinant Htr(1-157) and ligated [15N] Htr(1-114), the obtained 
masses were even smaller than an N-terminal methionine deletion (∆M=-131.2 Da) can 
explain (table 3.2, column ∆M). Interestingly the experimental masses are in good 
agreement with theoretical masses considering a loss of the first two amino acids in 
both proteins: M=17219 for Htr(3-157) and M=11387 for [15N] 84-114 Htr(3-114) G84C. 
An explanation of this phenomenon could not be found, since the low resolution of the 
spectra did not allow a more detailed analysis.  
In summary the mass deviation of the long ligation product was similar to the one 
found for the reference protein from solely recombinant source and does not contradict 
signal assignment that was made.  
According to the hypothesis of an N-terminal degradation of the HtrMxeCBD 
precursor at the loop between TM1 and TM2 (see section 3.2.1.1), the observed mass of 
6590 amu (figure 3.20, panel D) can be explained by a [15N]-labelled Htr(48-114) 
fragment with a theoretical mass of 6525+41=6566 Da. In the range of the obtained 
spectral resolution this theoretical mass matches the experimental mass quite well. 
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3.3.2 EPL utilising HtrMxeCBD isolated from E.coli inclusion bodies 
3.3.2.1 HtrMxeCBD purification and folding 
 
The expressed protein ligation utilises inteins to generate activated α-thioester species 
that are subsequently joined together with a peptide containing an N-terminal cysteine. 
The intein fusion protein HtrMxeCBD was successfully expressed in E.coli. However, 
Ni-NTA purification of the DDM solubilised membrane fraction revealed the presence 
of N-terminally degraded HtrMxeCBD form (see section 3.3.1). Since this intein fusion 
species was fully functional, in EPL reactions this contamination led to two products, 
the desired target protein and a respective N-terminally degraded by-product. A 
separation of the desired full-length semi-synthetic transducer from the shortened 
product or a separation of the full-length intein from the truncated one could not be 
achieved using size exclusion, anion exchange or Ni-NTA chromatographic purification 
methods.  
The analysis of HtrMxeCBD protein partitioning revealed, that E.coli inclusion bodies 
consisted predominantly of the desired long precursor (figure 3.13). The establishment 
of a successful EPL utilising this well-defined target protein circumvents the 
contamination of the segmental isotope labelled transducer with an N-terminally 
degraded by-product. Therefore the following section describes attempts to purify, to 
refold the full-length HtrMxeCBD intein fusion protein from purified inclusion bodies 
and to use the refolded protein in EPL reactions to generate a segmental isotope 
labelled transducer. 
In a first step the isolation and purification of inclusion bodies was performed. 
Therefore the inclusion bodies were separated  from cytoplasma by centrifugation, 
washed with cell washing buffer containing 0.25 % Triton X-100 to remove residual 
lipids and subsequently two times with cell washing buffer to remove the detergent. 
Approximately 100 mg off-white pellets of inclusion bodies per gram wet cells could be 
isolated. The resulting product was analyzed by performing SDS-PAGE and MALDI-
MS. 
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Figure 3.21. Purification and biochemical analysis of HtrMxeCBD inclusion bodies 
Panel A: SDS-PAGE analysis. The single protein band above the 
30 kDa reference band for the inclusion bodies fraction 
suggested a highly pure full-length precursor protein.  
Panel B: MALDI mass spectrum. Signals at 37214 amu, 18605 amu,  
12406 amu and 9304 amu corresponded to a molecular 
weight of M=37213 Da and was assigned to an N-terminal 
methionine deleted HtrMxeCBD (Mcalc=37226). 
 
SDS-PAGE monitoring the isolation of inclusion bodies documented a single protein 
band above the 30 kDa reference band for the fraction of inclusion bodies suggesting a 
highly pure full-length precursor protein (figure 3.21, panel A). An N-terminally 
degraded variant, as described for the HtrMxeCBD isolated from membranes, was 
detectable only in a very small amount (figure 3.21, panel A).  
The mass spectrum of the purified inclusion bodies displayed signals for one protein 
species carrying different numbers of positive charges (M+H)+=37214, 
(M+2H)2+=18605, (M+3H)3+=12406 and (M+4H)4+=9304 (figure 3.21, panel B) that 
corresponded to an experimental mass of M=37213 Da. The mass difference of 
∆M=-145 Da compared to the calculated mass of the desired intein fusion protein 
HtrMxeCBD (M=37357 Da) and can be explained by an N-terminal methionine 
deletion78. 
These results confirmed the high purity of the HtrMxeCBD protein isolated from 
inclusion bodies as was already indicated on the SDS-PAGE gel. Therefore no 
additional Ni-NTA purification step was carried out. 
The process of intein cleavage requires a functionally folded intein. In order to obtain 
such a functional HtrMxeCBD protein isolated from inclusion bodies, the isolated 
aggregates had to be completely solubilised and subsequently refolded. A variety of 
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solubilisation and refolding conditions were tested. Figure 3.22 summarizes the tested 
conditions in a flowchart.  
First denaturing experiments were performed using 8 M urea as denaturant (8 M urea, 
25 mM NaPi, 300 mM NaCl, 0.02 %DDM). However, under these conditions complete 
solubilisation of the aggregates was not possible. Therefore in later experiments 
inclusion bodies were dissolved in 6 M guanidine hydrochloride and subsequently 
dialysed against the above-mentioned 8 M urea-containing buffer to lead back the new 
solubilisation protocol to the already established refolding conditions.  
Starting from 8 M urea, the chaotrope concentration was lowered stepwise by dialysis to 
6 M, 4 M, 3 M and finally 2 M urea at 4 °C. Centrifugation steps performed with high 
centrifugal forces after each dialysis step have been proven to be useful, because 
although intein solutions appeared to be free of aggregates, often a small amount of 
aggregated material was isolated by centrifugation. This helped to prevent further 
aggregation. 
Dialysis in absence of a reducing agent let to almost quantitative protein aggregation at 
4 M urea concentrations. An initial reduction of the protein with 10 mM TCEP over 
night combined with 1 mM TCEP present in all dialysis buffers facilitated decreasing 
the urea concentration to 2 M without significant losses due to precipitation.  
Intein cleavage experiments under these conditions with 1 % MESNA gave rise to 
cleavage efficiencies of approximately 50 % after two days, which was documented by 
two protein bands of comparable intensity in SDS-PAGE analysis, which were assigned 
to the cleaved and the uncleaved intein precursor protein (figure 3.23, Panel A). 
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Figure 3.22. Summary of HtrMxeCBD refolding experiments. All dialyses started either 
directly from 8 M urea containing buffer or from 6 M guanidine 
hydrochloride, which was replaced in a first dialysis step by 8 M urea 
containing buffer. Subsequently, the chaotrope concentration was lowered 
stepwise by dialysis to 6 M, 4 M, 3 M and finally 2 M urea at 4 °C. 
Centrifugation steps with high g-forces were performed after each dialysis 
step. 
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MALDI-MS experiments performed to identify the desired Htr(1-83)-COSR thioester, 
revealed a signal at 8480 amu (figure 3.23, Panel B). This signal correlated to an 
experimental protein mass that was about 40 Da larger than the expected 8446 Da for 
the desired MESNA-thioester species. The observed mass difference was reproducible 
for different protein preparations excluding a measuring artefact due to the obtained 
low spectral resolution. A possible explanation for this mass difference is a carbamylated 
thioester protein: One of the disadvantages of using urea is that it can form cyanic acid, 
which can modify amine or thiol groups to yield a carbamylated protein 
(∆M=+40 Da)79. 
In order to verify this hypothesis, 20 mM L-histidine was added as a scavenger for 
cyanic acid to all dialysis buffers80 to prevent the postulated carbamylation reaction. The 
additive successfully suppressed the modification as was documented by MALDI-MS 
experiments. The MALDI MS spectrum (figure 3.23, Panel C) reproducibly showed a 
cleaved thioester species with M+=8422 Da which corresponded nicely to the expected 
molar mass of the thioester without Na+ as a counter-ion of the mercaptoethane 
sulfonic acid.  
However, by the addition of L-histidine as a scavenger the refolding yields were reduced 
to ca 50 % compared to the experiments without scavenger due to protein precipitation 
(data not shown). It remained unclear, if the L-histidine itself caused this precipitation 
or if the protein had different solubility characteristics upon cabamylation compared to 
the unmodified protein.  
In order to prevent such extensive protein precipitation, similar experiments were 
carried out when TCEP was replaced with ethane thiol. In contrast to TCEP, ethane 
thiol is able to induce the cleavage of the intein fusion protein81. The idea behind this 
substitution was to shift the equilibrium between the folded and the unfolded state of 
the protein by inducing the cleavage of once folded protein and thereby taking the 
folded protein out of the folding equilibrium. Indeed the tendency to form aggregates 
could be significantly reduced (data not shown). 
SDS-PAGE analysis was performed to determined the cleavage efficiency of the 
refolded precursor in the presence of 1 % EtSH after the addition of 1 % MESNA. The 
gel  (figure 3.23, Panel A)  revealed a relative intensity of the protein bands obtained for 
the uncleaved compared to the cleaved HtrMxeCBD precursor of approximately 3:1 
corresponding to a cleavage efficiency of ca. 25 %. In summary the replacement of 
TCEP by EtSH could not improve overall refolding/cleavage efficiency. 
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Figure 3.23. Refolding and cleavage of solubilised HtrMxeCBD from inclusion bodies 
Panel A. SDS-PAGE analysis of intein cleavage of refolded HtrMxeCBD  
from inclusion bodies referring to samples purified from 
solubilised E.coli membranes. Intensities of the protein bands of 
cleaved and uncleaved HtrMxeCBD upon 1 % MESNA 
addition revealed cleavage efficiencies of ca. 50 %, 25 % and 
75 % for refolded mature protein refolded by dialysis in 
presence of TCEP respectively EtSH  or by fast 1:10 dilution 
after two days.  
Panel B. MADLI-MS of cleaved HtrMxeCBD refolded by dialysis 
without L-histidine containing urea buffers. Signal at 8480amu 
was assigned to carbamylated Htr-COSR (Mcalc=8486 Da). 
Panel C. MALDI-MS of cleaved HtrMxeCBD refolded by dialysis with 
L-histidine containing urea buffers. Signal at 8422 amu was 
assigned to Htr-COSR without sodium counter-ion of the of 
the mercaptoethane sulfonic acid (Mcalc=8423 Da). 
Panel D. MALDI-MS of cleaved HtrMxeCBD refolded by fast 1:10 
dilution into guanidine hydrochloride free buffer. Signals at 
8170 amu and 8289 amu were assigned to hydrolysed Htr-
COOH with and without N-terminal methionine 
(Mcalc=8300 Da and 8169 Da).  
 
As alternative to the refolding protocol using dialysis, rapid 1:10 dilution of the 
solubilised HtrMxeCBD protein was carried out. Starting from a solution in 6 M 
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guanidine hydrochloride and 2 % DDM (6 M Gdm, 300 mM NaCl, 50 mM NaPi, 2 % 
DDM, 1 mM TCEP, pH 8.0) dilution was performed by pumping the solution with a 
flow rate of 0.1 ml/min into the respective guanidine hydrochloride free buffer 
containing 0.05 % DDM (Amem). Almost no losses due to precipitation were observed. 
Protein cleavage was induced by 1 % MESNA and reached efficiencies higher than 
50 % determined by the comparison of the protein bands of cleaved and uncleaved 
intein precursor on a SDS-PAGE gel (figure 3.24, panel A).  
MALDI-MS experiments were performed to identify the desired Htr(1-83)-COSR 
thioester. The mass spectrum (figure 3.23, panel D) showed a major signal at 
M+=8170 Da and a minor signal at M+=8289 Da, which could be explained by an 
hydrolysed Htr(2-83)-COOH species with the N-terminal methionine cleaved off 
(calculated mass M+=8169 Da) and an hydrolysed Htr(1-83)-COOH cleavage product 
(calculated mass M+=8300 Da).  
An explanation for this hydrolysis cannot be given. Sine it is not reasonable to assume 
altering stability properties of successfully formed Htr-MESNA thioester species under 
the different folding conditions performed with comparable buffers with altering 
chaotrope concentrations, the formation of the thioester species itself might be a critical 
point.  
A possible explanation could be the refolded  intein precursor (refolded by dilution) 
adopts a protein fold that facilitates water molecules to enter the active centre of the 
intein. As a possible consequence a  nucleophilic attack of water molecules to the 
thioester intermediate formed upon the initial N-S acyl shift as the first step of the 
protein splicing mechanism82-85 (see section 6.2.1), sets free the hydrolysed Htr-COOH 
N-extein. In contrast to this, the mature protein refolded by slow dialysis processes 
successfully prevents water entering the active centre of the intein, thus facilitating the 
thiol additive to trap the initial N/S acyl shift intermediate and to form an activated Htr-
MESNA thioester species.  
In summary, the isolated inclusion bodies were denatured and subsequently functionally 
refolded using different protocols. An activated α-thioester was generated with cleavage 
efficiencies of approximately 50 % using 1 % MESNA after refolding the HtrMxeCBD 
protein using dialysis in order to lower urea concentrations to 2 M in the presence of 
TCEP and L-histidine. Unfortunately, all attempts to isolate the resulting thioester 
species using HPLC purification methods failed due to irreversible adsorption of the 
protein to the material of the reverse phase column. 
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3.3.2.2 Expressed Protein Ligation 
 
The successful refolding of the mature HtrMxeCBD protein from inclusion bodies 
facilitated a preparative access to a functional intein precursor without the presence of 
an N-terminally degraded by-product. The alternative purification protocol using 
denaturing and refolding of over-expressed inclusion bodies was an important 
prerequisite for successful segmental isotope labelling of NpHtr(1-114) using EPL. The 
following experiments should establish an EPL protocol using refolded HtrMxeCBD 
fusion protein and isotope labelled peptides. 
In preliminary  attempts, the optimized EPL protocol using the HtrMxeCBD protein 
isolated from membranes (see section 3.3.1.2) that describes the in-situ cleavage of the 
intein in presence of the isotope labelled peptide, was used. However, using this 
protocol no ligation product could be detected, either in SDS-PAGE or in MALDI-MS 
experiments.  
Taking these conditions as a starting point, a set of EPL conditions using denaturing 
chaotropes or organic solvent additives was screened. In order to enhance the 
accessibility of the C-terminal thioester moiety in the Htr(1-83) segment, the EPL was 
performed under denaturing conditions. Therefore in a first step the cleavage of the 
refolded HtrMxeCBD protein was initiated with 3 % ethane thiol in the absence of any 
chaotrope81. In a second step the solution was adjusted to denaturing conditions by the 
addition of 6 M guanidine hydrochloride with or without 30 % TFE. This step rather 
then stopping the cleavage reaction by unfolding the Mxe intein, enhances the C-
terminal accessibility of the N-terminal transmembrane segment. The ligation itself was 
subsequently initiated by the addition of 1 % MESNA to generate a more reactive 
thioester species and by the addition of the C-terminal peptide fragment (1:1 
stoichiometry). After 48 h of incubation (72 h after cleavage initiation) samples were 
precipitated with 5 % TCA, washed and monitored with analytical SDS-PAGE and 
MALDI-MS. (figure 3.24).  
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Figure 3.24. Screening of EPL conditions using chaotropic or organic solvent additives. 
Panel A: SDS-PAGE gel. Cleavage of the refolded HtrMxeCBD with 3 % 
EtSH without chaotropes. Adjustment to 6 M guanidine 
hydrochloride with or without 30 % TFE after 1 d. EPL 
initiation with 1 % MESNA and [15N] peptide (1:1). The two 
protein bands at 37 kDa and 30 kDa are assigned to uncleaved 
and cleaved precursor. No product band at 11.5 kDa  is 
observed in any case. 
Panel B: MALDI-MS of crude EPL without chaotropic or organic solvent 
additives after 72 h. Signals for uncleaved HtrMxeCBD at 
37280 amu, 18648 amu, 12423 amu, for cleaved MxeCBD 
29141 amu, 14574 amu, for degraded HtrMxeCBD 31533 amu, 
15765 amu and for unligated α-thioester 8438 amu, 16871 amu. 
A signal at 11380 amu for the desired product is not observed. 
 
 
The SDS-PAGE gel showed two protein bands of comparable intensities with 
mobilities corresponding to ca. 37 kDa and 30 kDa. According to the results obtained 
from HtrMxeCBD expression and intein cleavage experiments (see section 3.3.1) these 
bands were assigned to the uncleaved and cleaved intein precursor protein. This 
observation suggests that all investigated samples reached an intein cleavage efficiency 
of approximately 50 % after 72 h. This  was observed, in the previously described 
refolding and cleavage experiments of HtrMxeCBD isolated from inclusion bodies (see 
section 3.3.2.1). The adjustment of the EPL reaction mixture to denaturating conditions 
after 24 h of intein cleavage with ethane thiol, showed no significant effect on cleavage 
efficiencies. 
Unfortunately, no protein band with an apparent molecular weight of about 11.5 kDa as 
expected for a formed ligation product appeared in the SDS-PAGE gel (figure 3.22, 
panel A). The two visible bands that were observed in all samples including the 
Results 
 75
references without any peptide between 16.5 and 25 kDa, were protein contaminations 
found for this HtrMxeCBD protein preparation. 
In addition to the electrophoretic investigations MALDI-MS experiments were 
performed to evaluate the ligation reactions. The spectra did not reveal any product 
formation either.. The displayed MALDI spectrum represents an EPL performed with 
1 % MESNA in the absence of chaotropes and shows signals for not cleaved 
HtrMxeCBD (M+H)+=37280 Da, (M+2H)2+=18648 Da, (M+3H)3+=12423 Da, for 
cleaved MxeCBD (M+H)+=29141 Da, (M+2H)2+=14574 Da, for N-terminally degraded 
HtrMxeCBD protein (M+H)+=31533 Da, (M+2H)2+=15765 Da and for the not ligated 
α-thioester (M+H)+=8438 Da, (M2+H)+=16871 Da (figure 3.22, panel B). A signal 
around 11380 amu (see section 3.3.1.2) for the desired [15N] transducer was not 
observed in any case.  
The MALDI spectra representing the EPL reactions performed under chaotropic 
conditions, displayed the same signals, differing only in their signal to noise ratio. 
Guanidine hydrochloride containing EPL samples, even after extensive washing, often 
did not produce M+-signals of the intein species (results not shown).  
The absence of any signal for the desired target protein remains unclear. A successful 
ligation reaction of Htr-thioester was expected as it was observed in experiments with 
HtrMxeCBD protein isolated from E.coli membranes (see section 3.3.1.2). The presence 
of chaotropes is reported to enhance thiol mediated ligation reactions of α-thioesters 
with peptides containing N-terminal cysteines86-90.  
In order to exclude inhibiting effects of TCEP and L-histidine that were used during the 
refolding of the HtrMxeCBD protein, control experiments without TCEP and 
L-histidine were performed. Here, as well no ligation product was detected (results not 
shown). An explanation for this phenomenon cannot be given. A reasonable hypothesis 
might be that refolding of the HtrMxeCBD protein leads to a cleavable intein that 
however, liberates a misfolded transmembrane Htr(1-83) fragment, whose C-terminus 
even in the presence of chaotropes is not accessible for the attacking thiol-moiety of the 
C-terminal EPL segment. 
Up to this time-point, all chosen EPL conditions contained DDM as a detergent. In 
order to alter this factor, a further set of experiments was carried out, where dodecyl 
maltoside was replaced by the mild zwitterionic detergent CHAPS. The replacement was 
achieved by ion exchange chromatography. A sample of refolded HtrMxeCBD protein 
(17 mg) in DDM containing buffer (2 M urea, 0.5 M NaCl, 10 mM TrisHCl, 20 mM L-
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histidine, 1 mM TCEP, 0.02 % DDM, pH 8.0) was diluted 1:10 with TrisHCl buffered 
CHAPS (2 M urea, 10 mM TrisHCl, 20 mM L-histidine, 1 mM TCEP, 3 % CHAPS 
pH 8.0) in order to lower the salt concentration below 80 mM. After loading the sample 
onto the column and a washing step with the respective buffer containing 80 mM NaCl 
in order to remove residual DDM, the protein was eluted with the respective buffer 
containing 500 mM sodium chloride. Protein yield was 10 mg corresponding to a 
recovery of about 60 %.  
With this protein sample EPL was performed as per the above-mentioned set of 
conditions including chaotrope-free or 6 M guanidine hydrochloride with or without 
TFE containing buffers. Again no product formation was detected with SDS-PAGE 
and MALDI-MS. 
A second attempt to avoid DDM as detergent was the usage of a lipidic cubic phase 
environment for the EPL91. In recent experiments the intein fusion protein in 
approximately 30 g/l concentrations was mixed in 2:1 stoichiometry with the C-terminal 
peptide segment and 200 mM MESNA. 1-Mono-oleoyl-rac-glycerol was rapidly mixed 
with this reaction mixture (0.67 g/ml)9,91. The mixture so obtained became highly 
viscous and turbid at once and formed a transparent gel after centrifugation. The lipidic 
cubic phase reaction mixture was incubated at 23 °C. After 3 days MALDI-MS 
investigations were performed with samples that were precipitated with 2 volumes of 
acetone and washed twice with ice-cold 70 % ethanol. 
 
Figure 3.25. MALDI-MS of expressed protein ligation in lipidic cubic phase 
using a [15N] labelled C-terminal peptide segment 
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The MALDI mass spectrum of the crude EPL reaction mixture containing a [15N] 
labelled peptide segment displayed two major peaks in a mass range up to 20 kDa, 
m/z=11398 amu and m/z=5705 amu. Within the measuring accuracy the signals could 
be assigned to (M+H)+=11398 Da and (M+2H)2+=5705 Da signals of the 
[15N]84-114(3-114)Htr G84C target protein suggesting a successful ligation of the 
transducer in lipidic cubic phase environment. The experimental mass was in a good 
agreement with the calculated mass of 11387 Da and the molecular weight of 11380 Da 
that was detected in experiments with the HtrMxeCBD protein isolated from E.coli 
membranes (see section 3.3.1.2). A signal of unligated Htr-thioester with 8446 amu was 
not detected.  
Attempts to purify the crude reaction mixture with RP-HPLC as described in literature91 
failed due to irreversible adsorption of the target protein to C18 and to C4 reverse phase 
materials. First purification experiments using DEAE anion exchange chromatography 
remained unsatisfactory due to incomplete solubilisation of the target protein with 
DDM as detergent from the lipidic cubic phase environment (results not shown). 
Further optimisation of the ligation reaction itself and of a suitable purification protocol 
has to be done in order to establish a robust and efficient semi-synthetic access to the 
transducer protein starting with HtrMxeCBD refolded from E.coli inclusion bodies.  
These experiments in lipidic cubic phase environment emphasise the critical role of the 
correct folding of the Htr(1-83) thioester during EPL. Only the reconstitution of the 
membrane protein into a lipid bilayer made the C-terminal thioester moiety accessible 
for the peptide and thereby make a successful ligation reaction possible. 
 
 
3.3.3 Biological evaluation of the semi-synthetic transducer NpHtrII 
 
In the sections 3.3.1.2 and 3.3.2.2 attempts to establish a semi-synthetic access to the 
archeabacterial transducer from N.pharaonis were described. The HtrMxeCBD intein 
fusion protein that was used in the EPL, was either isolated from E.coli membranes or 
was refolded from insoluble inclusion bodies.  
The following experiments were performed to answer the question-‘ if a semi-synthetic 
protein with its full biological function was obtained’. Hippler-Mreyen et al. successfully 
characterised the SRII/HtrII complex formation of differently truncated transducer 
constructs using blue-native gel electrophoresis60,62-64. In this work BN-PAGE was used 
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as well to determine the capability of the recombinant Htr(1-114) G84C mutant to bind 
to its cognate receptor (see section 3.1). 
Due to the lack of a suitable purification method of the semi-synthetic transducer that 
was obtained from EPL experiments in lipidic cubic phase environment, BN-PAGE 
investigations were only performed with the semi-synthetic transducer obtained from 
membrane partitioned HtrMxeCBD protein. Similar experiments with the semi-
synthetic transducer derived from the refolded intein fusion protein have to be done, 
when a suitable purification method is established.  
The semi-synthetic transducer was mixed with its SRII binding partner in a 1:1 and 1:2 
stoichiometry and was incubated at 4 °C overnight. As reference a 1:1 mixture of 
NpHtr157/NpSRII was used. 
 
 
Figure 3.26. Investigation of complex formation between semi-synthetic Htr and SRII 
Panel A: BN-PAGE gel with different SRII/Htr stoichiometries. Samples 
neither with 1:2 nor with 1:1 stoichiometry show a protein band 
referring to an Htr/SRII complex. The observed intensive 
bands showed mobilities comparable to the SRII reference 
indicating unbound SRII. 
Panel B: Silver stained 2D-PAGE gel with BN-PAGE in 1st and SDS- 
PAGE in 2nd dimension (black box). The intensive BN-PAGE 
protein band only consists of unbound SRII indicated by a 
single protein band with low mobility marked by the black 
arrow verifying the absence of a Htr/SRII complex.  
 
The blue-native PAGE gel (figure 3.26, panel A) did not show a protein band referring 
to an Htr/SRII complex. The observed protein bands with high intensity for samples 
with 1:2 or 1:1 stoichiometry (SRII:Htr) displayed mobilities comparable to the SRII 
reference. Compared to the Htr157 reference no shift of the SRII band to higher 
molecular masses was observed due to complex formation.  
Results 
 79
In order to exclude a SRII-shift due to complex formation that could not be observed 
because of a low electrophoretic signal resolution, the BN-PAGE lane of the ligation 
product sample (black box) was cut out and polymerised on a SDS-PAGE gel. The 
resulting 2D-gel (figure 3.26. panel B) showed a signal corresponding to SRII (black 
arrow), however revealed no crosspeak for an Htr/SRII complex and therefore 
confirmed the absence of an Htr/SRII complex. 
Sanders and co-workers reported a method that uses reconstitution into lipids to refold 
the integral membrane protein diacylglycerol kinase, which is found in the cytoplasmic 
membrane of many bacteria92. They used reconstitutive refolding for the successful 
renaturation of 65 single-cysteine mutants of DAGK by reconstituting the mutants into 
POPC vesicles and by dialysing the detergent dodecylphosphocholine out of the 
micellar mixtures. This in-vitro refolding investigation revealed the important role that 
membrane lipids play in the folding process of membrane proteins. 
According to these results, the influence of the membrane environment to correct 
folding of the semi-synthetic transducer and its influence to the complex formation with 
SRII was investigated. 
The ligation product was reconstituted into polar purple membrane lipids and 
subsequently re-solubilised again with DDM containing buffer. After performing 
DEAE anion exchange chromatography to remove excessive detergent and lipids, 
which disturb BN-PAGE experiments, the binding assay was repeated with a 1:1 
stoichiometry of SRII to semi-synthetic Htr114.  
The BN-PAGE gel (figure 3.27, panel A) showed a faint band for the re-solubilised 
sample with a mobility higher than the Htr(1-157)/SRII complex reference band and 
lower than the SRII reference band. Therefore it was concluded that the re-solubilised 
transducer formed a complex with its binding partner SRII, although uncomplexed SRII 
was still detectable. A corresponding complex band of the not reconstituted reference 
was not observed, confirming the above-mentioned BN-PAGE results.  
The ratio between functionally folded semi-synthetic transducer, capable of undergoing 
complex formation and inactive transducer was estimated based on band intensities to 
be approximately 1:5. The presence of the N-terminally degraded ligation by-product 
(see section 3.3.1.2) and a low refolding efficiency of the full-length semi-synthetic 
transducer could explain the incomplete complex formation. 
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Figure 3.27. Investigation of complex formation of re-solubilised semi-synthetic NpHtr.  
Panel A: BN-PAGE gel of reconstituted and re-solubilised Htr referring  
to recombinant Htr(1-157) in 1:1 stoichiometry with SRII. The 
faint protein band (black arrow) with a mobility higher than 
Htr(1-157)/SRII complex reference band and lower than SRII 
reference band is assigned to an Htr/SRII complex. 
Panel B: BN-PAGE with 1:5 SRII/Htr stoichiometry. The intensive 
band (black arrow) indicates quantitative complex formation for a 
1:5 stoichiometry, no band of free SRII is detected.  
Panel C: 2D SDS-PAGE with BN-PAGE gel lane 1:5 as 1st dimension. 
The upper protein band corresponds to SRII and the signal with 
higher mobility (black arrow) indicates semi-synthetic Htr(1-114) 
revealing successful Htr/SRII complex formation. 
  
In order to verify the estimated amount of functionally folded semi-synthetic transducer 
in the sample, the 5-fold amount of re-solubilised ligation product was incubated with 
SRII and investigated with BN-PAGE. The gel (figure 3.27, Panel B) displayed an 
intensive band indicating quantitative complex formation in 1:5 stoichiometry; no band 
of free SRII was detected. 2D-SDS-PAGE experiments were performed to verify the 
complex formation. The BN-PAGE lane of the ligation product (black box) was cut out 
and polymerised on a SDS-PAGE gel. The resulting 2D-gel (figure 3.27. panel C) 
showed a signal corresponding to SRII and a signal with higher mobility (black arrow) 
indicating semi-synthetic Htr114 revealing successful Htr/SRII complex formation. 
The blue-native electrophoresis experiments revealed the ability of the semi-synthetic 
transducer to form a complex with its cognate receptor. In addition, evidence was found 
that the reconstitution of the ligation product into a lipid bilayer is necessary for the 
correct folding of the semi-synthetic membrane protein. 
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3.4 Expression of uniformly isotope labelled proteins from N.pharaonis 
 
In the sections 3.3.1.2 and 3.3.2.2 attempts to establish a semi-synthetic access to the 
archeabacterial transducer from N.pharaonis were described. The HtrMxeCBD intein 
fusion protein that was used in the EPL reactions, was either isolated from E.coli 
membranes or was refolded from insoluble inclusion bodies.  
However, purification of the DDM-solubilised membrane fraction revealed the 
presence of an N-terminally degraded HtrMxeCBD protein (see section 3.3.1). Since 
this intein fusion species showed full intein cleavage activity, this contamination led to 
an N-terminally degraded EPL by-product. A separation of the desired full-length semi-
synthetic transducer from the degraded product or a separation of the full-length intein 
from the truncated one could not be achieved. 
Analysis of HtrMxeCBD protein partitioning revealed that the desired long intein 
precursor was deposited predominantly in E.coli inclusion bodies. Attempts to establish 
a successful ligation reaction using a lipidic cubic phase environment91  circumvented 
the contamination of the segmental isotope labelled transducer with an N-terminally 
degraded by-product (see section 3.3.2.2). However, further optimisation of the ligation 
reaction itself and of a suitable purification protocol has to be done in order to establish 
a robust and efficient semi-synthetic access to the transducer protein starting with 
HtrMxeCBD refolded from E.coli inclusion bodies.  
In addition to the establishment of a semi-synthetic access to domain specific isotope 
labelled Htr114, uniform isotope labelled transducer variants were expressed in E.coli. 
The spectroscopic analyses of these proteins using magic angle solid state NMR and 
Fourier transform infrared spectroscopy would build together with data obtained in 
from segmental isotope labelled transducers the experimental base of a spectroscopic 
structure determination of the N.pharaonis transducer.  
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3.4.1 [ 13C,15N] NpHtr(1 -114) 
 
The C-terminally truncated Htr(1-114) protein was expressed in minimal medium 
containing [13C]-D-glucose and [15N]-ammonium chloride as carbon and nitrogen source 
respectively, in order to obtain a uniformly isotope labelled transducer. The time course 
of the expression and the purification of the His-tagged protein was analysed with SDS-
PAGE. 
 
 
Figure 3.28. Expression, purification and evaluation of [13C,15N] labelled Htr(1-114). 
Panel A. SDS-PAGE monitoring expression, Ni-NTA and DEAE  
anion exchange chromatography. The protein band above 
the 14.4 kDa reference band (black arrows) appearing after 
2 h after IPTG induction is assigned to isotope labelled 
Htr(1-114). The absence of numerous faint protein bands in 
addition to this transducer band documents significant 
improvement of the sample purity upon DEAE anion 
exchange chromatography. 
Panel B. MALDI-MS of [13C,15N] labelled Htr. The signals at 
13244 amu and 6619 amu are assigned to the (M+H)+ and 
the (M+H2)2+ signal of the isotope labelled transducer with 
an expected mass of 13257.8 Da. 
 
The SDS-PAGE gel (figure 3.28, panel A) documented a protein band (black arrow) 
above the 14.4 kDa reference band appearing after 2 h after IPTG induction. Due to 
the good agreement with the calculated molecular weight of 12.7 kDa, this band was 
assigned to isotope labelled, recombinant Htr(1-114). Longer incubation times 
significantly decreased again the Htr114 expression level: After 4 h of induction no 
recombinant target protein could be isolated (results not shown).  
Protein purification was performed exploiting the C-terminal histidine tag. After binding 
of the protein to Ni-NTA matrix and a washing step with 20 mM imidazole, the target 
Results 
 83
protein was eluted with 200 mM imidazole. In order to remove the competitor again, 
preparative DEAE anion exchange chromatography was performed yielding around 
2-2.5 mg purified protein per litre minimal medium.  
Purification was monitored using SDS-PAGE analysis. The gel (figure 3.28, panel A) 
showed a protein band above the 14.1 kDa reference band for the Ni-NTA and DEAE 
eluate corresponding to the desired protein. Anion exchange chromatography 
significantly improved the purity of the sample as was indicated by the absence of 
numerous faint bands of contaminating proteins. 
In order to determine the isotope labelling efficiency of the purified protein, MALDI-
MS experiments were performed. The mass spectrum showed a signal at 13244 amu and 
a second signal at 6619 amu, which were assigned to the (M+H)+ and the (M+H2)2+ 
signal of the isotope labelled transducer.  
The expected mass of the uniformly [13C,15N] labelled target protein was calculated to be 
12543+x(559+163)=13243 Da with M=12543 Da representing the experimental mass 
of the unlabelled Htr(1-114) (see section 3.3.1.2) and with x representing an observed 
isotope labelling efficiency. The experimentally observed labelling efficiency of 97.0 % 
was in a good agreement with the content of isotope in the respective 13C and 15N 
sources of 99 %.  
 
 
3.4.2 [ 13C,15N] NpHtr(1 -157) 
 
[13C,15N]-labelling of Htr(1-157) was achieved using protein expression in synthetic 
minimal medium with isotope enriched D-glucose and ammonium chloride as sole 
carbon nitrogen sources. Purification of the protein was performed by exploiting the 
affinity of the C-terminal histidine-tags to Ni-NTA matrix. After a washing step with 
Cmem buffer containing 20 mM imidazole, the proteins were eluted with Dmem buffer 
containing 200 mM imidazole. Subsequently DEAE anion exchange chromatography 
was carried out. The protein was obtained in yields of about 2-2.5 mg per litre medium.  
Protein purification was monitor with SDS-PAGE analysis. The gel (figure 3.29, panel 
A) showed a protein band with a mobility comparable to the 21.1 kDa reference band 
(black arrow). According to the achieved electrophoretic resolution this experimental 
molecular weight is in a good agreement with the theoretical value of 17.4 kDa. 
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Therefore the protein band was assigned to the isotope labelled, recombinant Htr157 
transducer.  
After DEAE anion exchange chromatography an analytical pure transducer was 
obtained. The gel showed a faint protein band above the 30 kDa reference, besides the 
band for the monomer (figure 3.29, panel A, black arrow). The observed mobility of this 
band is in agreement with the mobility of a postulated homo-transducer dimer 
(34.8 kDa).  
 
 
Figure 3.29. Purification of [13C,15N] labelled sensory rhodopsin II and Htr(1-157). 
Panel A: SDS-PAGE monitoring [13C,15N] Htr157-purification. The 
protein band with mobility comparable to the 21.1 kDa 
reference band (black arrow) was assigned to isotope 
labelled, recombinant transducer. The faint above the 
30 kDa reference suggests dimer formation. 
Panel B: MALDI-MS of purified [13C,15N] labelled Htr157. The 
signals at 18162 amu, 9085 amu and 6039 amu were 
assigned to different protonated states of the isotope 
labelled Htr157. 
 
In order to determine isotope labelling efficiency, MALDI-MS experiments were 
performed. The spectrum (figure 3.29, panel B) showed three major signals at 
18162 amu, 9085 amu and 6039 amu. These signals were assigned to a series of 
differently protonated states of the isotope labelled Htr157. The expected mass of this 
protein was calculated to be M=17222+x(755+220)=18162 with 17222 Da representing 
the already determined experimental mass of the unlabelled protein (see section 3.3.1.2) 
and with x representing the observed labelling efficiency. The experimentally obtained 
molecular weight of 18162 Da corresponded to an observed labelling efficiency of 
96.4 %, which was in a good agreement with the observed efficiency of 97.0 % for 
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Htr(1-114) (see 3.4.1) and corresponded to the content of isotopes in the respective 13C 
and 15N sources of 99 %.  
 
 
3.4.2 [ 13C,15N] NpSRII 
 
Isotope labelling of SRII was done in a manner similar to the labelling of the 
transducers (see section 3.4.1 und 3.4.2) in minimal medium with labelled glucose and 
ammonium chloride. Upon solubilisation of the protein from the E.coli membranes Ni-
NTA-based separation of the receptor was performed. DEAE anion exchange 
chromatography removed the imidazole that was used for the elution of the histidine-
tagged protein from the Ni-matrix.  
Figure 3.30 shows a SDS-PAGE gel documenting a protein band above the 21.1 kDa 
reference band (black arrow) that was assigned to isotope labelled, recombinant SRII. 
The protein was obtained in analytically pure form in yields of about 1-1.5 mg/l.  
 
 
 
Figure 3.30. SDS-PAGE monitoring [13C,15N] labelled sensory rhodopsin II purification. 
The protein band above the 21.1 kDa reference band (black arrow) was 
assigned to pure, isotope labelled, recombinant SRII. 
 
In order to determine SRII isotope labelling efficiency, MS experiments were carried 
out. Unfortunately no mass spectrum of the labelled receptor was obtained either with 
MALDI-MS according to the already described modified method from Cadene et al.58 
(see section 3.3.1.2) or with ESI-MS according to Hufnagel et al.59.  
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First steady-state FTIR measurements using the labelled receptor answered the question 
of the obtained labelling efficiency: A qualitative downshift of the characteristic C=O 
stretch vibration of Asp75 from 1765 cm-1 to 1720 cm-1 indicated a quantitative isotope 
labelling of the receptor (for detailed discussion the section 3.6). 
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3.5 Nuclear magnetic resonance (NMR) spectroscopy 
3.5.1 Isotope labelled NpHtrII(84-114) G84C peptides 
 
The cytoplasmic domain of NpHtrII comprising residues 84 to 114 was soluble in 
aqueous buffers without any detergents or chaotrope additives. NMR experiments 
investigating the degree of isotope labelling of the different peptides were performed in 
20 mM NaPi, 8 % D2O, pH 6.5 at 25 °C. Under these conditions peptide 
concentrations of 0.85-1.65 mM were used without any problems of precipitation. A 
complete set of 1D and 2D spectral data was recorded using a Bruker 500 MHz (11.7 T) 
or Varian 600 MHz (14.1 T) NMR spectrometer. The water signal was suppressed by 
selective pre-saturation during the preparation period and/or mixing time. A summary 
of the experiments performed is given in table 3.3. 
 
HtrII(84-114) G84C Experiments Nucleus Concentration pH 
unlabelled 
1D 1H  
2D TOCSY  
2D NOESY  
1H 1.03 6.5 
[15N] labelled 
1D 1H 
2D 1H,15N-HSQC 
3D 1H,15N-NOESY 
1H,15N 0.85 6.5 
[13C, 15N] labelled 
1D 1H 
2D 1H,15N-HSQC 
2D 1H,13C-HSQC 
1H,15N 
1H,13C 
1.65 6.5 
 
Table 3.3. Summary of recorded NMR experiments of HtrII (84-114) G84C. 
 
The assignment of proton resonances was performed iteratively with TOCSY and 
NOESY spectra in two steps: first the amino acid spin systems were identified in 
TOCSY spectra, subsequently the sequential order of the spin systems was determined 
by the interpretation of dipolar couplings in NOESY spectra. Software assisted data 
evaluation was carried out using AURELIA software (Bruker Inc.). A small 
experimental resonance signal dispersion of only 0.54 ppm for HN chemical shifts and 
0.77 ppm for Hα chemical shifts complicated the signal assignment of the 31-residue  
comprising peptide (figure 3.31). 
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Figure 3.31. HN/Hα region of a TOCSY spectrum of Htr (84-114) G84C. 
 
A 15N-separated 1H,15N-3D NOESY experiment could resolve partially overlapping 
resonances of five alanine and four leucine residues. All ambiguities were solved and a 
complete sequential assignment except for residues Cys84 and Asp85 was obtained 
(table 3.4).  
Signal broadening due to fast proton exchange prevented NH3+ identification of Cys84. 
The Asp85 Hα resonance partially overlapped with the water signal and could not be 
assigned. An HN/Hα NOE path depicts the complete sequential resonance assignment 
of the peptide (figure 3.32, panel A).  
This small signal dispersion was especially observed for the residues up to 
approximately Met100. Beginning from there, a significant higher dispersion was 
detected due to sequential alteration of glycine and aspartic acid residues, which have 
highly different Hα  random coil shifts. However, the signal dispersion of the residue-
cluster Asp106 to Arg112 could not be explained only with differences of the random 
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coil shifts. The strength of the sequential NOE signals between HN of residue i with HN 
of residue i+1 in the HN/HN region (figure 3.29, panel B) combined with higher signal 
dispersion suggested the formation of an α-helical stretch within this cluster.  
 
 
 
Figure 3.32. Sequential assignment in a NOESY spectrum of Htr (84-114) G84C 
    Panel A: HN/Hα region 
    Panel B: HN/ HN region 
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Residue 15N HN Hα Hβ Hγ Others 
Cys84 - - - - - - 
Asp85 117.03 8.28 4.67 2.58 - - 
Thr86 117.08 8.27 4.23 4.25 1.18 - 
Ala87 128.05 8.38 4.20 1.36 - - 
Ala88 124.63 8.19 4.23 1.34 - - 
Ser89 116.66 8.16 4.36 3.82 
3.88 
- - 
Leu90 125.56 8.19 4.31 1.58 
1.65 
1.66 Hδ1 0.82 
Hδ2 0.87 
Ser91 117.78 8.23 4.40 3.82 
3.89 
- - 
Thr92 117.98 8.03 4.24 4.22 1.17 - 
Leu93 125.53 8.02 4.23 1.55 
1.61 
1.61 Hδ1 0.82 
Hδ2 0.87 
Ala94 124.61 8.06 4.22 1.35 - - 
Ala95 125.98 8.10 4.20 1.34 - - 
Lys96 122.02 8.11 4.19 1.73 
1.80 
1.39 
1.44 
Hδ1 1.63 Hε1 2.94 
Hδ2 1.63  Hε2 2.94 
Ala97 126.49 8.19 4.28 1.37 - - 
Ser98 116.84 8.18 4.38 3.83 
3.83 
- - 
Arg99 124.45 8.27 4.34 1.73 
1.85 
1.58 
1.58 
Hδ1 3.15  Hδ2 3.15 
Hε 7.25 
Met100 123.40 8.42 4.44 1.97 
2.05 
2.49 
2.57 
Hε 2.04 
Gly101 112.42 8.45 3.91 
3.95 
- - - 
Asp102 122.37 8.23 4.57 2.59 
2.67 
- - 
Gly103 111.11 8.38 3.90 
3.90 
- - - 
Asp104 122.24 8.17 4.55 2.55 
2.66 
- - 
Leu105 123.64 8.12 4.27 1.54 
1.62 
1.58 Hδ1 0.80 
Hδ2 0.86 
Asp106 123.35 8.32 4.56 2.55 
2.68 
- - 
Val107 121.52 7.91 4.04 2.05 0.88 
0.88 
- 
Glu108 125.51 8.37 4.21 1.90 
1.99 
2.18 
2.25 
- 
Leu109 124.74 8.13 4.24 1.54 
1.63 
1.61 Hδ1 0.81 
Hδ2 0.88 
Glu110 122.83 8.31 4.24 1.94 
2.00 
2.22 
2.22 
- 
Thr111 117.23 8.06 4.23 4.12 1.15 - 
Arg112 126.13 8.30 4.30 1.74 
1.80 
1.54 
1.60 
Hδ1 3.14  Hδ2 3.14 
Hε 7.24 
Arg113 125.82 8.42 4.33 1.71 
1.83 
1.59 
1.59 
Hδ1 3.15  Hδ2 3.15 
Hε 7.19 
Glu114 128.99 8.00 4.08 1.83 
1.99 
2.14 
2.14 
- 
 
Table 3.4. 15N and 1H shifts of NpHtrII (84-114) G84C peptide at 25 °C, pH 6.5 
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In order to investigate the tendencies towards the formation α-helical structures that 
were observed in the NOESY spectra, further spectral investigations of the chemical 
shift perturbation were performed.  
Structure predictions can be made in particular based on deviations of Hα and HN 
proton resonances from random coil values. A shift of Hα and HN resonances to higher 
field strengths compared to random coil values indicates tendencies towards an helical 
conformation93-95.  
All experimental chemical shifts did not differ much from those observed for random 
coils. Nevertheless two sequential clusters with characteristic chemical shift deviations 
could be identified. One cluster comprising residues Ser91 to Ser98 and a second 
cluster, in correspondence with the NOESY results, included amino acids Asp104 to 
Thr111 (figure 3.33).  
In summary, comparison of NOESY experiments and chemical shift indices led to the 
conclusion that Htr(84-114) G84C is a random coiled peptide with α-helical tendencies. 
 
 
Figure 3.33. Chemical shift index of NpHtrII (84-114) G84C 
        Panel A: ∆Hα=Hα(random coil)-Hα(experimental) 
        Panel B: ∆HΝ=HΝ(random coil)-HΝ(experimental) 
 
 
In an additional set of NMR experiments 15N and 13C labelling of the cytoplasmic 
transducer domain were verified. Therefore 1H,15N-2D and 1H,13C-2D HSQC spectra of 
[15N]- and [13C,15N]-labelled Htr(84-114) G84C were recorded (figure 3.34).  
The 15N signals were completely assigned. The signals for the two glycines, six serines 
and threonine residues were significantly shifted to high-field as was reported in 
literature93. 
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Figure 3.34. 15N HSQC spectrum of [15N] labelled (84-114) Htr G84C peptide. 
               
 
3.5.2 Semi-synthetic, isotope labelled NpHtrII(1-114) G84C  
 
Attempts to establish a semi-synthetic access to a domain specific isotope labelled 
archeabacterial transducer were described in section 3.3.1.2: A [15N]-labelled peptide 
HtrII(84-114) G84C (generation and analytics: see section 3.2.4) was ligated with an in-
situ generated unlabelled thioester protein Htr(1-83) in a 2-mercaptoethansulfonic acid 
(MESNA) mediated EPL reaction. The ligation product Htr(1-114) G84C was purified 
and characterised using SDS-PAGE and MALDI-MS. After reconstitution into polar 
purple membrane lipids and resolubilisation, a functional semi-synthetic membrane 
protein was generated (see section 3.3.3).  
In initial NMR experiments the purified ligation product was investigated in aqueous 
buffers (100mM NaCl, 20 mM NaPi, 2 mM DTT, pH 8.0) with DDM concentrations 
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varying between 0.5 and 0.005 % at 25 and 42 °C. The protein concentration was kept 
constant at 0.6 mM. Figure 3.35 summarizes the results.  
 
 
 
 
Figure 3.35. 1D 1H NMR spectra of [15N] 84-114Htr(1-114) G84C. The purified ligation 
product was investigated in aqueous buffers (100mM NaCl, 20 mM 
NaPi, 2 mM DTT, pH 8.0) with various DDM concentrations between 
0.5 and 0.005 % at 25 and 42 °C. The protein concentration was kept 
constant at 0.6 mM. Lowering the DDM concentration from 0.5 % to 
0.1 % improves the signal to noise ratios (S/N) from 10/1 to 15/1. A 
further decrease to 0.005 % has no significant influence on the S/N. 
Increasing the temperature from 25 °C to 42 °C corresponds to a S/R 
improvement to 25/1. 
 
The signal to noise ratios (S/N) of the recorded spectra were improved from 10/1 at 
25 °C and 0.5 % DDM to approximately 15/1 by lowering the DDM concentration by a 
factor of five to 0.1 % (10 times the critical micellar concentration, cmc). This 
corresponded quite well to the expected influence of the detergent on the tumbling 
frequency of the protein/detergent complexes: Lowering the detergent concentration 
leads to a lower solvent viscosity and therefore to higher tumbling frequencies and 
sharper resonance signals.  
A further decrease of the DDM concentration below the cmc of DDM to 0.005 % had 
no significant influence on the S/N. The stability of the sample was not influenced by 
decreasing the DDM concentration below the cmc: No protein precipitation was 
observed. This may correspond to the fact that the dissociation constant of the 
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protein/detergent complex is significantly lower than the cmc of the detergent. 
Although the surrounding solution contains no micelles, the number of detergent 
molecules adsorbed to the protein and therefore the tumbling frequencies was not 
significantly reduced.  
Increasing the temperature from 25 °C to 42 °C should enhance the Brownian motion 
in the system and therefore increase the tumbling frequency of the protein. This became 
obvious in a S/R improvement to 25/1.   
The HN region of the obtained spectra of the ligated sample displayed a significantly 
larger signal dispersion (9.6 to 6.6 ppm) than observed for the spectra of the unligated 
peptides. While the strong signals below 8 ppm might have been caused by the two 
transmembrane α-helices of the semi-synthetic transducer, the origin of the signals 
above 8.5 ppm remained unclear. In principle their HN shifts correspond to β-sheet 
domains or to aromatic amino acid residues. However, both possibilities can be 
eliminated for the α-helical transducer that comprises no aromatic amino acid residues.  
Although in the NMR spectra of the ligated transducer the signal to noise ratio was 
improved by a factor of 2-3 by variation of detergent concentration and temperature, no 
2D 1H,15N-HSQC spectrum in aqueous solution was obtained.  
Therefore, experiments in organic solvents without detergent as solubilising additive 
were carried out. These experiments were not performed to gain any structural 
information under these strong denaturing, artificial conditions, but rather to collect 
further evidence for a successful labelling and ligation reaction.  
In contrast to the unligated peptide, the ligation product was expected to show a signal 
for residue Cys84. Due to the formation of the native peptide bond during the EPL, the 
HN signal of Cys84 is not suppressed by fast proton exchange as it was the case for the 
N-terminal Cys84 NH3+-moiety of the unligated peptide. 
In order to replace the water by organic solvents, the protein was dialysed against 
ammonium bicarbonate buffer containing 0.1 % β-mercaptoethanol and subsequently 
dialysed several times against pure water to remove salt and detergent. The partially 
precipitated protein sample was lyophilized and afterwards dissolved in 100 µl DCOOH 
and diluted with 200 µl D3COH/CDCl3 (1:1). In order to avoid a fast H/D exchange of 
the HN and Hα protons that would drastically decrease the signal intensity in the NMR 
spectra, only partially deuterated solvents were used 
Results 
 95
 
 
Figure 3.36. 1H,15N-HSQC spectrum of the semi-synthetic transducer  
[15N]84-114Htr(1-114) G84C in DCOOH/D3COH/CDCl3 
(1:1:1) at 25 °C (600 MHz Varian NMR spectrometer). 
 
The 2D 1H,15N-HSQC spectrum (figure 3.36) showed a poor signal to noise ratio of 
approximately 2:1. A comparison of this spectrum with that of the labelled peptide led 
to the following conclusions: The spectral signal dispersion from 0.5 ppm in the 1H 
dimension was similar in both spectra, although the signals in organic solvents were 
significantly shifted to lower field compared to the peptide spectrum in aqueous 
solution. This could be explained by the influence of the lower polarity and the higher 
acid content of the organic solvents that were used.  
Signals for threonines and serines could not be resolved, however resonance signals 
corresponding to the residues Gly101 or Gly103 were observed (figure 3.36, 
HN: 9.05 ppm; 15N: 106 ppm).  
The spectrum verified a successful 15N-labelling of the semi-synthetic transducer. 
However, due to  low signal intensities, an assignment was not possible. Therefore the 
experiment did not confirm a successful ligation reaction by resolving resonance signals 
of the cysteine residue at position 84. 
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3.5.3 ssNMR of u-[13C,15N] labelled Htr114 in complex with SRII in PM lipids 
 
The secondary structure elements of transmembrane proteins differ in terms of their 
flexibility. Membrane spanning helices or β-sheets for example are well-structured 
regions that are relatively immobile compared to loops at both the N- and C-terminus 
of a protein. These differences in the mobility of divers regions of a protein can be used 
in solid state NMR to separate the signals of flexible regions from those of more 
immobile regions.  
A recently established method (M. Baldus, MPI Göttingen, personal correspondence) 
able to distinguish between signals of flexible and immobile residues, is based on the 
variety of the J-coupling in the distinct regions. Under MAS conditions the J-coupling in 
immobile protein domains is effectively averaged out. However, in more dynamic 
regions it is still present. This leads to the possibility to transfer magnetization from 
protons to hetero-atoms either with cross-polarization-type methods via dipolar 
coupling in immobile domains or via J-coupling with INEPT-type methods (insensitive 
nuclei enhanced by polarization transfer) in mobile regions of a protein. The resulting 
1H,15N- or 1H,13C-single quantum spectra show either predominately signals of mobile 
or predominately signals of immobile regions of the investigated protein. These 
methods were used to separate the signals of the two transmembrane helices of the 
transducer from the signals of the N- and above all of the C-terminus, that is important 
for the capability of the protein to form a stable complex60,96 with its cognate receptor.  
A C-terminal truncated variant of the transducer comprising the two transmembrane 
helices and the cytoplasmic domain until amino acid residue Glu114 in complex with 
the SRII receptor was used for MAS ssNMR measurements. A similar complex was 
already investigated in the crystallographic studies of Gordeliy et al.9.  
For NMR measurements the truncated Htr114 protein was expressed in minimal 
medium containing [13C]-D-glucose and [15N]-ammonium chloride as carbon and 
nitrogen source respectively, in order to obtain a uniformly isotope labelled transducer 
(see section 3.4.1).  
The purified protein was mixed in a ratio of 1:1.05 with unlabelled SRII. The excessive 
amount of receptor (5 %) would ensure a quantitative complex formation of all 
transducer molecules. The complex was reconstituted into purple membrane lipids 
isolated from H.salinarum with a constant protein/lipid ratio of 1:45. The reconstituted 
sample was washed with buffer containing 20 mM NaPi, pH 8.0 to remove excess salt 
Results 
 97
that was used during the reconstitution process. Finally the sample was transferred into 
a MAS spinning rotor of 4 mm-diameter and an approximate volume of 50 µl. 
In first experiments that were performed in cooperation with M. Baldus and C. Seidel at 
the MPI in Göttingen (Germany), a cross-polarization-type 1H,13C-single-quantum 
NMR-spectrum at 5 °C with a MAS spinning frequency of 12.5 kHz was recorded 
(figure 3.37, panel A). A preliminary assignment of the observed signals to intra-residual 
spin-systems could be achieved.  
In a second step a set of INEPT-type spectra at –30 °C, –20 °C and -10 °C was 
recorded (figure 3.37, panel B).  
 
 
 
Figure 3.37. MAS ssNMR spectra of the SRII/[13C,15N]-Htr114-complex in PM lipids. 
Black arrows indicate signals whose chemical shifts are summarized in 
table 3.4. 
Panel A: Cross-polarization-type single quantum spectrum at 5 °C 
Panel B: INEPT-type single quantum spectrum at -10 °C (red), 
-20 °C (green) and -30 °C (blue). Black boxes indicate absent 
signals due to the absence of a carbon/carbon polarization 
transfer by a C/C mixing time. 
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At –30 °C only a few signals of amino acid residues with a low spectral resolution were 
observed indicating a few residues that are mobile at this low temperature. The dynamic 
of most of the amino acid residues was frozen.  
At higher temperature (–20 °C) a number of additional spectroscopic signals were 
observed suggesting a rising number of mobile residues. This increased residual mobility 
improved the spectral resolution as well.  
At –10 °C the highest number of signals of mobile amino acid residues combined with 
the best spectral resolution was observed.  
Since the INEPT-type of experiments were performed without a carbon/carbon 
polarization transfer, no corresponding cross peaks (figure 3.37, panel B indicated by 
dotted black boxes) were observed in contrast to the cross-polarisation-type spectrum 
(figure 3.37, panel A).  
The temperature-dependency of the spectroscopic signals in the INEPT type of 
experiments is in a good agreement with the expected signal behaviour of mobile 
protein clusters, like both N- and C-terminus and the loop between the two 
transmembrane helices.  
In addition to the information about the flexibility of these clusters, the recorded 
spectra contained information about their secondary structure. A comparison of the 
observed Cα−shifts in the INEPT-type spectrum (table 3.5) with those of random coil 
chemical shift values allow to predict secondary structure elements of the mobile 
protein domains93-95. 
 
 
 
 
 
 
 
 
 
 
 
Table 3.5. Comparison of chemical shifts of exemplary residues (indicated  
with arrows in figure 3.35) with random coil shifts. 
 
Residue Experimental
shift 
Random coil
Shift 
Thr-Cβ 69.7 69.8 
Ser- Cβ 63.7 63.8 
Val-Cα 62.4 62.2 
Ala- Cα 52.2 52.5 
Gly- Cα 45.2 45.1 
Leu- Cβ 42.3 42.5 
Glu- Cβ 29.8 29.9 
Met-Cε 17.0 16.9 
Results 
 99
The chemical shifts did not differ significantly from those observed for random coils 
(table 3.5). Combined with the information about the mobility of the amino acid 
residues at different temperatures, these results suggest that the mobile protein domains, 
like the loop between TM1 and TM2 and both termini, are highly mobile, random coil 
amino acid clusters under the chosen low salt conditions.  
At higher temperatures a rising number of amino acid residues are included into these 
flexible clusters. Any signs for a defined secondary structure of these domains, like 
significant chemical shift deviations, were not found. Due to the lack of a sequential 
signal assignment, at the moment no information about the exact sequence of the 
mobile clusters is available. 
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3.6 Fourier-Transform Infrared Spectroscopy (FTIR) 
 
The recently reported crystallographic structure of SRII in complex with its cognate 
transducer protein9 revealed that the observed structure is almost identical with the 
crystal structure of SRII itself36,37. In fact, the backbone structures are similar, while 
there are some deviations in the orientations of some side chains.  
In addition, the photocycle of SRII is not much influenced by the presence of the 
transducer13,97. However, it remains unclear how HtrII influences the structural changes 
of the receptor upon photo-isomerization of the retinal-chromophore.  
Steady state and rapid-scan FTIR spectroscopy were applied in cooperation with 
F. Siebert and I. Radu at the University of Freiburg (Germany) to investigate the 
structural changes in atomic details of both complex partners during the photocycle of 
the receptor. 
In initial measurements the unlabelled protein complex was investigated under steady-
state conditions. For sample preparation the SRII receptor was mixed with two different 
transducer variants, Htr114 and Htr157 respectively, in 1:1 stoichiometry and was 
reconstituted into purple membrane lipids. After a washing step with buffer containing 
20 mM NaPi, pH 8.0 included to remove excess salt that was used during the 
reconstitution process, the membranes were dried onto the lower window of the 
measurement cuvette. Hydration of samples was achieved by overlaying them with 
approximately 20 µl of measuring buffer (200 mM bis-tris-propane, 150 mM NaCl, 
pH 8.0). The second plane window with a circular groove at its border squeezed excess 
buffer into this groove serving as a buffer reservoir. Sample thickness was either 2.5 or 
4.5 µm. This newly established sandwich-sample preparation98 guaranteed a sufficient 
hydration of the sample during several measurements and improved therefore the yields 
of the late M/O photo intermediate.  
Figure 3.38 shows the steady-state FTIR difference spectra of the photo-intermediate M 
with contributions of the O-intermediate minus the respective unphotolysed 
groundstates (M/O minus groundstate) of samples comprising SRII in complex with 
different transducer variants referring to the receptor alone. 
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Figure 3.38. Steady-state spectra of the M/O signalling state of different SRII/Htr 
complexes with black arrows indicating observed spectral changes. 
Blue trace:  SRII reference without any transducer. 
Red trace:   SRII complexed with Htr114. 
Black trace: SRII complexed with Htr157. 
 
 
The spectra of the complexes SRII/Htr(1-114) (figure 3.38, red trace) and 
SRII/Htr(1-157) (figure 3.38, black trace) showed spectral changes due to the binding of 
the transducer referring to the receptor spectrum (figure 3.38, blue trace).  
The signal at 1764 cm-1 is broadened in the spectrum of the complex with Htr114 
(figure 3.38, red trace). A similar effect is more pronounced for the Htr157-complex 
(figure 3.38, black trace). According Engelhard et al.99 this signal was assigned to the 
C=O moiety of the counter-ion Asp75 that becomes protonated upon M-formation.  
In addition, the amplitude of the negative band at 1675 cm-1 was significantly larger in 
the spectrum of the receptor (figure 3.38, blue trace) compared to the spectra of the 
complexes (figure 3.38, red and black traces). For the longer transducer fragment a 
splitting of this signal was observed (figure 3.38, black trace). This band in the amide I 
region of the spectra was assigned to an αI-helical C=O stretch vibration of the protein 
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backbone of the complex and indicated distortions of the complex partners upon 
transducer binding. These distortions were more distinct in the complex with the longer 
transducer fragment (figure 3.38, black trace).  
A further difference between the spectrum of the receptor and the spectra of the 
receptor in complex formed with the transducer variants was a larger signal amplitude of 
the ethylenic C=C stretch vibration of the retinal-chromophore at 1544 cm-1. Again a 
more pronounced effect was observed for the longer transducer variant.  
The spectral changes upon SRII/Htr complex formation suggest alterations of the 
retinal binding pocket affecting the protonation of the Asp75 counter-ion and 
conformational distortions of the protein backbones of both complex partners. The 
observed changes were more pronounced for the longer transducer.  
In order to facilitate an assignment of the spectral changes to contributions of either the 
receptor or its transducers, uniform isotope labelling of the transducer variants was 
performed (see section 3.4).  
For initial rapid-scan FTIR measurements isotope labelled Htr(1-114) and Htr(1-157) 
were complexed with unlabelled receptor in a 1:1.05 stoichiometry to ensure 
quantitative complex formation of the transducers. Sample preparation was performed 
as above-mentioned.  
Figure 3.39 shows the time-resolved difference spectra of the M2 intermediate minus the 
groundstate (M2 minus groundstate) of the labelled SRII/Htr157-complex referring to 
the unlabelled complex. The spectra were measured at -17 °C to improve the yield of 
the signalling state. 
Interestingly, both spectra showed only minor differences. Especially the amide I/II 
spectral ranges were not influenced by labelling indicating that the observed spectral 
changes represent predominately conformational changes of the SRII receptor. 
Indications for conformational changes of the transducer protein backbone upon signal 
transfer from the receptor were not obtained. This phenomenon was recently reported 
by Kandori and co-workers as well 100.  
Due to the low spectral resolution, in the ranges between 1500-1460 cm-1 and 1380-
1340 cm-1 non-reproducible, minor changes were observed (indicated by arrows). These 
observations led to the conclusion that the contributions of the transducer to the 
observed spectral changes might be hidden by much stronger contributions of the 
receptor.  
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Figure 3.39. Overlay of the rapid-scan M2-difference spectra of SRII/[13C,15N] Htr157 
(red trace) and unlabelled SRII/Htr157 (blue trace) measured at -17 °C.  
The amide I/II spectral ranges were not influenced by isotope labelling. 
Due to the low spectral resolution, in the ranges between 1500-
1460 cm-1 and 1380-1340 cm-1 irreproducible, minor changes were 
observed (indicated by arrows). 
 
 
While the investigated protein complexes consisting of isotope labelled transducer and 
unlabelled receptor, revealed no detectable isotope shift, investigations with complexes 
of isotope labelled receptor with unlabelled transducer were performed. These 
complexes are expected to exhibit a downshift by approximately 30 cm-1 of the amide I 
and by approximately 10 cm-1 of the amide II bands of the receptor. This effect may 
facilitate the spectroscopic resolution of vibrational transducer bands. 
For initial rapid-scan FTIR measurements isotope labelled SRII (protein expression and 
purification see section 3.4.2) was complexed with either unlabelled Htr(1-114) or 
unlabelled Htr(1-157) in a 1:1.05 stoichiometry to ensure quantitative complex 
formation of the labelled receptor. Sample preparation was performed as mentioned 
above. 
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Figure 3.40. Steady-State difference spectrum of the M/O state minus the groundstate 
of [13C,15N] SRII in complex with different unlabelled transducers 
referring to the respective unlabelled complexes.  
Panel A: Spectrum of [13C,15N] SRII/Htr114 (red) and SRII/Htr114  
(blue). 
Panel B: Spectrum of [13C,15N]-SRII/Htr157 (red) and SRII/Htr157  
(blue). 
 
 
A comparison of the M/O-state difference spectra of the labelled complexes (figure 
3.40, panel A and B, red traces) with those of the unlabelled complexes (figure 3.40, 
panel A and B, blue traces) revealed a quantitative downshift of the characteristic C=O 
stretch vibration of SRII-Asp75 from 1765 cm-1 to 1720 cm-1 in the spectra of labelled 
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receptor in complex with both different transducers (figure 3.40, panel A and B, red 
traces). This  indicates an almost quantitative isotope labelling of the receptor.  
In addition to that, a significant isotope shift of the amide I and amide II vibrational 
bands of the labelled complexes (figure 3.40, panel A and B, red traces) was observed. 
Interestingly, the signal amplitudes of the labelled receptor in complex with the longer 
Htr157 transducer (figure 3.40, panel B, red trace) are improved compared to the 
corresponding complex with the short Htr114 transducers. This phenomenon was 
observed as well for the corresponding unlabelled complexes (figure 3.38, red and black 
trances).  
As a consequence of the isotope shift of the amide I/II receptor vibrations, two bands 
appeared in the spectra of the labelled complexes at 1693 cm-1 and 1682 cm-1 (figure 
3.40, red traces, indicated by vertical lines). These bands were insensitive to receptor 
labelling and their amplitudes were significantly enlarged for the longer transducer 
Htr157 compared to the shorter one. However, the origin this spectral shift from 
1693 cm-1 to 1683 cm-1 remained unclear. 
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4. Discussion 
4.1 Semi-synthetic access to domain specific isotope labelled NpHtrII 
 
Sensory rhodopsin II in complex with its transducer protein HtrII from N.pharaonis 
initiates the photophobic reaction of the bacterium to green-blue light. Recently the X-
ray structure of this complex yielded insights into the transmembrane structure of the 
complex components. In the membrane the complex is a 2:2 heterodimer: Two 
receptor/transducer units with tightly packed receptor helices F, G and the transducer 
helices TM1 and TM2.  
Unfortunately, the crystallographic structure did not provide information about the C-
terminal cytoplasmic fragment of the transducer including amino acids 83 to 1149. This 
region of the transducer is essential for the receptor–transducer interaction resulting in a 
low dissociation constant (Kd < 100 nM)60 and the capability of the transducer to inhibit 
basal proton pump activity of the receptor upon complex formation17,96.  
Different reasons can explain the missing electron density information for this protein 
region: The C-terminal poly-histidine purification tag  used for the Htr114 construct 
may disturb a correct folding of this domain. The tight packing of the complexes in the 
crystal may as well prevent a correct folding of the cytoplasmic domain.  
In order to address this problem of the unknown structure of the cytoplasmic linker 
domain of NpHtrII other methods had to be used. Besides X-ray crystallography and 
electron microscopy, NMR is the only method to determine structures of proteins with 
atomic resolution95. In the case of membrane proteins the protein structure is strongly 
influenced by the native membrane environment. Magic angle spinning solid-state NMR 
spectroscopy (MAS ssNMR) offers the possibility to investigate membrane protein 
structures, such as the SRII/HtrII-complex, in their natural lipid environment101. 
Although MAS techniques have extended the sensitivity and the spectral resolution of 
solid-state NMR spectroscopy, the still limited spectral resolution could not permit a 
widespread application like high-resolution liquid 1H NMR spectroscopy. Therefore it is 
yet not possible to resolve the NMR signals of the entire SRII/HtrII-complex or of the 
complete Htr114 construct alone with MAS ssNMR techniques and complete signal 
assignment for structural calculations cannot be achieved.  
A method that allows domain specific isotope labelling of only the cytoplasmic Htr114 
C-terminus, would considerably reduce the problem of signal overlapping: Unlabelled 
regions of the protein can be filtered out using suitable heteronuclear correlation 
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experiments leaving only the signals from the labelled part of the protein. In 
combination with the crystallographic data it would be possible to build a detailed 
model of the C-terminally truncated transducer on the atomic level.  
The feasibility of domain specific isotope labelling has been demonstrated using two 
different protein-engineering methods, protein trans-splicing102-104 and expressed protein 
ligation105,106. In a first study, Nakamura and co-workers102 exploited the trans-spicing 
phenomenon for segmental [15N] labelling of the C-terminal domain of the E.coli RNA 
polymerase α subunit. In a complementary study106 EPL was used to achieve a domain 
specific [15N] labelling within a Src-homology domain pair derived from the Abl protein 
tyrosine kinase. NMR experiments illustrated the power of segmental isotope labelling 
for studying large proteins.  
The trans-splicing method convinces with methodical elegance. However, its 
requirement for denaturants and elevated temperatures at various points is a potential 
drawback. Although successful refolding of denatured integral membrane proteins has 
been reported, e.g. the halobacterial proton-pump bacteriorhodopsin107, the E.coli outer 
membrane protein OmpA108 or the bacterial potassium channel KcsA109, functional 
refolding of integral membrane proteins remains a challenging task.  
The method of expressed protein ligation offers the possibility to perform ligation 
reactions under mild physiological conditions. This renders EPL as a promising 
procedure to extend domain specific isotope labelling to the class of integral membrane 
proteins.  
EPL was extensively used for the semi-synthesis of soluble proteins,110,111 however, at 
the beginning of this project no example for the  semi-synthesis of membrane proteins 
was reported. In the meanwhile Muir and co-workers described the use of EPL in the 
synthesis of a truncated form of the potassium channel KcsA112. This truncated form 
corresponded to the entire membrane-spanning region of the protein. The N-terminal 
peptide was fused with the Mycobacterium xenopi GyrA intein (Mxe) and a MESNA-
thioester of this N-terminal KcsA segment was generated under mild conditions in the 
presence of the detergent Triton X-100. Native chemical ligation of the N-terminal α-
thioester and the synthetic C-terminal peptide was performed. The ligation product was 
folded into the native tetrameric form by incorporation into lipid vesicles.  
The extension of C-terminal domain specific isotope labelling of proteins to the 
truncated membrane protein NpHtrII requires access to uniformly isotope labelled 
peptides containing an N-terminal cysteine residue. Labelled amino acid building blocks 
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for solid phase peptide synthesis (SPPS) are commercially available and could be used to 
synthesise such peptides. However, the costs for the synthesis of a peptide comprising 
an entire protein domain would be immense.  
A visible alternative are highly optimised protocols for recombinant labelling of proteins 
using synthetic minimal media containing [13C] D-glucose and/or [15N] ammonium 
chloride as sole carbon respectively nitrogen sources are well established72,73. The 
combination of recombinant isotope labelling with recombinant methods for the 
generation of peptide building blocks for an EPL-based approach offers an access to 
domain specific isotope labelled membrane proteins .  
Two approaches for the generation of recombinant peptide building blocks with N-
terminal cysteine are reported. The first approach makes use of proteolytic removal of 
an N-terminal leader sequence from a precursor protein by specific proteases that cleave 
C-terminal at their recognition site. 
The tobacco etch virus nuclear inclusion A protease (TEV) fulfils the requirements to 
be a suitable tool for the preparative generation of peptides containing an N-terminal 
cysteine. It is an inexpensive, highly specific cysteine protease that cleaves C-terminal at 
its recognition site (ExxYxQ▼, where x can be any amino acid)74 and can be 
heterologously expressed in E.coli.113.  
An alternative approach does not require a separate proteolysis step and utilises N-
terminal M.xenopi Gyr A intein fusion proteins that on temperature induction cleaves off 
the required peptide carrying an N-terminal cysteine45,114. A disadvantage of this 
approach is the possibility of in-vivo auto-cleavage or low in-vitro cleavage efficiencies of 
the purified precursor, diminishing the peptide yields or even preventing any yield of the 
peptide45. 
On the other hand a proteolytic digest of a precursor protein may lead to incomplete or 
unspecific cleavage of the precursor fusion protein. However, these risks can be 
minimized by the choice of the protease and a careful optimisation of the digest 
conditions.  
The studies of Blaschke et al.105 and Tolbert et al.74 showed the generation of peptides 
with N-terminal cysteine residues by the proteolytic removal of a leader-sequence from 
a precursor protein. The function of these leader-sequences was to facilitate a 
recombinant access to the precursor protein and to serve as a purification tag thus  
facilitating a straightforward purification of the precursor protein.  
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The Schistosoma japonicum glutathione-S-transferase (GST) gene fusion system combines 
these features in an excellent manner115. It is a versatile system for the expression and 
purification of fusion proteins produced in E.coli. The system is based on inducible, 
high-level expression of genes or gene fragments as fusions with GST and yields fusion 
proteins with the GST moiety at the N-terminus of the protein of interest. The fusion 
protein accumulates within the cytoplasm of the cells and is purified in high yields 
exploiting the specific interaction of the GST with glutathion (GSH).  
A fusion protein consisting of the desired cytoplasmic transducer fragment and the 
glutathione-S-transferase (GST)115 linked by a TEV protease recognition site in a way 
that the N-terminal cysteine of the peptide is in the P1’ position of the TEV recognition 
site promised to be a suitable construct to generate a building block for the EPL-based 
approach to an segmental isotope labelled transducer. 
Based on this components, a semi-synthetic strategy was developed that allowed 
NpHtrII to be generated from two protein segments by a single ligation reaction in a C-
terminal truncated form (residues 1–114) (figure 4.1). This transducer construct 
comprises two unlabelled transmembrane helices and an additional isotope labelled 
cytoplasmic fragment representing a transducer that possesses the ability to form a 
native-like receptor–transducer complex showing a low dissociation constant 
(Kd < 100 nM)60 and that possesses the capability to inhibit the proton pump activity of 
the receptor17,96.  
Gly83-Gly84 was selected as the ligation site, because all the residues of the putative 
cytoplasmic receptor binding site with unknown structure are located C-terminal to this 
site60 and will allow structure determination by MAS ssNMR with isotope labelled 
samples. The transmembrane transducer fragment comprising amino acids 1-83 was 
fused to the N-terminal splice-junction of the Mycobacterium xenopi gyrase A intein that is 
C-terminally fused to the Bacillus circulans chitin-binding domain (MxeCBD).  
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Figure 4.1. strategy for the generation of domain specific isotope labelled NpHtr114 
using expressed protein ligation. The transmembrane domain comprising 
residues 1-83 was fused to the N-terminus of the MxeCBD mini-intein. 
The cytoplasmic domain comprising residues 84-114 was fused to the C-
terminus of a GST-tag with a TEV protease recognition site in between. 
After expression in isotope enriched minimal medium, a TEV protease 
digest liberated the desired isotope labelled peptide containing an N-
terminal cysteine residue for the subsequent ligation reaction. 
 
  
The Mxe GyrA intein is a natural mini-intein (198 amino acids), which lacks a central 
intein endonuclease domain common to other naturally occurring inteins45. As a 
bacterial protein, it can be over expressed in E.coli116. In the absence of its native C-
extein comprising a N-terminal cysteine residue, the Mxe intein remains as a precursor 
fusion protein at 37 °C and can then be thiol-induced to cleave at 16-23 °C116.  
Gly-83 at position –1 of the MxeCBD intein construct promises high in-vitro intein 
cleavage efficiencies45, because Perler and co-workers evaluated the effect of the 
-1 residue on N-terminal Mxe intein cleavage efficiencies and determined a negligible in-
vitro cleavage and an almost quantitative DTT-induced in-vitro cleavage for glycine at this 
position.  
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These observations in combination with high ligation efficiencies observed for a C-
terminal glycine-thioester in a model peptide with the sequence LYRAx in a native 
chemical ligation study61 led to the conclusion, that position G83-G84 of the transducer 
is a suitable ligation site.  
A successful EPL reaction at this ligation site results in a G84C point mutation in the 
semi-synthetic transducer. In order to investigate, if this mutation is functionally 
tolerated in a C-terminally truncated NpHtr114 construct, an in-vitro binding assay based 
on blue native PAGE gels and  a recombinant NpHtr114 G84C mutant was used. These 
gels clearly indicated that a complex is formed between the G84C mutant and its 
cognate transducer. This suggests that a cysteine substitution at this position does not 
abolish complex formation between the transducer and the receptor.  
Additional evidence for this finding was provided by Spudich and co-workers with full-
length H.salinarum transducer cysteine mutants117. In their study a G84C mutant 
exhibited a similar repellent phototaxis response to stimulating light at a wavelength of 
500 nm as the wild type transducer. Both investigations suggest that position Gly84 is a 
suitable ligation site because the glycine to cysteine mutation at this position is 
functionally tolerated.  
 
 
4.2 Generation of isotope labelled NpHtr(84-114) G84C peptides 
 
The generation of domain specific isotope labelled semi-synthetic NpHtrII variants by 
EPL is based on the accessibility of isotope labelled peptides containing an N-terminal 
cysteine residue. Here the generation of [15N] and [13C,15N] double-labelled peptides 
comprising the cytoplasmic region of the halobacterial transducer from residue 84-114 is 
presented.  
An N-terminal cysteine residue was generated by TEV protease  digest of a glutathion-
S-transferase leader-sequence. The GST-carrier facilitated a high yield over-expression 
of the soluble precursor protein. 30 mg per litre minimal medium were obtained and 
purified by exploiting the specific interaction of the GST with glutathion (GSH) that is 
immobilised on a solid matrix.  
Quantitative proteolytic liberation of the desired peptide was achieved with a molar ratio 
of TEV to GSH fusion protein of 1/45. A comparable high TEV concentration for an 
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effective cut was observed as well in a model study investigating the P1’ specificity of 
the TEV protease75.  
The authors reported a 1:80 molar ratio for the processing of a fusion protein between 
E.coli maltose binding protein and Aquifex aeolicus NusG (MBP-NusG) with Ser, Ala and 
Gly at position P1’, however for Cys, Phe, Gln, Tyr, Asn and Trp a 1:30 ratio was 
needed to achieve an efficient digest. 
The target peptides in this work were obtained in analytically pure form after protease 
cleavage and RP-HPLC purification. The observed labelling efficiencies of 98 % 
corresponded well to the isotope content of the respective isotope sources. Yields were 
usually 1-2.5 mg per litre M9 minimal medium.  
A number of publications have described the expression of isotope labelled peptides for 
NMR studies118-124 that were produced together with small and highly expressed carrier 
proteins, like GST or ketosteroide isomerase. In some cases carrier proteins with low 
solubility have been exploited to direct the peptide to inclusion bodies, thereby 
minimising proteolytic degardation118,121,124.  
Sprules et al.119 reported an enrichment of GST-fused peptides with 15N and 13C isotopes 
that was liberated using the PreScission Protease (Amersham Biosciences). Although 
this set-up was similar to the one presented in this work, the use of the commercially 
available PreScission protease leads to a predetermined N-terminus of the target peptide 
with Gly and Pro as the first two amino acid residues.  
As alternative to a proteolytic digest, the application of cyanogens bromide (CNBr) for 
peptide release118,121,123,124 allows the generation of peptides with any desired amino acid 
residue at its N-terminus. However, since CNBr cleavage occurs after each methionine 
residue, the method is intrinsically limited to peptide sequences without internal Met 
residues. Therefore it was not suitable for the generation of the cytoplasmic segment of 
NpHtrII that includes a methionine at position 100.  
An interesting extension of the carrier fusion concept is the introduction of tandem 
repeats of peptide sequences separated by protease cleavage sites124,125. Takasuga et al.125 
presented the efficient production of the pentapeptide DSDGK that potently inhibits 
primary IgE antibody formation. The short peptide was expressed as a 28 tandem repeat 
construct in E.coli. The fused peptides were digested with trypsin that cleaved after the 
positively charged Lys residue and the monomeric peptide was purified by HPLC. 
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Kuliopulus and Walsh124 extended this approach by using single methionine residues 
interspersing peptide tandem repeats. This produced isotope labelled 13mer yeast α-
mating factor produced with a yield of 56 mg/L.  
The method presented in this work fulfils highest demands in the generation of isotope 
labelled peptides without any N- or C-terminal modification. Except proline any amino 
acid residue can be generated at the N-terminus of the target peptide using  TEV 
protease as a reliable tool for the generation of small isotope labelled peptides carrying 
an N-terminal cysteine. 
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4.3 Domain specific isotope labelling of NpHtrII(1-114) using EPL 
 
The potential of expressed protein ligation to achieve domain specific isotope labelling 
of proteins has been demonstrated105,106 in a model study with a Src-homology domain 
pair derived from the Abl protein tyrosine kinase. Here in this study an extension of this 
concept to domain specific isotope labelling of membrane proteins is reported.  
For the generation of an activated α-thioester derivative of recombinant NpHtrII 
comprising its transmembrane domain up to amino acid residue Gly83,  a fusion protein 
with the Gyr A intein was generated and over-expressed in E.coli.  
The target HtrMxeCBD fusion protein was either found to be incorporated in into the 
bacterial membrane or to be deposited as insoluble inclusion bodies (90 %). From the 
solubilised membrane fraction two cleavable intein fusion protein species were isolated: 
the desired full-length protein (ca. 30-50 %) and, as the main product, an N-terminally 
degraded form. 
MALDI mass spectrometry suggested a truncation of the HtrMxeCBD protein in the 
loop region between the two transmembrane helices. Since both components of this 
fusion protein, namely NpHtrII(1-83)60 and the Gyr A mini intein116, are reported to be 
functionally expressed in E.coli, the chosen manner of fusing both proteins together 
obviously caused the observed proteolytic degradation in an alanine-rich loop that 
connects both transmembrane helices of the transmembrane transducer domain.  
Figure 4.2, panel A shows a representation of the HtrMxeCBD fusion protein lacking 
the chitin-binding domain. This model was built up from the crystal structures of both 
proteins9,126. Thereby Ala residue -1 of the N-extein was replaced in-silico by glycine and 
Ser1 of the crystallized Mxe intein by cysteine that was linked to Gly82 of the transducer 
extending the N-exteine. The dashed lines confine the major hydrophobic core of the 
protein according to the crystallographic data from Gordeliy et al.9.  
This model indicates that the ligation site G83-G84 may force the soluble intein domain 
into the hydrophobic membrane environment. This may lead to an incorrect 
incorporation of the fusion protein into the lipid bilayer resulting in a misfolded protein 
that either aggregates or is degraded by proteases. This hypothesis is in a good 
agreement with the observation of the degraded protein species isolated from the 
membrane fraction, and with the observation that the protein is deposited in insoluble 
inclusion bodies. 
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Figure 4.2. Side view of a Htr-Mxe fusion protein model lacking the CBD based on 
crystallographic data from Gordeliy et al.9 (Htr in blue) and Klabunde et 
al.126 (GyrA intein in grey). Cs, cytoplasmic side; ES, extra-cellular side. 
The dotted black lines confine the major hydrophobic of the transducer.  
Panel A. The chosen G83-C84 fusion site forces the soluble GyrA 
intein into the membrane. This might induce misfolding of the 
entire fusion protein leading to insoluble aggregates (inclusion 
bodies) or proteolytic degradation. 
Panel B. Assuming a helical continuation of TM2, a A94-C95 fusion site 
might facilitate a membrane independent orientation of the 
soluble GyrA intein. This might avoid  misfolding leading to a 
functionally membrane incorporated conjugate. 
 
 
Muir and co-workers as well reported similar problems with the expression of a 
transmembrane Mxe intein fusion protein112, where the Mxe-intein was fused to the C-
terminus of the KcsA potassium channel  at position 73, that is located C-terminally to 
the end of the pore forming helix.  
A variety of different expression conditions was tested. However, in no instance was the 
desired product detected. The authors argued that the hydrophobic N-extein targeted 
the intein fusion protein to the secretory pathways. To circumvent this problem, a 
sandwich fusion approach was chosen with a GST domain at the N-terminus of the N-
extein-intein fusion protein. This construct was thus targeted  to inclusion bodies.  
A comparison of these results with the results presented in this work suggests that it 
may be important for functional incorporation of membrane protein-intein fusions into 
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the lipid bilayer, to limit interaction of the soluble intein domain with the bacterial 
membrane.  
Positioning of the fusion site into flexible cytoplasmic loop regions of membrane 
proteins may prevent the intein to be forced into the lipid bilayer and may avoid 
misfolding, protein aggregation or degradation.  
The work of Erni and co-workers supports these criteria for the choice of potential 
ligation sites. They generated a cyclized E.coli glucose transporter subunit II CBGlc by in-
vivo trans-splicing127. The N-intein of the split recA intein of M.tuberculosis was fused to the 
flexible N-terminus of the eight transmembrane helices containing C domain of the 
transporter and the C-intein was fused to the C-terminus of the cytoplasmic B domain. 
After expression cyclisation took place cyclized splicing product was successfully 
incorporated into the membrane.  
Taking these results into account, a relocation of the NpHtrII fusion site from 
Gly83-Gly84 to Ala94-Ala95, as indicated in figure 4.2, panel B, may help to avoid the 
N-terminal degradation of the HtrMxeCBD fusion protein. This additional amino acid 
stretch might provide sufficient space for the intein domain from the lipid bilayer and 
therefore successful incorporation of the functionally folded fusion protein into the 
bacterial membrane might become possible. Experiments to test this hypothesis are in 
progress. 
In contrast to the solubilised membrane fraction, the isolated inclusion bodies of the 
HtrMxeCBD expression contained predominantly non-degraded intein fusion protein. 
Therefore  the fusion protein was refolded from these aggregates.  
The isolated inclusion bodies were solubilised in buffer containing 6 M guanidine 
hydrochloride and TCEP as a reducing agent in the presence of DDM as a detergent 
and were subsequently functionally refolded using different protocols. An α-thioester 
was generated with cleavage efficiencies of approximately 50 % after refolding of the 
HtrMxeCBD protein using dialysis to replace guanidine hydrochloride against 8 M urea 
and to lower stepwise the chaotrope concentration to 6 M, 4 M, 3 M and finally 2 M 
urea.  
In the literature, only a few examples for the functional refolding of inteins were 
reported besides a large number of examples for the refolding of split-inteins102-104. 
Anraku and co-workers128 described in 1996 that a precursor protein containing the 
yeast VMA intein, can undergo protein splicing upon refolding from inclusion bodies by 
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dialysis. The inclusion bodies were solubilised in buffer containing 6 M guanidine 
hydrochloride and DTT as a reducing agent.  
In 1999, Muir and co-workers reported the results of studies to explore the scope and 
limitations of EPL. With the above-mentioned protocol only 5 % of a similar VMA 
precursor had been cleaved after refolding81.  
A publication by Sydor et al.129 described the first successful renaturation of the Gyr A 
intein in fusion with green fluorescent protein N-extein from inclusion bodies. Their 
protocol used a 1:10 dilution of the solubilised inclusion bodies in buffer containing 6 M 
guanidine hydrochloride and DTT with a buffer containing 4 M urea followed by 
removing residual guanidine hydrochloride by dialysis against the chaotrope-free 
dilution buffer. An EPL reaction was subsequently performed under these denaturing 
conditions.  
In the same year Muir and co-workers described the refolding of a fusion protein of the 
potassium channel KcsA and the MxeCBD intein by a simple dialysis step against 
chaotrope-free buffer. They started with a solution of the KcsAMxeCBD protein in 
buffer containing 6 M guanidine hydrochloride without any reducing agent.  
All these experiments reported in literature and in this work show that the yeast VMA 
and the bacterial Gyr A intein can be functionally refolded. Noteworthy is the fact that 
cleavage of the Mxe intein in the presence of a certain amount of urea (up to 4 M) is 
possible. However, a common protocol for the renaturation of fusion proteins 
containing the Gyr A intein does not exist; for each construct a new refolding protocol  
needs to be established. 
After successful intein cleavage and generation of a thioester derivative purification of 
the desired Htr(1-83) thioester using RP-HPLC methods failed. The target protein 
irreversibly adsorbed to the used RP-materials. Attempts with different elution buffers 
like isopropanol/acetonitrile mixtures that were successfully used for the purification of 
a semi-synthetic helix 1 from BR91, or formic acid/isopropanol mixtures that allowed 
the purification of a synthetic F1F0 synthetase subunit C, remained unsuccessful.  
Therefore an in-situ ligation strategy without intermediate thioester isolation was 
developed. The cleavage of the HtrMxeCBD fusion protein was initiated in the presence 
of the isotope labelled C-terminal transducer segment by the addition of MESNA. 
Cleavage and ligation were done in a one-pot reaction.  
In the literature many examples have been described using this strategy81,110,130-132, 
however, in most cases a huge excess of the synthetic peptide is used. Since the amount 
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of isotope labelled peptide including an N-terminal cysteine residue was a limiting factor 
in this work, a reaction stoichiometry of 1:1 was chosen. While with HtrMxeCBD 
fusion protein isolated from E.coli membranes product formation was observed under 
these conditions, the strategy failed for the refolded HtrMxeCBD.  
Although this reaction was done in the presence of 2 M urea as denaturant, which is 
reported to enhance ligation rates by destabilising secondary structures and therefore 
improving the accessibility of the thioester moiety for the attacking cysteine residue, no 
ligation product was found. Even an increase of the concentration of the chaotrope to 
6 M guanidine hydrochloride, after a successful generation of the Htr-thioester did not 
lead to a successful ligation reaction. 
Hunter and Kochendoerfer91 report a possible shielding effect of detergent molecules 
that has been observed which prevents the ligation reactions of hydrophobic peptides. 
However this effect alone cannot be the reason for the unsuccessful ligation reaction, 
since the reaction with the membrane isolated intein precursor was not prevented due to 
the presence of DDM as detergent.  
This suggests an additional factor preventing the ligation reaction using refolded Htr 
thioester. Dawson and co-workers report that the self-assembly of two peptide 
fragments of the chymotrypsin inhibitor 2 enhanced their ligation rate due to the close 
proximity of the respective termini133. This conformational assistance had a bigger 
influence on the ligation rate than the presence of denaturants in the ligation mixture.  
If a favourable thioester conformation enhances ligation reactions, it is reasonable to 
assume that an unfavourable thioester conformation would inhibit the ligation reaction. 
In combination with the shielding effect of DDM detergent, an unfavourable 
conformation of the Htr-thioester with an inaccessible C-terminus, in which the 
refolded thioester species was trapped during the refolding process, may have prevented 
the ligation reaction of the transducer fragments.  
In order to avoid DDM as a detergent, expressed protein ligation of the refolded Htr-
thioester was performed in a lipidic cubic phase environment. The successful product 
formation supports the postulated conformational hindrance of the ligation reaction in 
the presence of detergent and chaotropes. In contrast to the chaotropes used, the 
incorporation of the Htr-thioester into the bilayer of the lipidic cubic phase managed to 
facilitate the accessibility of the C-terminal thioester moiety for the isotope labelled 
transducer fragment. The key feature of this approach that was recently reported by 
Kochendoerfer and co-workers91, is the reconstitution of the membrane polypeptide 
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into the lipidic cubic phase, which consists of a lipid bilayer and two aqueous channels 
that are both topologically unbounded, giving the aqueous phase access to both sides of 
an infinite lipid bilayer134.  
In this work the lipidic cubic phase concept was a useful tool to facilitate the chemical 
ligation reaction of the archeabacterial transducer. Nevertheless it remains unclear, if the 
lipidic cubic phase serves as a “solvent” that successfully prevents the precipitation of 
hydrophobic peptides as proposed by Kochendoerfer and co-workers, or if it acts as a 
“lipochaperone” that facilitates correct folding of α-helical peptides spanning the entire 
lipid bilayer.  
 
Semi-synthetic access to the domain specific isotope labelled archeabacterial transducer 
in a C-terminally truncated variant is a successful extension of the segmental isotope 
labelling concept to the field of membrane proteins utilising the expressed protein 
ligation. The formation of the desired product was observed using either a membrane 
isolated HtrMxeCBD intein precursor or the respective protein refolded from insoluble 
inclusion bodies.  
For the purification protocols of the products derived under two different reaction 
conditions, with and without lipidic cubic phase, different crucial points had to be 
considered: During the purification of the product derived from the membrane isolated 
HtrMxeCBD intein precursor, the observed full-length Htr114 had to separated from 
the N-terminally degraded by-product, the purification protocol of the lipidic cubic 
phase product required the successful solubilisation of the reaction product from the 
bilayer environment.  
In both cases a RP-HPLC assisted purification was not successful due to irreversible 
adsorption of the membrane proteins to the reversed phase used.  
Although the separation of unligated peptide, the Htr-thioester and the uncleaved intein 
precursor from the full-length and the degraded product, which were observed in 
reactions without lipidic cubic phase, was successfully carried out using DEAE anion 
exchange chromatography, a quantitative separation of both ligation products failed. 
However, the main part of the N-terminally degraded transducer by-product was 
removed.  
The extension of the anion exchange chromatography to the transducer derived from 
reactions in lipidic cubic phase  was not achieved due to insufficient solubilisation of the 
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protein from the lipids. Here a careful optimisation of the protocol has to be done in 
near future. 
 
Besides ligation and purification of semi-synthetic or synthetic proteins, their successful 
refolding is an important step on the way to a functional protein. Numerous examples 
of functionally refolded synthetic or semi-synthetic soluble protein are reported110,135. 
However, membrane protein folding remains a challenging task108.  
In experiments of this work using blue native gel electrophoresis to investigate the 
ability of the semi-synthetic transducer to bind to the SRII receptor, no complex 
formation was observed. After reconstitution of the misfolded semi-synthetic Htr into 
purple membrane lipids from H.salinarum, the transducer was able to bind to the 
receptor.  
Further BN-PAGE experiments revealed a refolding efficiency of around 20 %. This 
efficiency is similar to the one observed for the semi-synthetic potassium channel 
KcsA112. Muir and co-workers were able to refold the ligated monomer with an 
estimated efficiency of 30 % into the functional tetrameric from. Their refolding 
protocol included a reconstitution step of the membrane protein as well; in this case 
from SDS containing buffer into soybean lipid vesicles.  
Sanders and co-workers published a study concerning the reconstitutive refolding of the 
integral membrane protein diacylglycerol kinase, which is found in the cytoplasmic 
membrane of many bacteria92. Their method for successful refolding of 65 single-
cysteine mutants of DAGK is based on reconstituting the proteins into POPC vesicles.  
All these in-vitro refolding investigations revealed the important role that membrane 
lipids play in the folding process of membrane proteins. Biophysical studies on model 
systems, like bacteriorhodopsin, are beginning to provide a sound physical basis for 
membrane protein folding.  
For the folding of α-helical membrane proteins, like the semi-synthetic transducer or 
the potassium channel, a two-stage model has been proposed that breaks  the processes 
down to two key stages136. In the first stage, individually stable transmembrane α-helices 
form and in a second, these helices pack to form a functional protein.  
For bacteriorhodopsin as a model system a rate-limiting folding step has been identified 
that results in the key folding intermediate to which retinal binds137. Surprisingly, a slow 
formation of α−helices has been observed during this rate-limiting step138. It was 
proposed that this helix formation reflects the apparently slow folding of the ends of the 
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transmembrane α-helices following the formation of a helical bundle consisting of only 
the central regions of the α-helices within the hydrophobic bilayer interior. This model 
indicates that only these central helical segments are independently stable enough to fold 
according to the two-stage model. In the second stage the lipid bilayer seems to be 
necessary for the final folding events of α−helix formation139.  
The consideration of these results suggests a plausible model of the receptor binding 
behaviour of the ligated transducer: Folding intermediates of the semi-synthetic Htr 
consisting of the stable central α-helical regions of TM1 and TM2, may be trapped by 
the interaction with detergent micelles. At this stage the transducer would not be able to 
bind the receptor. Upon the interaction with the purple membrane bilayer the protein 
may be able to undergo conformational changes leading to the properly folded integral 
membrane protein. The lipidic cubic phase environment could play a similar role during 
the ligation reaction with the refolded intein precursor.  
In this context it will be an interesting result, if the semi-synthetic transducer isolated 
from the lipidic cubic phase will be able to bind the SRII without an additional 
reconstitution step of the protein into purple membrane lipids. Such a result could help 
to understand the chaperone like role of lipids as an important structure-forming 
environment140. 
 
The presented work demonstrates the feasibility of expressed protein ligation for 
domain specific isotope labelling of membrane proteins. The results are an extension of 
the work of Nakamura and Muir, who established methods for segmental isotope 
labelling of soluble proteins based on either trans-splicing102-104 or expressed protein 
ligation105,106. The results presented here may help to circumvent the limits of spectral 
resolution of solid state NMR or may assist signal assignment in FTIR spectroscopy 
supporting structural investigations of integral membrane proteins. 
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4.3 Investigations of the SRII/HtrII complex using NMR and FTIR 
 
An important step in understanding the structural basis of signal transduction in 
archeabacterial phototaxis was the determination of the crystal structure of sensory 
rhodopsin II alone36,37 and co-crystallized with a truncated transducer variant comprising 
the two transmembrane helices TM1 and TM2 and a short, 30 amino acids long,  part of 
the cytoplasmic linker domain9. 
The obtained structure shows a tight packing of the receptor helices F, G and the 
transducer helices TM1 and TM2 within the membrane. The observation that the SRII 
activation causes an outward movement of helix F 19,20 resulting in a rotation of 
transducer helix TM2.  
Time-resolved EPR experiments revealed a synchronisation of the outward movement 
of helix F and the rotation of TM221. These synchronised movements occur during the 
UV spectroscopically silent M1→M2 transition13. Hein et al.141 were able to distinguish 
between these two M states by static and time-resolved step-scan FTIR spectroscopy. 
Both states exhibited the characteristic signal at 1764 cm-1 of the protonated counter-ion 
Asp75 of the Schiff base, however, the second M state differed in the observed amide 
I/II signal amplitudes.  
In this work the influence of complex formation on the receptor in combination with 
two C-terminally truncated transducer variants, Htr(1-114) and Htr(1-157), was 
investigated using static and time-resolved rapid scan FTIR methods. The spectra of a 
mixture of M and O state of the complex, so obtained were surprisingly similar to the 
receptor reference spectrum.  Only alterations of the C=O signal of Asp75 and of the 
amide I region indicated complex formation and can be interpreted as distortions of the 
protein backbone of the complex partners upon transducer binding. No explanations  
for the rotary movement of the transducer helix TM2 were found.  As well Kandori and 
co-workers100 did not find any hints for such a movement in their previous FTIR 
studies.  
In addition, no changes of the difference FTIR spectra of the early K142 or the signalling 
M state with isotope labelled, truncated transducers in complex with unlabelled 
receptors were observed. The absence of transducer signals suggests that the Htr 
constructs may have either unstructured C-termini that show no backbone motion as a 
response to the transmembrane activation, or that the rotation of the transducer helix 
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TM2 induces “rigid body” movements of complete secondary structure elements 
without significant distortions of the protein backbone.  
In this context the observation of a spectral downshift of the vibrational bands of 
Htr(1-114) respectively Htr(1-157) at 1693 cm-1 in complex with uniformly isotope 
labelled SRII due to the formation of the signalling M-state, is interesting. The 
frequency of these bands is characteristic for either a C=O stretching vibration of an 
asparagine or glutamine residue, respectively or an amide I vibration of the transducer 
backbone. 
Kandori and co-workers suggested an assignment of these two bands to Asn74 of the 
transducer100. The X-ray structure of the complex9 showed that this residue forms a 
hydrogen bond with Tyr199 of the SRII in the middle of the membrane. An N74T 
point mutation in Htr(1-159) caused the disappearance of these bands. From this fact it 
was concluded that not an amide I vibration of the transducer backbone but Asn74 was 
the origin of the signal.  
However, taking the measurements with the different transducer constructs into 
account, it cannot be explained, why Asn74 showed such different signal amplitudes in 
the spectra obtained, as similar amplitudes for both variants were expected.  
The data published by Furutani et al.100 does not exclude the disappearance of the 
observed bands due to a distortion of the protein backbone upon introduction of a 
point mutation. The exchange of the hydrogen bond acceptor asparagine by the donor 
threonine, accompanied by the loss of the hydrogen bond with Tyr199 of the receptor, 
may cause conformational changes in the transducer. These conformational changes 
possibly will influence the FTIR spectrum, however, they do not cause the dissociation 
of the complex100.  
At the moment it remains unclear, why the observed spectral shift of the 1693 cm-1 
band exhibits significantly increased amplitudes for the longer transducer Htr(1-157). In 
this context secondary structure predictions for the transducer may help to address this 
question. The cytoplasmic linker domain of the transducer contains two so-called 
heptad repeats a-b-c-d-e-f-g with hydrophobic side chains at positions a and d indicating 
the presence of two amphiphatic helices comprising amino acids 83-101 and 115-131 
connected by an unstructured loop region. These amphiphatic helices 1 and 2 are 
predicted to form a coiled-coil structure.  
The truncation of the shorter transducer variant Htr(1-114) after amino acid residue 
Glu114 that was performed by Hippler et al.62 in order to identify a putative receptor-
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binding site, removed the complete amphiphatic helix 2. Its absence may possibly lead 
to the loss of the predicted coiled-coil structure that could serve as a kind of “anchor” 
that stabilises the HAMP domain structure in the cytoplasm. These structural 
differences may be reflected by the differences observed in the amplitude of the 
negative band at 1693 cm-1 and the positive band at 1682 cm-1 in the amide I region of 
the isotope labelled SRII in complex with either Htr(1-157) or Htr(1-114).  
While the predicted loop between both amphiphatic helices may be C-terminally fixed 
in the longer transducer variant by the predicted coiled coil, the unfixed and 
unstructured loop in the shorter Htr(1-114) variant will possibly exhibit a very high 
mobility.  
This is in good agreement with the MAS ssNMR data obtained, of the complex 
comprising an unlabelled SRII and an uniformly isotope labelled Htr(1-114) presented 
in this study. They suggest unstructured random coil regions at both N- and C-terminus, 
which turn into more rigid, structured regions as more residues come close to the 
membrane spanning helices TM1 and TM2.  
While the C-terminus of Htr(1-114) seems to be unstructured, MAS ssNMR 
experiments reported by Saito and co-workers143 suggest a more structured cytoplasmic 
domain of the longer Htr variant. In dipolar decoupled MAS experiments with a [3-13C] 
Ala and [1-13C] Val labelled truncated transducer Htr(1-159) complexed with SRII they 
observed two kinds of 13C NMR signals. One of these resonances, a low-field α-helical 
peak (αII-helix), was identified as a cytoplasmic α-helix protruding from the bilayer. The 
other resonance was the high-field α-helical peak (αI-helix) of the transmembrane 
helices.  
The first signal was almost completely suppressed in cross-polarization MAS 
experiments indicating a higher structural mobility of the cytoplasmic helices compared 
to the more rigid transmembrane helices.  
In summary the discussed FTIR spectroscopic results revealed a different receptor 
binding behaviour of the Htr(1-114), a minimal model for the transmembrane SRII 
binding domain of the transducer protein, compared to Htr(1-157) including a predicted 
cytoplasmic coiled-coil structure. It will be of interest in further NMR and FTIR 
experiments, which information about the nature of the HAMP domain can be obtained 
from experiments with these constructs.  
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The differences observed in the FTIR data of the short transducer compared to the long 
transducer lead to the question about the importance of the amino acid residues 83-114 
for the binding of the transducer to the receptor. Calorimetric60 and 
electrophysiological96 methods showed that the Htr(1-114) variant is in contrast to 
Htr(1-101) able to bind to the SRII receptor suggesting an direct interaction of the 
amino acids Gly101 to Glu114.  
The calorimetric investigations reported in this work suggest a direct interaction of  
SRII with the peptide comprising the amino acid residues Gly84 to Arg113. The 
dissociation constant of this interaction was determined to be 240 nM at 22 °C with a 
binding heat of –4.6 kJ/mole. Interestingly, the observed binding constant was similar 
to the one observed for the corresponding truncated Htr(1-114) transducer variant 
comprising both transmembrane helices (KD=230 nM)60. This result comes as a surprise, 
because the van-der-Waals interactions that were observed in the transmembrane 
receptor-transducer binding interface9 are expected to contribute to the receptor binding 
process. However, these interactions were not reflected by an alteration of the observed 
binding constant. 
Taking into account the NMR and CD spectroscopic evaluations of the peptide, which 
show a predominantly random coil conformation with weak α-helical tendencies, the  
interaction with the receptor has to initiate a folding process of the peptide that 
subsequently facilitates the interaction of the folded peptide with the receptor. 
However, the observed binding curve or the binding constant did not indicate such a 
folding process.   
Kamo and co-workers reported hints for a folding event in investigations with a isotope 
labelled peptide comprising amino acid residues Gly83 to Gln14967. They compared the 
1H,15N 2D HSQC spectra of the peptide in absence/ presence of SRII and concluded a 
secondary structure formation in the peptide from line broadening and spectral shifts 
upon addition of the receptor. However, the observed signal dispersion of 
approximately 0.5 ppm in the 1H dimension, which is comparable to the one found in 
this work for the short peptide, indicates random coil conformations even in the 
presence of the receptor contradicting a folding event of the peptide.  
In summary, although the peptide comprising Gly83 to Arg113 was shown to interact 
with the SRII receptor exhibiting a similar dissociation constant as was observed for 
truncated transducer constructs Htr(1-114) and Htr(1-157), it remains unclear, why this 
amino acid stretch is an important binding determinant.  
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EPR experiments with the truncated transducer Htr(1-157) can provide important hints 
to answering this question. These measurements revealed a low spin label mobility for 
site-directed spin labelled cysteine mutants for the amino acid residues up to Ala94 and 
starting with Ala95, a very high spin label mobility (Klare,J.P., unpublished data).  
These data suggest a structured amino acid stretch following the transmembrane helix 2 
up to residue Ala95. The presence of the flexible unstructured loop region that normally 
links two amphiphatic helices, at the C-terminus in the short Htr(1-114) construct may 
prevent the structured amino acid stretch Gly83-Ala95 from unfolding. Removing this 
flexible loop, as in the Htr(1-101) variant, disturbs the folding of the structured stretch 
following TM2 and leads to the loss of the ability to bind to the receptor.  
According to these arguments the amino acid stretch Gly101 to Glu114 would be no 
classical receptor-binding domain that supports the receptor binding with specific 
interactions between both binding partners. Rather its presence may prevent unfolding 
of the amino acid cluster Gly83-Ala95, which seems to be a very important receptor-
binding determinant.  
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5. Summary 
 
Crystallographic studies of the photophobic receptor-transducer-complex from 
N.pharaonis9 yielded insights into the structural and functional organisation of the 
transmembrane domains of the complex components. However, they did not provide 
information about the structure of the C-terminal cytoplasmic domain of the transducer 
that is thought to play an important role in receptor binding and signal propagation.  
In order to elucidate the structure of the cytoplasmic domain of a C-terminally 
truncated Htr(1-114) construct, magic angle spinning solid state NMR (MAS ssNMR) 
spectroscopy was applied. To circumvent the limits of the spectral resolution of MAS 
ssNMR, a semi-synthetic access to a domain-specific isotope labelled HtrII protein 
based on expressed protein ligation was introduced. 
In a first step the generation of an isotope labelled peptide building block with an N-
terminal cysteine comprising the cytoplasmic part 84-114 of the transducer was 
established. This peptide was C-terminally fused to a glutathion-S-transferase leading 
sequence linked by a TEV protease recognition site. After expression in isotope 
enriched minimal medium, a TEV protease digest liberated the desired isotope labelled 
C-terminal segment. 
The N-terminal transmembrane segment comprising residues 1-83 of the transducer 
was fused to the N-terminus of the MxeCBD mini-intein. The resulting HtrMxeCBD 
fusion protein was expressed in E.coli. Ni-NTA purification of target protein solubilised 
from the bacterial membrane revealed the presence of an N-terminally degraded 
HtrMxeCBD form in addition to the target protein. 
Since this degraded intein species showed full intein cleavage activity, in ligation 
reactions an N-terminally degraded by-product besides the desired target product was 
observed. A complete separation of the desired semi-synthetic transducer from the 
degraded by-product or a separation of the target intein precursor protein from the 
degraded one could not be achieved even by different chromatographic methods.  
The ability of product so obtained to form a complex with its cognate receptor was 
investigated in blue-native electrophoresis experiments. After a reconstitution into 
purple membrane lipids, complex formation of the semi-synthetic transducer was 
observed indicating that the membrane bilayer contributes to the correct folding of the 
semi-synthetic protein. 
Analysis of HtrMxeCBD protein partitioning revealed that the desired not degraded 
intein precursor protein was deposited predominantly in inclusion bodies. After 
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successful refolding of the protein, the formation of the desired semi-synthetic product 
without an N-terminally degraded by-product was observed in ligation reactions in 
lipidic cubic phase environment. However, a purification protocol including an effective 
solubilisation of the target protein from the lipidic cubic phase has yet to optimised. 
In addition to the establishment of a semi-synthetic access to domain specific isotope 
labelled Htr(1-114), uniformly isotope labelled transducer constructs were expressed in 
E.coli. The spectroscopic analysis of uniformly labelled Htr(1-114) in complex with 
unlabelled SRII receptor using magic angle solid state NMR revealed unstructured 
random coil regions at both N- and C-terminus of the Htr-construct, which turn into 
more rigid, structured regions the more the residues come close to the membrane 
spanning helices TM1 and TM2.   
The influence of SRII/HtrII complex formation on the structure of the receptor in 
combination with two C-terminally truncated transducer variants, Htr(1-114) and 
Htr(1-157), was investigated using static and time-resolved rapid scan FTIR methods. 
The observed spectra showed alterations of the C=O signal of Asp75 of the receptor 
and of the amide I region with increased signal amplitudes for the Htr(1-157) construct 
indicating complex formation. No changes in the difference spectrum of the signalling 
M state of both labelled transducer constructs in complex with unlabelled receptors 
were observed. In contrast to this, isotope labelling of the SRII receptor led to the 
observation of a spectral downshift of vibrational bands of unlabelled Htr(1-114) and 
Htr(1-157) at 1693 cm-1 due to the formation of the M-state. Again an increased signal 
amplitude for the Htr(1-157) construct was observed. 
These observations led to the question about the importance of the amino acid cluster 
83-114 for SRII-binding. ITC experiments with a peptide comprising amino acids Gly84 
to Arg113, which was found to be predominantly random coiled with α-helical 
tendencies in NMR- and CD-experiments, revealed an interaction with SRII 
characterised by a KD of 240 nM at 22 °C and a binding heat of -4.6 kJ/mole. The 
observed binding constant was similar to the one observed for a Htr(1-114) transducer 
construct (KD=230 nM)60. 
The method of domain specific isotope labelling of proteins using expressed protein 
ligation was extended in this work to the field of membrane proteins. With the C-
terminally truncated transducer Htr(1-114) as an example, a semi-synthetic strategy was 
introduced that may contribute to provide detailed insights into the phototactic signal 
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transduction process of N.pharaonis on atomic level in further MAS ssNMR and FTIR 
investigations. 
 
 
5. Summary (german) 
 
Kristallographische Untersuchungen des phototaktischen Rezeptor-Transducer-
Komplexes aus N.pharaonis9 ergaben Einblicke in die strukturelle und funktionelle 
Organisation der transmembranen Domänen der Komplexkomponenten. Jedoch 
konnten keine Information über die Struktur der zytoplasmatischen Domäne des 
Transducers erhalten werden, die eine wichtige Rolle im Prozess der Rezeptorbindung 
und der Signalweiterleitung spielt60.  
Magic angle spinning Festkörper-NMR (MAS ssNMR) Spektroskopie wurde zur 
strukturellen Untersuchung der zytoplasmatischen Domäne eines C-terminal verkürzten 
Htr(1-114) Konstrukts angewendet. Um die Grenzen der spektralen Auflösung der 
MAS ssNMR Spektroskopie zu umgehen, wurde ein halb-synthetischer Zugang auf der 
Basis der expressed protein ligation zu einem domänenspezifisch isotopenmarkierten HtrII-
Protein vorgestellt. 
In einem ersten Syntheseschritt wurde die Erzeugung eines isotopenmarkierten Peptids 
etabliert, das die Aminosäurereste 84-114 des zytoplasmatischen Teils des Transducers 
und ein  N-terminales Cystein umfasst. Dieses Peptid wurde, verbrückt durch eine TEV 
Protease Erkennungssequenz, an den C-Terminus einer Glutathion-S-transferase-
Leitsequenz fusioniert. Nach der Expression des Fusionsproteins in 
isotopenangereichertem Minimalmedium setzte ein Verdau mit TEV-Protease das 
gewünschte isotopenmarkierte C-terminale Segment frei. 
Das N-terminale, transmembrane Segment, das die Reste 1-83 des Transducers 
umfasste, wurde an den N-Terminus des MxeCBD Mini-Inteins fusioniert.  Das 
erhaltene HtrMxeCBD Fusionsprotein wurde in E.coli exprimiert. Eine Ni-NTA 
Aufreinigung des Zielproteins, das aus der bakteriellen Membran solubilisiert wurde,  
offenbarte die Gegenwart einer N-terminal degradierten Form des HtrMxeCBD 
Proteins.  
Diese Inteinspezies zeigte jedoch volle Intein-Spaltaktivität, weshalb in 
Ligationsreaktionen ein N-terminal degradiertes Nebenprodukt zum gewünschten 
Zielprodukt beobachtet wurde. Eine vollständige Abtrennung des halb-synthetischen 
Transducers oder eine  Trennung des gewünschten Inteinvorläufers vom degradierten  
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Fusionsprotein konnte unter Verwendung unterschiedlicher chromatographischer 
Methoden nicht erreicht werden. 
Die Fähigkeit des so erhaltenen Produkts zur Bindung des SRII-Rezeptor, wurde in 
Experimenten mit Blau-nativer Gelelektrophorese untersucht. Eine Komplexbildung 
des halb-synthetischen Transducers konnte erst nach dessen Rekonstitution in Lipide 
aus Purpurmembran beobachtet werden. Dies deutet an, dass die 
Membrandoppelschicht zur korrekten Faltung des halb-synthetischen Proteins beiträgt.  
Die Analyse der Verteilung des HtrMxeCBD Proteins ergab, dass nicht degradiertes 
Vorläuferprotein in Form von inclusion bodies vorlag. Nach erfolgreicher Faltung des auf 
diese Weise gewonnenen Proteins konnte in Ligationsreaktionen in kubischen 
Lipidphasen die Bildung des gewünschten halb-synthetischen Produkts ohne ein N-
terminal degradiertes Nebenprodukt nachgewiesen werden. Die Optimierung eines 
Protokoll zur Produkt-Aufreinigung, das einen Schritt zur effektiven Solubilisierung des 
Zielproteins von der kubischen Lipidphase beinhalten muss, steht aus.  
Zusätzlich zur Etablierung eines halb-synthetischen Zugangs zu domänenspezifisch 
isotopenmarkiertem Htr(1-114), wurden vollständig isotopenmarkierte Transducer-
Konstrukte in E.coli exprimiert. Die MAS ssNMR spektroskopische Untersuchung eines 
Komplexes aus vollständig markiertem Htr(1-114) und unmarkiertem SRII-Rezeptor 
ergab unstrukturierte Zufallsknäuelstrukturen an beiden Enden des Htr-Konstruktes, 
die zu strukturierten Regionen übergehen, je mehr sie sich den Helices TM1 und TM2 
nähern.  
Der Einfluss der SRII/HtrII-Komplexbildung auf die Struktur des Rezeptors in 
Kombination mit zwei C-terminal verkürzten Transducer-Varianten, Htr(1-114) und 
Htr(1-157), wurde in statischen und zeitaufgelösten rapid scan FTIR Experimenten 
untersucht. Die erhaltenen Spektren zeigten durch die Komplexbildung hervorgerufene 
Änderungen des C=O Signals von Asp75 des Rezeptors und Änderungen in der Amid-I 
Region mit größeren Signalamplituden für das Htr(1-157)-Konstrukt im Vergleich zur 
kürzeren Variante.  
Zwischen den Differentspektren des signalgebenden M-Zustandes beider markierten 
Transducer-Konstrukte im Komplex mit unmarkiertem Rezeptor wurden keine 
Änderungen beobachtet. Im Gegensatz dazu ermöglichte die Isotopenmarkierung des 
SRII-Rezeptors die Beobachtung einer spektralen Verschiebung von 
Schwingungsbanden des unmarkierten Htr(1-114) und des unmarkierten Htr(1-157) bei 
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1693 cm-1 aufgrund der Komplexbildung. Hier wurde ebenfalls eine größere 
Signalamplitude für das Htr(1-157)-Konstrukt beobachtet. 
Diese Beobachtung führte zur Frage nach der Wichtigkeit der Aminosäurereste 83-114 
für die Bindung des SRII-Rezeptors. ITC Experimente mit einem entsprechenden 
Peptid Gly84- Arg113, das sich in Experimenten mit NMR- und CD-Spektroskopie als 
Zufallsknäuel mit α-helicalen Tendenzen zeigte, enthüllte eine Wechselwirkung dieses 
Peptids mit dem SRII-Rezeptor, die durch ein KD von 240 nM bei 22 °C und einer 
Bindungswärme von -4.6 kJ/mol gekennzeichnet ist. Die beobachtete 
Bindungskonstante war ähnlich der, die für einen Htr(1-114) Transducer beobachtet 
wurde (KD=230 nM)60. 
Die Methode der domänenspezifischen Isotopenmarkierung von Membranproteinen 
unter Ausnutzung der expressed protein ligation wurde in dieser Arbeit auf das Arbeitsfeld 
der Membranproteine übertragen. Am Beispiel des C-terminal verkürztem Transducers 
Htr(1-114) wurde eine halb-synthetische Strategie vorgestellt, die in weiterführenden 
MAS ssNMR- und FTIR-Untersuchungen zu detaillierten Einblicke in den Prozess der 
phototaktischen Signaltransduktion in N.pharaonis auf atomarer Ebene beitragen kann.     
   
Appendices 
 132
6. Appendices 
6.1 Plasmid maps 
6.1.1 pTXB1his-htr 
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6.1.2 pGEX2T-tevhtr 
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6.2 Protein sequences 
 
GST-tevHtr 
 
MSPILGYWKI KGLVQPTRLL LEYLEEKYEE HLYERDEGDK WRNKKFELGL 
EFPNLPYYID GDVKLTQSMA IIRYIADKHN MLGGCPKERA EISMLEGAVL 
DIRYGVSRIA YSKDFETLKV DFLSKLPEML KMFEDRLCHK TYLNGDHVTH 
PDFMLYDALD VVLYMDPMCL DAFPKLVCFK KRIEAIPQID KYLKSSKYIA 
WPLQGWQATF GGGDHPPKSD LVPRGSENLY FQCDTAASLS TLAAKASRMG 
DGDLDVELET RRE 
Number of amino acids: 263 
Molecular weight: 30370.0 
Formula: C1373H2129N351O396S15 
 
 
Htr-MxeCBD 
 
MSLNVSRLLL PSRVRHSYTG KMGAVFIFVG ALTVLFGAIA YGEVTAAAAT 
GDAAAVQEAA VSAILGLIIL LGINLGLVAA TLGCITGDAL VALPEGESVR 
IADIVPGARP NSDNAIDLKV LDRHGNPVLA DRLFHSGEHP VYTVRTVEGL 
RVTGTANHPL LCLVDVAGVP TLLWKLIDEI KPGDYAVIQR SAFSVDCAGF 
ARGKPEFAPT TYTVGVPGLV RFLEAHHRDP DAQAIADELT DGRFYYAKVA 
SVTDAGVQPV YSLRVDTADH AFITNGFVSH ATGLTGIHHH HHHHSGLNSG 
LTTNPGVSAW QVNTAYTAGQ LVTYNGKTYK CLQPHTSLAG WEPSNVPALW 
QLQ 
Number of amino acids: 353 
Molecular weight: 37357.5 
Formula: C1680H2629N465O489S6 
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NpHtrII(1-114) 
 
MSLNVSRLLL PSRVRHSYTG KMGAVFIFVG ALTVLFGAIA YGEVTAAAAT 
GDAAAVQEAA VSAILGLIIL LGINLGLVAA TLGGDTAASL STLAAKASRM 
GDGDLDVELE TRRENSHHHH HHH 
Number of amino acids: 123 
Molecular weight: 12679.5 
Formula: C559H907N163O167S3 
 
 
NpHtrII(1-114) G84C 
 
MSLNVSRLLL PSRVRHSYTG KMGAVFIFVG ALTVLFGAIA YGEVTAAAAT 
GDAAAVQEAA VSAILGLIIL LGINLGLVAA TLGCDTAASL STLAAKASRM 
GDGDLDVELE TRRENSHHHH HHH 
Number of amino acids: 123 
Molecular weight: 12709.6 
Formula: C560H909N163O167S4 
 
 
NpHtrII(1-157) 
 
MAVSRLLLPS RVRHSYTGKM GAVFIFVGAL TVLFGAIAYG EVTAAAATGD 
AAAVQEAAVS AILGLIILLG INLGLVAATL GGDTAASLST LAAKASRMGD 
GDLDVELETR REDEIGDLYA AFDEMRQSVR TSLEDDAKNA EEDAEQAQKR 
AEEINTNSHH HHHHH 
Number of amino acids: 165 
Molecular weight: 17421.5 
Formula: C755H1214N220O245S4 
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NpSRII 
 
MVGLTTLFWL GAIGMLVGTL AFAWAGRDAG SGERRYYVTL VGISGIAAVA 
YVVMALGVGW VPVAERTVFA PRYIDWILTT PLIVYFLGLL AGLDSREFGI 
VITLNTVVML AGFAGAMVPG IERYALFGMG AVAFLGLVYY LVGPMTESAS 
QRSSGIKSLY VRLRNLTVIL WAIYPFIWLL GPPGVALLTP TVDVALIVYL 
DLVTKVGFGF IALDAAATLR AEHGESLAGV DTDAPAVADE NSHHHHHHH 
Number of amino acids: 249 
Molecular weight without retinal: 26645.2 
Molecular weight with retinal:      26911.6 
Formula: C1244H1922N310O325S7 
 
 
Semi-synthetic NpHtrII(1-114) G84C: 
 
MSLNVSRLLL PSRVRHSYTG KMGAVFIFVG ALTVLFGAIA YGEVTAAAAT 
GDAAAVQEAA VSAILGLIIL LGINLGLVAA TLGCDTAASL STLAAKASRM 
GDGDLDVELE TRRE 
Number of amino acids: 114 
Molecular weight: 11564.4 
Formula: C511H849N139O156S4 
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6.3 Additional material 
6.3.1 Introduction to Expressed Protein Ligation 
 
Proteins show an enormous variety of structure-function-relationships. However, they 
only consist out of 21 different building blocks, the canonical amino acids. The amino 
acid sequence of a protein determines its structure and therefore the function of the 
protein. In order to elucidate this complicate relationship, often methods of molecular 
biology are used to alter the amino acid sequence of a protein to study the observed 
effects of this alteration on the structure and the function of the mutant.  
Most methods are using the cellular synthesis apparatus of simple organisms like 
bacteria or yeasts to produce the desired mutant and therefore they are restricted in the 
choice of the amino acids to the 21 canonical amino acids. However, for many 
applications a larger variety of the amino acid composition of polypeptides would be 
desirable.  
In order to overcome this restriction Schulz and co-workers144 introduced the cell free 
synthesis of proteins to facilitate the incorporation of non-coded amino acids into 
proteins. The method applies the suppression of the amber stop codon by a chemically 
amino acylated tRNA. The codon is introduced on the DNA or the RNA level by site-
directed mutagenesis. The corresponding tRNA linked to a non-coded amino acid, 
recognizes the amber codon and this amino acid is incorporated into the desired 
protein. The Achilles’ heel of this cell free synthesis method are the observed low yields 
in combination with low loading rates of the tRNA due to the labile amino acyl bond 
between non-coded amino acid and tRNA.  
While cell free synthesis is a valuable extension to biosynthetic methods that utilise a 
biological synthesis apparatus, chemical peptide synthesis provides the complete 
freedom over the covalent structure of proteins. E. Fischer was the first to propose an 
in-solution coupling of individual amino acid building blocks for the synthesis of short 
peptides. Further development of this method facilitated the synthesis of insulin in 
1966145. Insulin consists of two short polypeptide chains connected by disulfide bonds. 
Peptide synthesis in solution is related to an enormous chemical expenditure, since the 
desired product has to be isolated after each coupling step. The introduction of solid 
phase peptide synthesis (SPPS) by Bruce Merrifield146 represents an important 
improvement in the field of chemical peptide synthesis. SPPS is based on the linkage of 
the growing peptide chain to a solid polymer support by a removable linker. This set up 
allows a purification of the desired product after each coupling step by simple filtration. 
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This method represented a breakthrough on the way to the total chemical synthesis of 
proteins. However, the accumulation of a growing amount of very similar by-products 
with increasing chain lengths complicating the isolation of the target peptide and limits 
the accessible size of polypeptides to around 60 residues147.  
An important step to overcome this limitation was the introduction of the native 
chemical ligation of peptides87. Two synthetic peptide segments are joined together by 
the thiol-mediated formation of a native peptide bond (Figure 2.1).  
A prerequisite for the ligation reaction to occur is an N-terminal peptide segment 
containing a carboxy-terminal α-thioester and a C-terminal peptide possessing an amino 
terminal cysteine residue. In a transesterfication reaction the sulfhydryl moiety of the N-
terminal cysteine attacks the carboxyl carbon atom of the thioester. Subsequently an 
S-N acyl shift that is irreversible under the chosen reaction conditions, leads to the 
formation of a native peptide bond at the ligation site.  
 
 
 
Figure 2.1. Schematic representation of the native chemical ligation. 
 
The concept of native chemical ligation has proven to be very useful for the synthesis of 
small proteins or protein domains, however it could not be extended to the synthesis of 
proteins beyond approximately 20 kDa88. One possibility to further expand the scope of 
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this method is the chemical ligation of small synthetic peptides and large recombinant 
segments.  
Although methods to generate proteins with N-terminal cysteines have been reported74, 
until the beginning 1990s no appropriate method to generate recombinant proteins 
containing C-terminal α-thioesters was established86. Protein splicing, a phenomenon of 
an intra-molecular protein rearrangement leading to the extrusion of an internal 
fragment (intein) and the ligation of the two adjacent peptide sequences, has been 
shown to form an α-thioester intermediate (figure 2.2)148.  
 
 
 
Figure 2.2. Schematic representation of the protein splicing mechanism. 
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Mechanistically the cleavage event is initiated by an N-S(O) acyl shift at the N-terminus 
of the intein which has to contain a cysteine, serine or threonine residue for this 
purposes84. The fold of the intein brings the exteins close together and enables a 
transesterfication reaction leading to a branched intermediate149 with two free N-
terminal amino moieties. The subsequent release of the intein by asparagine cyclisation 
leaves the N-extein attached to the side chain of the attacking cysteine of the C-extein 
(or Ser, Thr) via an (thio) ester bond, which is resolved by a spontaneous S(O)-N acyl 
rearrangement resulting a native peptide bond.  
Intein mutants with C-terminal asparagines replaced by other amino acids like alanine 
have been shown to be defective in accomplishing the complete splice procedure but to 
be still capable of the initial α-thioester formation. This intermediate can be trapped by 
thiols and subsequently used reactions called expressed protein ligation (EPL) or intein 
mediated ligation (IML) (figure 2.3), which are analogue to the native chemical ligation 
reaction.  
 
 
 
Figure 2.3. Expressed protein ligation. The commercially available pTXB45 vectors for 
high-level protein expression of the short GyrA intein from Mycobacterium 
xenopi (Mxe-intein) in E.coli fused to a chitin binding domain facilitate the 
generation of the desired target protein containing a C-terminal α-thioester.  
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6.3.1 Introduction to Nuclear Magnetic Resonance Spectroscopy (NMR) 
 
The phenomenon of nuclear magnetic resonance is based on the interaction of the 
magnetic momentum µ of a nucleus with an external magnetic field of strength B. The 
magnetic momentum and is proportional to the angular momentum J: 
( )1+=⇒= IIJ hγµγµ  
The constant of proportionality γ is called gyromagnetic ratio and is a characteristic for 
each nucleus. The angular momentum orientates itself in the external magnetic field in 
that way as the vector component is parallel to the field. Jz is a whole- or half-numbered 
multiple of Planck’s  constant: 
hh γµ mmJ zz =⇒=  
whereas the magnetic quantum number m can be –I, -I+1, …, +I. The external 
magnetic field splits up the energy levels of the nucleus. The energy E of these levels 
can be classically described by the formula of a magnetic dipole in a homogenous 
magnet field of strength B: 
BmBE z hγµ −=−=  
When a group of spins is placed in a magnetic field, each spin aligns in one of the two 
possible orientations. At room temperature, the number of spins in the lower energy 
level, N+, slightly outnumbers the number in the upper level, N-. Boltzmann statistics 
describes the ratio of both  as: 
kT
E
e
N
N −
+
−
=  
The signal in NMR spectroscopy results from the difference between the energy 
absorbed by the spins which make a transition from the lower energy state to the higher 
energy state, and the energy emitted by the spins which simultaneously make a transition 
from the higher energy state to the lower energy state. The signal is thus proportional to 
the population difference between the states. At any instant in time, a magnetization 
vector can represent the magnetic field due to the spins. The size of each vector is 
proportional to (N+ - N-). The vector sum of the magnetization vectors from all spins 
is the net magnetization. At equilibrium, the net magnetization vector lies along the 
direction of the applied magnetic field B and is called the equilibrium magnetization Mo. 
In this configuration, the Z component of magnetization MZ equals Mo. MZ is referred 
to as the longitudinal magnetization. There is no transverse (MX or MY) magnetization 
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here. It is possible to change the net magnetization by exposing the nuclear spin system 
to energy of a frequency equal to the energy difference between the spin states. If 
enough energy is put into the system, it is possible to saturate the spin system and make 
MZ=0. The time constant, which describes how MZ returns to its equilibrium value, is 
called the spin lattice relaxation time (T1). The equation governing this behaviour as a 
function of the time t after its displacement is:  




−=
−
110
T
t
z eMM  
If the net magnetization is placed in the XY plane it will rotate about the Z-axis at a 
frequency equal to the frequency of the photon, which would cause a transition between 
the two energy levels of the spin. This frequency is called the Larmor frequency ω0, 
which corresponds to the resonance frequency of the spins and therefore to the 
transition frequency between the energy levels: 
BhEB γωωνγ =⇒==∆= 00hh  
In addition to the rotation, the net magnetization starts to dephase because each of the 
spin making it up is experiencing a slightly different magnetic field and rotates at its own 
Larmor frequency. The time constant, which describes the return to equilibrium of the 
transverse magnetization, MXY, is called the spin-spin relaxation time, T2.  T2 is always 
less than or equal to T1. The net magnetization in the XY plane goes to zero and then 
the longitudinal magnetization grows in until Mo is along Z.  It is convenient to define a 
rotating frame of reference (X’,Y’,Z) that rotates about the Z-axis at the Larmor 
frequency. A magnetization vector rotating at the Larmor frequency in the laboratory 
frame appears stationary in a frame of reference rotating about the Z-axis. A coil of wire 
placed around the X-axis will provide a magnetic field along the X-axis when a 
alternating current is passed through the coil. In a frame of reference rotating about the 
Z axis at a frequency equal to that of the alternating current, the magnetic field along the 
X' axis will be constant. In magnetic resonance, the magnetic field created by the coil 
passing an alternating current at the Larmor frequency is called the B1 magnetic field. 
When the alternating current is turned on and off, it creates a pulsed B1 magnetic field 
along the X' axis.  
The spins respond to this pulse in such a way as to cause the net magnetization vector 
to rotate about the direction of the applied B1 field inducting a voltage in a detector coil, 
which is registered. The rotation angle depends on the length of time the field is on, ,  
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and its magnitude B1 
θ=2πγτB1 
A 90 ° pulse is one which rotates the magnetization vector clockwise by 90 degrees 
about the X' axis and rotates the equilibrium magnetization down to the Y' axis. After a 
90° pulse the free induction decays (FID) in time due to T2 relaxation processes. The 
time-resolved signal  is a superposition of all exited frequencies and is converted from 
time to frequency domain by Fourier transformation (FT).  
In a molecule the electrons surrounding the nuclei produce themselves a weak magnetic 
field and insulate therefore the nucleus marginally from the external field. As a result the 
Lamor frequencies of the nuclei differ due to different chemical environments. This 
effect is called chemical shift. Nuclei experiencing the same chemical environment or 
chemical shift are called equivalent. Nuclei, which are close to one another, exert an 
influence on each other's effective magnetic field. If the distance between two non-
equivalent nuclei A and B is less than or equal to three bond lengths, this effect is 
observable and called spin-spin coupling or J coupling. For two nuclei, A and B, three 
bonds away from one another in a molecule the spin of each nucleus can be either 
aligned with the external field or opposed to the external. The magnetic field at nucleus 
A will be either greater than Bo or less than Bo by a constant amount due to the 
influence of nucleus B. In NMR, only transitions between these states are allowed where 
the spin of one nucleus changes from spin up to spin down, or spin down to spin up. 
Absorptions of energy where two or more nuclei change spin at the same time are 
forbidden. Therefore two absorption frequencies for the nucleus A and two for the B 
nucleus can be observed centred on A and B, respectively The distance between two 
split absorption lines is called the J coupling constant or the spin-spin splitting constant 
and is a measure of the magnetic interaction between two nuclei. The coupling constant 
is depending on the strength of the external magnetic field and of the torsion angle 
between the two nuclei. Therefore coupling constants contain structural information 
and especially the torsion angle φ of the protein backbone can be determined by means 
of 3J(HN-Hα) coupling constants. 
The interpretation of a 1D NMR spectrum of more complex molecules becomes more 
or less impossible due to signal overlapping. This restriction can be overcome by the 
introduction of a second spectral dimension. In a 2D NMR experiment after a first 90 ° 
pulse the spins start to depahse. After an evolution time (t1) the magnetization is 
transferred with a second pulse to an other nucleus. Finally the FID of the transferred 
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magnetization is recorded as a function of time (t2). In the consecutive 1D experiments 
of a 2D experiment the evolution time is stepwise varied. Therefore the indirect time 
domain is screened. This data is Fourier transformed first in the t2 direction to give a set 
of one-dimensional spectra modulated in t1, the δ2 dimension. A second Fourier 
transformation in the t1 direction gives a δ1 dimension.  
In NMR structure determination three kinds of homo-nuclear 2D experiments become 
more and more important: 2D-COSY, 2D-TOCSY and 2D-NOESY. The 2D-COSY 
(Correlation Spectroscopy) experiment transfers magnetization via J-coupling from one 
nucleus to the other and yields therefore structural information in form of 3J(HN-Hα) 
coupling constants. In a 2D-TOCSY experiment (Total Correlation Spectroscopy) the 
magnetization is successively transferred via J-coupling to all spin systems of a amino 
acid residue. On this basis the amino acids of a protein can be identified. Decisive for 
protein structure analysis is the NOESY experiment (Nuclear Overhauser and 
Exchange Spectroscopy). It is based on dipolar coupling of nuclear spins through space, 
the Nuclear Overhauser Effect, and is in first order reciprocal proportional to the sixth 
order of magnitude of the distance between both spins. Therefore in the spectrum spins 
are correlated, which can be are far away from each other in primary structure, however 
are close together in ternary structure. This is the most important structural information 
in NMR structure determination.  
The number of signals in a 2D-1H spectrum disproportionately  rises with rising protein 
sizes. The resulting limited  the spectral resolution can be enhanced by hetero-nuclear 
NMR experiments. Besides hydrogen a protein contains other magnetically active nuclei, 
namely 13C and 15N. However, their low natural abundance and low gyromagnetic ratios 
compared to 1H limit the spectral sensitivity. Therefore mainly two strategies are used to 
enhance the sensibility: isotopic labelling during protein expression on [15N] ammonium 
chloride and/or [13C] glucose containing minimal media and effective transfer of huge 
proton magnetization to hetero-nuclei and back. The HSQC experiment (Hetero-
nuclear Single Quantum Coherence) is the most important Experiment, which utilises 
the magnetization transfer to a heteroatom. In a 2D experiment the hetero nucleus 
frequency is correlated to the bounded proton frequency. Therefore overlapping homo-
nuclear signals can be displayed in the heteroatom dimension with improved signal 
resolution. Homologue experiments can be performed either with 15N or with 13C 
nuclei. 
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The relevance of NMR for structural biology enormously rose since the end of 1960s 
with the introduction of pulsed Fourier-Transform-NMR150 and multi-dimensional 
NMR spectroscopy151 accompanied with the development of super-induction magnets 
and computational methods. Besides X-ray crystallography and electron microscopy 
NMR spectroscopy is the only method to determine structures of proteins and nucleic 
acids on atomic level95. In addition, time-resolved investigations of intra-molecular 
dynamics, molecular recognition processes, reaction kinetics or of protein folding are 
the unique strength of NMR152-154.  
Although NMR spectroscopy based on observation of only a small number of spins 
yielded biologically relevant information on human haemoglobin155 (M=65 000 Da) as 
early as 1969, the use of NMR for de novo structure determination was limited until the 
middle 1990s to relatively small, soluble proteins (<30 000 Da). At high magnetic fields, 
typically used for studies of proteins in solution, chemical shift anisotropy interaction 
forms a significant source of relaxation in addition to dipole-dipole relaxation. This 
leads to increasing overall transverse relaxation rates, therefore to poor spectral 
resolution, and a low signal-to-noise ratio. For studies of membrane protein, the size of 
the mixed protein-detergent micelles needed to solubilize membrane proteins in water is 
beyond the limit of conventional NMR experiments. Recently the introduction of 
transverse relaxation-optimized spectroscopy (TROSY)156 at high magnetic fields, 
combined with refined isotope labelling strategies157 extended NMR studies to molecular 
sizes up to 100 kDa. As an example the structure of the integral membrane protein 
OmpX from E.coli reconstituted in 60 kDa DHPC micelles could be calculated158. 
However, a significant barrier to membrane protein research is retaining the structure 
and function of the protein during solubilization in detergents159. Some proteins are 
soluble only in one detergent species; others are soluble in many detergents, however 
are only functionally active in one of them. Therefore the structural investigation of 
membrane proteins in their native membrane environment is in the centre of scientific 
interest. In order to study solid-phase systems special NMR techniques were designed. 
In an asymmetric molecule, the chemical shift is dependent on the orientation of the 
molecule relative to the external magnetic field, thus each possible orientation has its 
own resonance frequency, leading to a broad lin width, the so-called “powder pattern” 
under static conditions. Another reason for broad spectral lines is dipolar broadening. 
The magnitude of the interaction of two spins varies with angle θ of their relative 
orientation and  is a function of (3cos2θ-1). 
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When the angle in the above term is 54.7 °, 125.3 °, 234.7 °, or 305.3 °, the dipole 
interaction vanishes and the spectral line width is narrowed to the fast tumbling limit. 
The angle 54.7 ° is called the magic angle, m. In magic angle solid-state NMR 
(MAS ssNMR) experiments samples are oriented at m with respect to the B0 magnetic 
field and spun at a rate comparable to the solid-state line width. Such conditions have, 
thus far, not permitted a widespread application of high-resolution 1H NMR, however 
they have greatly extended the possibilities to study multiply or uniformly [13C,15N] 
labelled polypeptides in high sensitivity and adequate spectral resolution101. The first 
example for which almost complete sequential resonance assignments were obtained 
providing the basis of 3D structure calculations160, was the SH3 domain of α-spectrin 
(62 residues)161. A further example is the elucidation of inter-atomic distances in an 
uniformly [13C,15N] labelled light-driven proton pump bacteriorrhodopsin (BR)162. 
Frequency-selective methods allowed distance measurements between Nε of Lys216, 
which binds the retinal chromophore via a protonated Schiff base, and the Cγ of 
surrounding aspartic acid residues. Advances in sample preparation including for 
example modular labelling and improvements in NMR hardware instrumentation could 
open up the opportunity to complete 3D characterization of larger membrane proteins. 
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